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Section one of this thesis describes a meta-ethnographic approach to the synthesis of 
24 qualitative studies exploring the experiences of stigma in adults with epilepsy across the 
globe. Five themes were generated: societal negative perceptions of epilepsy result in 
discrimination and rejection; internal attributions of blame lead to negative self-perception 
and shame; impact of stigma on everyday life and associated reliance on others; attempts to 
manage stigma through concealment and avoidance; support from others is beneficial but 
dependent on own and others’ understandings of epilepsy. The synthesis highlighted the key 
individual experiences of epilepsy stigma, which appeared to be to some degree culturally 
specific. Culturally informed misconceptions of epilepsy were readily internalised which 
resulted in emotional challenges for participants and impacted on participants’ lives. 
Section two provides an empirical report of a qualitative exploration into the 
experiences of self-disgust in adults with epilepsy. Three key themes were identified from 
analysis of the data: being an outsider, “the feeling of being a bit of a freak;” the inescapable 
presence of self-disgust, “it’s a niggling feeling that something’s not quite right” and 
preventing exposure, “living a protected life.” People with epilepsy experienced disgust in 
reaction to the physical symptoms of seizures and these disgust-based feelings appeared to 
become internalised following others’ disgust reactions. Avoidance as a strategy to manage 
self-disgust can be protective but may inadvertently maintain self-disgust. 
Section three provides a critical appraisal of the thesis. This offers a reflective account 
of the experiences of developing and conducting this research and some of the strengths and 
weaknesses of the research. The potential implications for clinical practice and future 
research are discussed, as well as personal reflections of the research process.  
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Abstract 
Objective: Stigma is reported to cause as much distress and effect on the quality of 
life of individuals with epilepsy as the physical symptoms of seizures. Existing quantitative 
reviews have focused on describing levels of stigma in epilepsy, but no qualitative review has 
been currently undertaken despite the increasing number of studies in this area. In attempt to 
understand the experiences of stigma in adults with epilepsy across different sociocultural 
contexts, this review reports the results of a qualitative synthesis.  
Methods: A systematic database search was conducted. The search strategy yielded an 
initial set of 2,877 relevant papers, of which 24 were included. A meta-synthesis was 
conducted according to the meta-ethnographic approach described by Noblit and Hare (1988) 
adapted for health research by Britten et al. (2002). 
Results: Five themes were generated: societal negative perceptions of epilepsy result 
in discrimination and rejection; internal attributions of blame lead to negative self-perception 
and shame; impact of stigma on everyday life and associated reliance on others; attempts to 
manage stigma through concealment and avoidance; support from others is beneficial but 
dependent on own and others’ understandings of epilepsy. These themes highlighted the key 
individual experiences of epilepsy stigma, which appeared to be to some degree culturally 
specific. Culturally informed misconceptions of epilepsy were readily internalised which 
resulted in emotional challenges and impacted on participants’ lives. Strategies for coping 
with this were described.  
Significance: The synthesis demonstrated the experiences of stigma in adults with 
epilepsy and highlighted some of the key similarities and differences in these experiences 
across sociocultural contexts. Educational programmes to inform communities about epilepsy 
continue to have relevance.  
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Epilepsy has recently been re-defined to aid clinical usage and understandings of the 
condition1 (see Appendix 1-A).  As such, it is understood that there are many different types 
of epileptic seizures and epilepsy is viewed as a heterogenous condition in terms of cause, 
severity and consequences.  As such, having a persistent condition characterised by an 
increased risk of experiencing unprovoked seizures has multifaceted implications for the lives 
of individuals with the condition beyond the impact of acute seizures themselves.2  Therefore, 
people with epilepsy who continue to experience seizures are more likely to report negative 
consequences of the condition than those who are seizure free.3  People with epilepsy are 
reported to experience difficulties in their lives as a result of cognitive, emotional and 
psychological factors.4  Thus, having epilepsy can impact on levels of anxiety, depression and 
self-esteem, as well as social and leisure opportunities and family functioning.5  People with 
epilepsy experience social and legal restrictions on their lives, in relation to driving6 and 
employment,7 which may have additional implications for their welfare.  
One factor which has been consistently found to be negatively associated with 
psychosocial wellbeing in people with epilepsy is stigma. Stigma may cause as much distress 
and affect the quality of life of individuals with epilepsy as the physical symptoms associated 
with the condition.8 As such, higher levels of perceived stigma have been found to correlate 
with more anxiety9 and depression5 and low self-esteem in people with epilepsy.10  
The term ‘stigma’ originated in the Greek word used to indicate the marks made on 
skin to indicate a negatively valued person within society, such as a thief or slave. More 
recently, stigma has been described as “an attitude that is deeply discrediting.”11 (p.3) 
Goffman, one of the first theorists on stigma from a sociological perspective, emphasised the 
importance of societal norms in the development of stigma.  He proposed that those who 
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deviate from these norms  are viewed as “not quite human”11 (p.5) and, therefore,  legitimate 
targets for social exclusion.  Link and Phelan12 further conceptualised stigma as a co-
occurrence of distinct components; individuals with differences are labelled as separate and 
linked to negative stereotypes, which leads to social separation and distancing, resulting in 
loss of status and discrimination.  They further argued that for stigma to exist, social power 
must be exercised.  Those who hold status are, therefore, entitled in imposing their negative 
appraisals, disapproval and rejection of socially different others.  Moreover, they argued that 
stigma would likely be a significant factor in affecting the life chances of individuals who 
experience it.  Stigmatised groups are, therefore, likely to experience difficulties in quality of 
life including social relationships, health, employment and educational outcomes.13   
Within health research, the conceptualisation of stigma has been extended to include 
anticipated stigma, along with enacted and internalized (or felt) stigma.14  Anticipated stigma 
can be understood as the degree to which individuals expect to receive discrimination or 
social rejection.  Enacted stigma is defined by the active discrimination experienced in the 
past, and internalized or felt stigma as the feelings associated with the internalisation of the 
reactions or beliefs of others.15,12  All three forms of stigma may be associated with poorer 
physical and psychological outcomes16 and may also have a deleterious impact on health 
behaviours.17 
Individuals with epilepsy are likely to have been at increased risk of experiencing 
stigma since the time when it was associated with the supernatural and contagion.18  Since the 
late 19th century, significant advances in the scientific understanding of epilepsy have been 
made.  However, misunderstandings about epilepsy and discrimination of people with the 
condition have persisted.19  Indeed, until a recent campaign for change, the wording for 
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epilepsy in China (dian xien) linked the disorder with ‘madness’ and the literal translation of 
epilepsy in Cambodia (Chhkourt chrouk) is ‘mad pig disease.’20  
Models of stigma in epilepsy have, therefore, been proposed which aim to improve 
understanding regarding stigma within this specific population.  Similar to those described in 
the wider stigma literature, these have described the experiences of discrimination and the 
internalisation of these negative interactions.21,22  However, how individuals with epilepsy 
experience stigma may differ across cultures.  More examples of enacted stigma in poorer, 
less resourced countries have been reported.23  In contrast, in a study conducted in Europe,24 
results indicated little evidence of overt discrimination, but significant levels of perceived 
stigma.24  Furthermore, the authors concluded that levels of stigma were not related to the 
frequency or severity of seizures, but that stigma may be based solely on the label of 
epilepsy.25  In keeping with this emphasis on the importance of the social construction of 
epilepsy, the authors described significant differences in levels of epilepsy stigma between 
countries.24 
Further, negative beliefs and lack of knowledge about epilepsy have even been 
described in those providing health care in some countries.26,27  In addition, evidence suggests 
that, across the globe, epilepsy continues to be misrepresented in the media.28  A study 
exploring how epilepsy is portrayed by people with and without seizures on the social media 
platform, Twitter suggested that 41% of comments were derogatory.29  As a result, 
considerable effort has been invested in improving awareness of epilepsy across the world.30  
However, despite this, recent reviews evaluating the impact of intervention studies aimed at 
reducing epilepsy stigma suggest that this remains.19, 31  
A recent review of studies investigating stigma in epilepsy, reported that quantitative 
questionnaire studies may fail to identify some more subtle forms of stigma.19  Indeed, in a 
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mixed methods review, it was concluded that adolescents did not report experiencing stigma 
on questionnaire measures but, on further exploration using qualitative methods, participants 
described keeping their epilepsy a secret.32  Therefore, qualitative studies may further uncover 
these more subtle beliefs and behaviours.  
Previous reviews have explored the qualitative literature in relation to experiences of 
stigma in children with epilepsy33 and their families.34  However, there may be distinct 
factors that influence stigma in adults with epilepsy that are not relevant to children, for 
example, the concept of marriage and employment.  One recent meta-synthesis considered 
the experiences of adults with epilepsy.35  However, the scope of the review was small, 
describing the experiences of people in particular countries (Africa, Asia, Eastern Europe and 
Latin America) and focusing on perceptions of causes and treatments for epilepsy.   
Research thus far has, therefore, highlighted the importance of stigma in the quality of 
life and lived experience of people with epilepsy.36  However, while quantitative reviews 
have offered information about this in numeric terms, these are not designed to deliver the 
sort of richly detailed description of stigma which qualitative research can offer.  In addition, 
due to the importance of socio-cultural factors in the experience of stigma in individuals with 
epilepsy, individual qualitative studies in this area and meta-syntheses so far have been 
limited by the setting and group of patients they have recruited.  A meta-synthesis of 
qualitative studies in adults with epilepsy across cultures, therefore, provides a means of 
seeking and highlighting themes which come out across different studies and which may give 
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Method 
Search strategy 
Two systematic literature searches were conducted; an original search conducted in 
January 2017 and an updated search in May 2019. Abstract and Title fields (or Abstract/Title 
for PubMed) of the databases PubMed, PsycINFO, Scopus and CINAHL were searched for 
appropriate articles. Following consultation with an academic librarian and in order to 
conduct the most comprehensive search possible, the search strategy included separate 
searching of key search terms and thesaurus entries or Medical Subject Headings (MeSH) for 
the major concepts of epilepsy, stigma and experiences (except for the Scopus database 
which does not endorse a thesaurus). Search terms and thesaurus entries were then combined 
with the Boolean operator ‘OR’ for each concept. Finally, the three concepts were then 
combined with ‘AND’ to provide the final search results. To complete as robust a search 
possible and prevent any articles being missed, reference lists of included papers were hand 
searched, citation searches of included articles were conducted and Table of Contents from 
relevant journals, for example Epilepsy & Behaviour, were also searched. Full details of the 
searches conducted can be found in Appendix 1-B.  
Studies were screened for inclusion in the review, according to the criteria described 
in Table 1.  As there has been no previous meta-synthesis in this area, no time restriction was 
applied.  
- Insert Table 1 about here - 
Search results were reviewed in the citation software Endnote X9. Duplicates were 
removed.  Titles and abstracts of studies identified by the literature search were screened and 
those which did not meet inclusion/exclusion criteria (for example, studies not on human 
populations or not epilepsy research) excluded.  Whenever it was uncertain whether all 
inclusion criteria were met, full text articles were retrieved and further considered.  The 74 
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full text articles were reviewed by the author.  For example, the full article by Aydemir and 
colleagues37 was excluded at this stage as the views of family members were included in the 
analysis, with no distinct separation.  Where there was uncertainty about inclusion (n = 12), 
this was discussed with a co-coder (another trainee clinical psychologist) and a final decision 
agreed.  For example, a study by Kilinc and colleagues was excluded on the basis that there 
was no direct reference made regarding stigma or discriminatory experiences in the article 
abstract.38   
Selected studies 
A flow chart of the search process is provided in Figure 1. Of a total of 2,877 
publications identified by the literature searches, 24 were found to be eligible for inclusion in 
the review.  Sixteen articles reported on original research samples.  Four groups of authors 
described a single study sample in two separate publications but were included in this review 
as they focused on different research questions and thus provided complementary information 
(n = 8).39-46  
- Insert Figure 1 about here - 
The following data were extracted from each eligible study: author(s), date of 
publication, title of article, data collection method and method of analysis, sample size, 
population (including type of epilepsy), age range, and country in which the study was 
conducted. 
Study characteristics  
The characteristics of the 24 included studies can be found in Table 2.   
-Insert Table 2 about here- 
The final 24 articles identified for this review were published between 2002 and 2019, 
representing 20 original research studies. The studies describe the experiences of stigma in 
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people with a range of epilepsy diagnoses and seizure types, within a diverse range of 
settings.  The countries of origin were the UK (n = 5), US (n = 4), Ireland (n = 1), Sweden (n 
= 3), Slovenia (n = 1), South Africa (n = 2), Nigeria (n = 1),  Zambia (n = 1), Canada (n = 1), 
Australia (n = 2), Argentina (n = 1) and Iran (n = 1). 
All the articles focused on the direct experiences of people with epilepsy.  Data was 
collated via individual interviews (n = 18), focus groups, or a combination of focus groups 
and individual of both (n = 1).  All the studies used a form of qualitative analysis to analyse 
the data guided by a range of methods including: content analysis (n = 8), thematic analysis 
(n = 6), phenomenological approach (n = 7), grounded theory (n = 2), and an ethnographic 
approach (n = 1).  
Quality Appraisal  
In order to assess the methodological and reporting quality of the included studies, the 
Critical Skills Appraisal Skills Programme (CASP) tool was administered.47 The CASP tool 
has been developed for use by qualitative researchers in the field of health research, in order 
to appraise research across ten domains, on rigour, credibility and methodological findings 
that are considered vital in qualitative research. The 24 included papers were assessed by the 
lead author using the tool. According to guidance, each paper was scored ‘yes’, ‘no’, or ‘can’t 
tell’ for the initial two screening questions. Further criteria were scored alongside a three-
point rating system developed by Duggleby and colleagues.48 Each paper was given a score 
between one and three, depending on whether the study provided a weak (1), moderate (2), or 
strong (3) description of the eight criteria.  Four papers (17%) were appraised by an external 
rater, (trainee clinical psychologist) to ensure rigour. Inter-rater agreement was 88% (28/32 
criteria).  Where discrepancy was found, this was discussed and a final score agreed.  A 
summary of the outcome of the quality rating procedure can be found in Table 3.   
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CASP scores ranged from 15 to 24 (potential range 8-24) indicating variability in the 
quality of reporting.  Following Sandelowski,49 studies were not excluded based on the 
appraisal score due to the lack of consensus of what makes ‘good’ qualitative research. For 
example, lower scores may be more indicative of reporting quality, influenced by journal 
word limit restrictions, rather than the actual research process.50  For this reason, the quality 
appraisal was conducted in order to highlight the quality of reporting, rather than as a basis 
for inclusion or exclusion from the review.  
-Insert Table 3 about here- 
Data Analysis  
Meta-synthesis is a method of systematically integrating the findings of qualitative 
research in an attempt to create new meaning.51  For this review, the qualitative data included 
in the final 24 studies was analysed using Noblit and Hare’s meta-ethnographic approach.52 
This approach was suited to the research question as it aims to retain the interpretative nature 
of qualitative studies rather than simply summarising the findings and attempts to identify 
new themes from the data.53  Thus, an interpretive position was assumed throughout the 
synthesis.  
Guidance for synthesizing qualitative literature52 was followed alongside a worked 
example adapted for health research.54  Recent guidance on the reporting of meta-
ethnographies was also followed.55  This seven-stage approach allows for the identification of 
higher order themes which provide an interpretative account of the synthesised studies.  
Following this process, the papers were read and re-read in order to become as familiar as 
possible with their content.  In order to follow a systematic approach and in line with Atkins 
et al.,50 studies were examined chronologically.  The first iteration of themes was produced 
by identifying key themes and subthemes from the results section of each paper and 
summarising these using the original authors’ language from the results and discussion 
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sections.  A summary of the key findings from each of the included articles can be found in 
Appendix 1-C.  
Next, studies were compared so that similarities and differences in themes and 
subthemes could be identified, determining how they were related. Through a process of 
reciprocal translation,52 similar concepts were grouped and second-order constructs were 
formed.  The same approach was used to develop the analysis, in which these translated 
constructs were grouped into new conceptual contexts to form final third-order constructs. 
Noblit and Hare’s52 method of generating ‘lines of argument’ was used to express the current 
author’s interpretation of the synthesised results and, thereby, offer conceptual development 
beyond that of the individual studies.56 To enhance validity, details of the analysis process are 
provided in Appendix 1-D.  
Results 
Five main themes were generated from the synthesis and are explored here.  
Theme 1:  Societal negative perceptions of epilepsy leading to discrimination and 
rejection  
This theme illustrates how people with epilepsy described being viewed as different 
from what was culturally expected and experienced varying levels of discrimination from the 
public and those with whom they had relationships.  This was often due to misconceptions 
about the nature of epilepsy but also due to the physical manifestations of seizures, which 
were not well understood. 
Participants described a lack of public understanding regarding epilepsy, including 
causation, which predominantly resulted in being viewed negatively.  In some cultures, 
misconceptions that epilepsy was caused by supernatural forces, such as witchcraft or 
demonic possession were described.  Thus, affected individuals may be feared by others. 
Religious beliefs often inferred the development of epilepsy as a punishment for wrong-doing 
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and that the person with the condition had been “damned.”57(p.111)  Such perceptions indicated 
beliefs of blame towards the individual which maintained negative perceptions.58  
Misunderstandings regarding the biological nature of epilepsy were also 
commonplace.  In a study conducted in Slovenia, concerns regarding contagion existed as 
described by one participant: “She asked me if it is contagious and if she can get ill.” 59(p.7)  
Similarly, the physical manifestations of seizures might be misperceived as resulting from 
being under the influence of or withdrawing from illicit substances.60  Public lack of 
knowledge regarding different types of epilepsy could also impact on others’ perceptions: “I 
mean if you go down on the floor and shake people know what’s going on… but when you’re 
just talking a load of rubbish you know, they just think you’re totally mad.”44(p.667)  Indeed, 
reports from a number of studies described perceptions regarding an association between 
epilepsy and mental illness.  
Thus, epilepsy was referred to as a “taboo”59(p.5) and across cultures and contexts,  
those with the condition were not acceptable within society and thus marked lower in social 
value.  Negative attitudes towards epilepsy were described across all studies as resulting in 
discrimination or rejection, both from the public and those closer to them. However, the 
extent and extremes of this varied, often dependent on the social and cultural perceptions 
regarding epilepsy in that setting.  
For example, in settings in which supernatural causes for epilepsy dominated, so did 
the use of alternative treatments in order to ‘cure’ epilepsy, such as religious healing: “they 
believe [in Nigeria] it was a spiritual attack…they might do some cleansing.” 61(p.454)  As 
such, people were vulnerable to extreme forms of assault: “I know of a woman with epilepsy 
who was beaten with extensive bodily injuries because she was thought to be possessed of an 
evil spirit.”62(p.45)  Other studies described experiences of physical and sexual assault, 
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rejection from the community and public humiliation and ridicule.  Such negative societal 
views regarding people with epilepsy could result in complete rejection, even from family. 
Participants described how women with epilepsy living in urban settings in Africa were “sent 
back to the village”63(p. 169) which was seen as a poorer and less privileged society with which 
to belong.  
Other misconceptions regarding epilepsy could result in enacted stigma, although less 
overt.  For example, those who were viewed as being under the influence of drugs might be 
inappropriately treated: “They told her that they wouldn’t call an ambulance for someone on 
drugs.”59(p.6) When epilepsy was not viewed as a medical condition requiring treatment, this 
was often withheld.  Even when epilepsy was viewed as having a biological cause, the 
perception that it might be hereditary could prevent others forming intimate relationships 
with someone with the condition, in case it was passed on to their children.59  
Furthermore, participants also experienced discrimination due to misunderstandings 
regarding the hidden nature of the illness.  For example, participants described experiences in 
which they were viewed as “lazy”43(p.31) perhaps for not working or not recovering quickly, 
because symptoms of the condition were invisible to others the majority of the time.  
Interestingly, discriminatory behaviour was received not only from personal 
relationships and members of the public but also from healthcare professionals, who 
participants expected to understand better the causes and consequences of epilepsy.  
Accounts reported doctors not having the time to listen to their concerns, lacking empathy, or 
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Theme 2: Internal attributions of blame lead to negative self-perception and shame  
This theme describes how epilepsy stigma from society became internalised, resulting 
in negative self-perceptions. Participants described distress at identifying as someone with 
epilepsy and feelings of shame, often due to the impact on others. 
Accounts indicated how cultural or societal beliefs about the nature of epilepsy 
influenced participants’ own beliefs. Cultural perceptions about the nature of epilepsy, 
therefore, appeared to influence how individuals learned to identify themselves as someone 
with the condition and, as a result, negative associations with epilepsy could become 
internalised.  For example, participants from African cultures, in which epilepsy was viewed 
as having supernatural causes, reported viewing themselves as “witches.” 61(p. 455)  Similarly, 
where epilepsy was viewed as a curse for wrong doing, this resulted in participants blaming 
themselves for their condition  
In contrast, in cultures in which a medical or neurological explanation for epilepsy 
was dominant, such as the US or Europe, participants described more readily accepting this 
explanation for their own condition.  However, even in these studies, lack of clear public 
knowledge about epilepsy and, therefore, unclear individual cognitions about the nature of 
the condition, could still result in participants questioning whether they were to blame.  For 
example, one participant in Sweden commented: “I think that I got the epilepsy due to the 
incident when my boyfriend died… He killed himself… I didn’t follow him home the night it 
happened… I don’t think I would have it if I had… and then I got my epilepsy 2 weeks later.” 
39(p.206)  Whilst another participant described: “It is an illness with spasms in the brain… the 
electrical currents [power] become too strong.” 39(p.205) Thus, accounts provided insight into 
how people with epilepsy appeared to make sense of their condition based on the dominant 
narratives within their society.  
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Therefore, cultural and individual perceptions about the nature of epilepsy, and 
negative associations led participants to feel different from what was expected within society.  
Moreover, in many studies, this sense of difference was described to be enduring, beyond the 
acute seizures themselves: “It’s not the seizures, it’s that effect of feeling different. It’s not 
the physical reality, it’s that psychological effect that just doesn’t go away.”64(p. 283)  One 
study described a women’s description of the word for her epilepsy “iyandiguqula” meaning 
‘epilepsy makes her a different person.’46  This enduring sense of being different often led to 
negative self-perceptions including low self-worth: “I thought it was a miracle that there are 
people out there who would even talk to us”59(p.5) and disgust: “I felt like a ‘mongo,’ epilepsy 
is yucky, people that have it are dirty.”39(p.205)  Furthermore, this resulted in an expectation of 
societal rejection and thus participants conceded to this: “I’m a reject you know, basically, 
I’m one of nature’s rejects.”44(p.669)  
 Therefore, having a condition which was viewed negatively within society elicited a 
range of different negative cognitive and emotional experiences. This often appeared to be 
related to feelings of lack of control over the condition, due to its uncertain nature.   
 A common emotion which appeared associated with stigma, was shame.  This 
appeared related to fears about the consequence of epilepsy becoming known to others due to 
its negative associations: “I don’t want anyone to know that I have it… it is shameful… and I 
am afraid that it will come out that I have it.”39(p. 206)  This was demonstrated in the majority 
of the studies, but which was found to vary in severity across cultures and settings.  Perhaps 
for this reason, in collectivist cultures, participants described greater distress and concern 
about the potential impact of their epilepsy on family members and community, than the 
personal emotional distress caused.  This was demonstrated by African participants in a study 
conducted in the UK “The shame on me, it was too much, and the name on the family… 
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another family doesn’t want anything to do with your family.”61(p.454)  Participants therefore 
demonstrated a sense of responsibility for others’ responses to their epilepsy.  
 Furthermore, experiencing seizures in public led to feelings of guilt due to the 
perceived negative impact on witnesses.  Participants described how seizures could be 
experienced as frightening to witness, particularly for children.65  Participants also reported 
guilt at the potential to injure others during seizures.   
Theme 3: Impact of stigma on everyday life and associated reliance on others 
This third theme describes how having a stigmatised condition, such as epilepsy, 
affected all areas of daily life.  Participants described the impact on fulfilling their expected 
societal roles and the possibilities for education and employment.  Reliance on others and 
externally enforced decisions about their lives often resulted in individuals struggling to resist 
epilepsy taking over.  
Participants described experiencing restrictions in many different areas of their lives 
as a result of epilepsy stigma, which appeared overwhelming and extensive, and meant that 
living a socially conventional lifestyle was more challenging.  Such experiences appeared to 
lead to participants having a sense of a diminished and limited life: “When you are whole, 
you can do anything… When epilepsy is on your record, all doors close.”59(p.5)  In all of the 
studies, epilepsy was described as having a significant impact on individuals’ ability to form 
and maintain relationships.  For example, participants described epilepsy causing the ending 
of marital relationships or perceived epilepsy as a potential deterrent to marriage, while 
others already married feared their spouse would abandon them because of epilepsy. 
Therefore, participants described feeling thankful to their partner for being “still here.”65(p. 756) 
In contrast, participants in a small number of studies described surprise at their partner’s 
positive and protective response to their condition: “My partner says to me, you are special. 
You are not like all the rest… Yes it’s a good match.”65(p. 756)  Such differences appeared to be 
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as a result of partners having a good understanding of epilepsy which protected against 
stigma.  
The majority of female participants also described restrictions in their aspiration to 
become parents.  Participants held beliefs that pregnancy could result in a worsening of their 
condition, that they may harm their developing baby or that their baby would also develop 
epilepsy, demonstrating their own misunderstanding regarding epilepsy.39  This often 
appeared related to a lack of sufficient information, either as a result of limited access to 
healthcare or because professionals did not take the time to discuss this.  In some cultures, the 
perceived inability to provide children within a relationship was described as being deeply 
shaming 63 and this perceived impossibility resulted in further feelings of grief and sadness: 
“It really hurts, knowing that I will never experience pregnancy, I will never have a child of 
my own.”39(p.206)  However, the impact of epilepsy on parenting in male participants was only 
clearly described in one study.42 
Participants also described difficulties making and sustaining friendships, often due to 
the need to explain a condition which might not be well understood and fearing rejection. 
Indeed, participants described experiencing rejection or distancing from others after 
witnessing a seizure: “I even had friends that I’ve had a seizure, and now they’re no longer 
my friends.”66(p.260)  Participants also described the discriminatory behaviour of others with 
whom they had formed relationships within wider society, such as friends from exercise 
settings,67 religious groups or their places of residence68 which resulted in decreased 
opportunities for social activities and interaction. 
Participants across studies described experiencing significant restrictions in finding 
employment: “I didn’t get a job because I have epilepsy and it was made very clear that that 
was the reason.” 64(p. 283) For some this was as a result of rejection from, or being unable to 
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access, school or disrupted education as a result of epilepsy in childhood which limited 
employment opportunities.58  Additional limitations, such as not being able to drive were also 
described as impacting on employment.65 
Having epilepsy could therefore have a negative impact on financial resources.  In 
contexts in which finding work was crucial, lack of employment opportunities could have a 
devastating impact, including rejection from their partner or family, resulting in living in 
poverty and, thus, further exclusion.62  In societies where this was available, participants 
described having to rely on support from benefit systems.  However, this was often 
complicated by the hidden nature of epilepsy and lack of understanding which meant that 
participants often had to prove to be deserving of assistance: “I’ve had problems with a lot of 
resources refusing to help me, cause they’re like you’re relatively articulate so you’re just 
making this up.”66(p.260)  However, not being able to work and having to rely on assistance 
could increase feelings of shame, due to concerns about not satisfactorily contributing to 
society.  Participants therefore often appeared in a personal conflict which could be difficult 
to resolve.  
Subsequent to the restrictions experienced by people with epilepsy, participant 
accounts described significant difficulties with loss of role, autonomy and independence. 
Participants described needing to rely heavily on others, for financial, practical and emotional 
support but which could result in a deep sense of disappointment and guilt about burdening 
those upon whom they depended.40, 58, 60 Moreover, participants frequently reported feeling as 
though their decisions were externally enforced, be that by healthcare professionals, family or 
employers,45 but which were sometimes believed to be incorrect as a result of others’ 
“ignorance” regarding epilepsy.65  Thus participants expressed a sense of powerlessness over 
their own lives.59  Interestingly participants often described a sense of conflict between 
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appreciation of the support they were provided and finding the level of dependence restrictive 
and infantilising, particularly in cultures in which independence was encouraged.42  
Theme 4: Attempts to manage stigma through concealment and avoidance.  
This fourth theme illustrates how participants attempted to manage and cope with the 
stigma resulting from having epilepsy and the challenges this presented. Participants 
described differences in accepting or denying their diagnosis and behavioural strategies they 
put in place as a result of this. For some these strategies were protective while others 
recognised the potential to maintain the stigma associated with epilepsy, although 
inadvertently.  
Participants described differences in their acceptance of their condition and 
adjustment to this. Several participant accounts described the denial of an epilepsy diagnosis. 
This often appeared related to participants’ own perceptions regarding epilepsy. For example, 
one participant reported denial of epilepsy based on their seizure manifestations, including 
the perceived view that: “I don’t have epilepsy because I do not foam from the mouth.”62(p.41) 
While others described more explicitly their lack of knowledge being the reason for their 
denial. However, this also appeared to be a protective mechanism, which allowed participants 
to separate themselves from something which was perceived as negative: “unlike me, he has 
those… terrible seizures.”69(p.110) Other participants described more active and severe 
behaviours in order to reject their condition, including relocating, in order to live “as though 
nothing has happened.”43(p.28) 
Even if participants accepted their condition, they often chose to keep this hidden 
from others in order to avoid stigma.  Participants described great fear at their epilepsy being 
known to others due to fear of their reactions, often as a result of previous negative 
experiences of disclosure.67  In some accounts, participants reported going to great lengths to 
keep their epilepsy concealed so to present themselves in a way which might be viewed as 
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‘normal’ within society: “I would get an aura [perceptual disturbance preceding a seizure], 
and I would get up and run to the bathroom, and I could hide it for years.”64(p.284) 
Concealment appeared particularly prevalent when considering employment situations. 
Indeed, even in societies in which employment laws were in place to protect citizens, such as 
the US, participants described the direct experience of colleagues or employers witnessing a 
seizure which then resulted in dismissal.64 
In contrast, other participants described being open about their epilepsy. For some this 
was on a need to know basis, for example regarding safety concerns and managing risk: “I 
tend to tell people, if they ask and if it’s important.”44(p.671) While for others this allowed a 
sense of liberation and the potential to be better understood by others.  However, participants 
described the importance of being selective regarding who they informed about their epilepsy 
and the benefit of practising telling beforehand.70  Moreover, levels of concealment were 
markedly dependent on context. Indeed, participants in studies conducted in societies where 
they might be more vulnerable to extreme levels of discrimination and abuse rarely described 
being open about their condition.  
The majority of participants described fear of forced disclosure of their epilepsy, as a 
result of having a seizure in public and the potential for further discrimination. As a result, 
social withdrawal behaviours and self-isolation were common: “in the end I will end up going 
nowhere in case of having a seizure… the risk is that one becomes… well… kind of 
isolated.” 40(p.1998)  While the majority of accounts described this as protective, some 
identified how such behaviour resulted in further limitations on life and the ability to form 
relationships.  However, this was also described as being the lesser of two evils: “it is easier 
to stay at home and be lonely than need to discuss [epilepsy] and be judged by society.”43(p.29) 
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Interestingly, however, participants identified how their own lack of disclosure might 
contribute to the lack of knowledge in others: "I don't speak about it so maybe that's the 
problem."68(p.89)  Therefore, it was felt that concealment may inadvertently have maintained 
stigma in epilepsy.69  This led to feelings of ambivalence in some participants.  However, in 
many contexts the risk of exposure continued to outweigh this responsibility and was 
therefore not sufficient to change disclosure behaviour. 
Theme 5: Support from others is beneficial but dependent on own and others’ 
understandings of epilepsy 
Contrary to the many difficulties described by participants in adjusting to the 
challenges presented by epilepsy and stigma, this final theme describes the strategies and 
resources adopted by participants.  Participants described the need for support, mostly from 
family but also wider society, which was improved by better knowledge about epilepsy. 
Participants therefore described the need for better education and more accurate media 
representation regarding epilepsy.  
Participants described relying on others for practical and emotional support. Perhaps 
due to the dependency on others previously outlined, participants described having a 
supportive family as critical to managing epilepsy and stigma.  Indeed, supportive others 
could improve accessing healthcare which might otherwise be inaccessible, due to practical 
restrictions, or feeling unable to navigate this independently.  Furthermore, participants 
described the benefit of family support to manage the emotional impact of stigma and 
practical limitations of the condition.71  
Therefore, participants in many of the studies described the ongoing need for 
education about epilepsy both for themselves and others, as it was believed that: “a lot of 
stuff people don’t understand, scares them.”72(p.110)  Participants, therefore, described how 
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increased awareness about the heterogenous nature of the condition and potential invisibility 
of epilepsy had the potential to reduce negative misperceptions and increase empathy.68 
Individual coping strategies were also reported. One participant described 
restructuring negative cognitions to view the self as a survivor.43 Others described the 
importance of improved self-care or resilience.68  However, these were often dependent on 
social circumstances and appeared predominantly in the descriptions of those who also 
reported sufficient support from others and who thus perceived themselves as having a better 
quality of life.  
Only a small number of participants described the benefits of professional emotional 
support, perhaps due to the focus of interview schedules, but likely related to frequent reports 
of inadequate healthcare.  Subsequently, participants described the need for improved 
knowledge of the wider socioeconomic impact of epilepsy in healthcare professionals in an 
attempt to improve empathy and care.69  
The benefit of support groups in which others shared the same knowledge and 
experiences of epilepsy and stigma were discussed, describing a unique opportunity for care. 
As many participants experienced social isolation, support groups provided an opportunity 
for social interaction and a means of expressing negative feelings: “So we need a place where 
people can go to open up. Some kind of group or something.”66(p. 261) However, these were 
not available to participants in the majority of studies and, therefore, mentioned rarely across 
accounts.   
Therefore, participants in a number of studies felt that it was the collective 
responsibility of the wider society to educate and correct misinformation about epilepsy. One 
participant described ongoing epilepsy stigma as a consequence of what is “seen on TV” 
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72(p.11) The authors in this study therefore discussed the potential for misrepresentations of 
epilepsy in the media maintaining stigma.  
Furthermore, participants in a number of studies described feeling let down by 
members of their community.  Descriptions regarding the responsibility of institutions, such 
as churches and schools, taking more responsibility for educating society about epilepsy were 
commonplace.  This was particularly evident in collectivist cultures, or settings in which 
particular institutions were significantly influential on the views of the community. 
Interestingly, even when misperceptions about the causes of epilepsy remained, a positive 
attitude towards epilepsy in a particular group or setting could be protective. 
Discussion 
The aim of this review was to understand and synthesise the experiences of stigma in 
adults with epilepsy across cultures and contexts.  The meta-ethnographic method of 
synthesis has allowed for individual perspectives of epilepsy, across a variety of contexts, to 
be incorporated into the review, from which key experiences have been identified.  Themes 
highlighted the adverse experiences of people with epilepsy as result of stigma and 
discrimination.  Although this has been evidenced in previous studies, this review offers a 
conceptualisation of the individual experiences of epilepsy-related stigma, dependent on 
sociocultural representations of epilepsy.  Misconceptions regarding epilepsy were readily 
internalised which led to negative self-perceptions and widespread implications for 
participants’ lives.  Thus, participants demonstrated a process of psychological and practical 
adaptation to overcome these challenges.  Although participants described a range of 
strategies, support from others appeared crucial.  Thus, the need for improved societal 
understandings regarding epilepsy was highlighted.  
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Misconceptions about epilepsy were common but influenced by the sociocultural 
context.  Negative representations of epilepsy were associated with varying degrees of 
discrimination.  Extreme acts arising from stigma were more common in  societies in which 
supernatural explanations dominated, such as parts of Africa, whereas more subtle 
experiences were described by participants in studies conducted in societies in which medical 
explanations dominated, such as the US and Europe.  It has previously been proposed that 
experiences of felt stigma might be of greater concern for people with epilepsy in the 
developed world (due to improved seizure control) compared to experiences of enacted 
stigma greater in the developing world.3  While this review provides some evidence for this 
distinction, qualitative exploration of these experiences highlighted that people with epilepsy 
across cultures experienced both felt and enacted stigma.  Such a broad distinction could 
therefore result in more subtle forms of stigma being ignored.  Instead, this review highlights 
the need for consideration of sociocultural factors to understand fully individual experiences 
of stigma. 
Furthermore, these culturally informed misconceptions were also internalised which 
resulted in significant negative self-perceptions.  It has been suggested that felt stigma, or fear 
of enacted stigma, may be more of a burden and have a greater influence on the lives of 
people with epilepsy than that of enacted stigma itself.73  Indeed, this review highlighted the 
extensive perceived implications of felt and anticipated stigma on participants’ lives and 
attempts to overcome this.   
Moreover, participants described restrictions in many aspects of daily life as a result 
of stigma, dependent on sociocultural context.  Participants described significant restrictions 
which were perceived as externally enforced, including the impact of stigma on forming and 
maintaining relationships, the ability to marry and start a family, possibilities for social 
activity, education and employment.  Social models of disability are, therefore, also likely to 
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be of relevance. Indeed, it is proposed that perspectives from both disability studies and 
clinical psychology can be usefully combined to understand distress in those who experience 
disability.74 
Social models of disability have been used to explain the experiences of people with 
mental health difficulties75, intellectual impairment76 and other neurological conditions.77 
While earlier social models of disability were criticised for not taking into sufficient account 
individual experiences of disability and the psychological and emotional processes 
involved,78 in a reformulation of such, Thomas introduced the concept of psycho-emotional 
disablism.78  This social relational definition of disablism identifies two dimensions that can 
disable people: environments that may exclude what people can ‘do’ (such as the lack of 
health care services or inappropriate workplaces described by participant accounts here) and 
social interactions that can impact on psychological wellbeing and what people can ‘be’.79  
Thus, it can be defined as: “a form of social oppression involving the social imposition of 
restrictions of activity on people with impairments and the socially engendered undermining 
of their psycho-emotional well-being.”80(p.73) 
Consistent with this concept, the majority of barriers described by participants 
appeared socially enforced; negative social interactions, such as avoidance and rejection from 
others, resulting in negative self-perceptions and shame.  As such, participants described 
reduced social interaction and attempts to conceal epilepsy, often through lack of disclosure. 
Disclosure behaviour in adjustment to epilepsy has previously been described.81  Here, the 
authors described three modes of disclosure: ‘pragmatic’ in which people advise those who 
need to know; ‘secret’ in which epilepsy is concealed; and ‘quasi-liberated’ in which the 
condition is disclosed in order to educate others about their prejudices.  However, across 
studies, significant cultural differences were evident in disclosure behaviour.  Further, 
participants in some studies identified the potential for lack of disclosure of epilepsy as 
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having the potential to maintain stigma as a result of continued lack of education about the 
heterogeneity of epilepsy.  However, such views were only relevant to societies in which 
disclosure may be safe due to legal protections. For participants who resided in cultures in 
which disclosure may increase risk of harm through vulnerability to abuse, concealment 
appeared adaptive. 
In social relational definitions of disablism, such concealment behaviours are 
described as ‘passing’82 and used in attempts to appear ‘normal’. However, passing can have 
negative psychological consequences, including significant physical and emotional efforts, 
and the risk of exposure.  Indeed, participants described extreme attempts to hide their 
epilepsy, for example relocating.  Furthermore, participants described the fear of epilepsy 
becoming discovered.  
A second form of psycho-emotional disablism, indirect psycho-emotional disablism, 
has been described.82  This relates to the psycho-emotional impact of physical or structural 
barriers.  In this review there was also significant evidence of indirect psycho-emotional 
disablism.  For example, participants who did not have accurate information regarding 
epilepsy and pregnancy perceived themselves as unable to have children.  Furthermore, 
participants described inability to work or receive income support benefits due to 
misunderstandings regarding epilepsy.   
Participants in a number of the studies described the shame they felt at the impact of 
their epilepsy on others, particularly their family.  This is consistent with the concept of 
‘courtesy stigma’.  Goffman originally argued that individuals can be subject to stigma 
through their association with a stigmatised person as opposed to an attribute of their own. 
Courtesy stigma has been shown in other health conditions such as HIV/AIDS83 and may 
explain the rejection of people with epilepsy from close others.  This is an important 
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consideration for improving the negative impact of stigma as seeking support was described 
as one of the main coping strategies.  
Participants described a range of negative cognitive and emotional experiences 
resulting from stigma and, therefore, the findings are consistent with quantitative studies that 
suggest that epilepsy stigma is correlated with poorer psychosocial wellbeing.9 
Recommendations have been made for the need for psychotherapeutic interventions that 
might address the spectrum of difficulties experienced by people with epilepsy.84  The 
findings here suggest that such interventions may be helpful for aspects of felt stigma to 
reappraise cognitions and enhance self-directed emotions and self-care.  However, few 
participants described access to such support.  Indeed, while there is a dearth of literature 
describing the psychosocial burden of epilepsy, few published studies have described 
psychological interventions for the impact of epilepsy,85 thus limiting our understanding of 
the outcomes of such.  Recent recommendations for the psychological treatment of people 
with epilepsy have been provided.86  However, while interventions to counter the 
psychosocial impact of epilepsy and stigma were strongly encouraged, recommendations 
focused solely on individual-based approaches, such as interventions aimed at improving 
social and communication skills or individual psycho-education regarding epilepsy.  The 
findings in this review, however, suggest that such interventions may not fully meet the needs 
of people with epilepsy due to the impact of sociocultural factors.  Furthermore, such an 
approach may in fact inadvertently maintain stigma by focusing the blame on the individual. 
Instead, this review highlights the need for ongoing educational programmes for improving 
awareness of epilepsy across the world. Future research should, therefore, continue to focus 
on distributing research and education to the wider population in order to combat epilepsy 
misconceptions in the future.  Indeed, if negative perceptions or misconceptions about 
epilepsy reduced, people with epilepsy would likely experience fewer negative social 
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interactions and less psycho-emotional disablism.  However, it is recognised that due to the 
deep-seated nature of stigma, change in perceptions is unlikely to be easy.87  However, 
lessons could be learnt from interventions aimed at reducing stigma in other conditions, such 
as HIV/AIDS.88  For example, interventions may need to consider target audience (for 
example family members, healthcare professionals) and outcome (for example stigma-related 
knowledge, attitudes, and intended behaviour).89  
A number of participants also described the benefit of support groups in order to 
provide a space to be open about their condition and as a means of securing safe social 
interaction.  Many epilepsy charities in the developed world, offer such opportunities. 
However, such groups may not be available in all societies.  Programmes which aim to 
provide opportunities for safe discussion about epilepsy in different sociocultural contexts 
would, therefore, be of benefit for future consideration. 
A qualitative meta-synthesis has allowed for the voices of a larger number of 
participants to be considered in understanding the experiences of epilepsy stigma across 
cultures and the meta-ethnographic approach has allowed for individual participants’ 
experiences to be preserved.  However, in terms of limitations, synthesis relies not only on 
the language of the participants but the interpretations of the authors of the individual studies. 
The results discussed here are, therefore, likely to be affected by the views of the authors of 
the original research.  The variability in the quality of the papers that were included in the 
synthesis has further potential impact for the findings presented here.  The CASP tool90 was 
utilised only to describe the reporting quality of  the included studies.  It is of note that few 
authors provided information regarding their own role and influence on the research process 
and therefore failed to demonstrate reflexivity, making it is difficult to judge the integrity of 
the findings.91  Further, many of the studies were limited in the transparency of their analysis, 
which is essential in qualitative research.92  
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The variation in samples of people with epilepsy may be considered both a strength 
and limitation to this review.  Within studies, different experiences of stigma were discussed 
according to seizure type. Therefore, the experiences of participants who experience tonic-
clonic seizures may be different from those of others.  However, incorporating studies which 
contained the experiences of participants with different aetiologies has also provided insights 
into these differences.  Similarly, studies were conducted at different time points ranging 
from 2002 to 2019 and their findings may have therefore been influenced by socioeconomic 
changes.  For example, the World Health Organization (WHO) Global Campaign against 
Epilepsy “Out of the Shadows”30 was ongoing throughout this time which could have 
involved education projects in the study settings.  
Studies conducted in a large number of different countries is a strength of this review. 
However, due to interviews being conducted in languages other than English, meaning may 
have been interpreted differently during the process of translation.  Therefore, the meta-
synthesis process relied on the quality of translations produced by the authors of the studies 
which cannot be determined.  
The revised literature search identified an increase in qualitative studies exploring 
epilepsy stigma conducted in recent years.  This is encouraging as it demonstrates an increase 
in research interest in this area of study.  It is recognised that earlier investigations into 
epilepsy stigma were confined to a relatively small number of researchers,93 which may have 
limited the scope of our understanding regarding the topic as it likely that existing models 
relied heavily on the experiences and assumptions of these authors.  Continued empirical 
investigations in this area will continue to add to the existing knowledge base, providing 
broader insights into the relationships between epilepsy and stigma and thus, further 
informing treatment approaches to such.  
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In conclusion, the current meta-synthesis has described the experiences of stigma in 
adults with epilepsy and highlighted some of the key similarities and differences in these 
experiences across sociocultural contexts.  Culturally informed misconceptions of epilepsy 
were readily internalised which resulted in emotional challenges for participants and had far-
reaching implications on participants’ lives.  While individual strategies to cope with the 
impact were utilised, opportunities for educational programmes to inform about the 
neurological nature of epilepsy continue to have relevance. 
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Table 1: Inclusion/Exclusion Criteria 
Studies eligible 
for inclusion in 
the review 
 
a. Studies which explored experiences of stigma from the perspective of adults with epilepsy. 
b. Studies which included people who had received a diagnosis of any form of epilepsy (but which had an onset at any time 
point). 
c. Studies which were based on a population of adult participants, 18 years or older at the time of the study (but whom may 
have received a diagnosis in childhood). 
d. Studies which used a qualitative content-based (as opposed to discourse-based) approach to data collection (using face to 
face methods such as interviews or focus groups). 
e. Studies in which the researcher(s) obtained, analysed and presented data from people with epilepsy separately from any 
other samples included in the research paper i.e. family members of people with epilepsy, controls, individuals people with 
predominantly other health conditions. 
f. Published in the English language. 
g. Studies which presented original research. 
h. Published in a peer-reviewed academic journal.   
Studies 
excluded from 
the review  
 
a. Studies in which the research question was focused on other experiences of epilepsy such that the concept of stigma was not 
explored sufficiently to be presented as a theme for discussion in the title or abstract of the article.  
b. Mixed-design studies in which the qualitative data were not separately analysed and presented. 
c. Publications which did not support themes with the inclusion of direct quotations from people with epilepsy. 
d. Studies which did not report a named method of qualitative data analysis.  
e. Studies in which the perspectives of other populations were included but which the experiences of participants with 






STIGMA IN EPILEPSY 
1-40 
 
Table 2: Characteristics of the included studies 
Authors Year Title Research 
question/Aim 
Methodology Participants/ Setting 
Bishop 2002 Barriers to employment 
among people with 
epilepsy: Report of a 
focus group 
To explore the 
employment 
experiences and barriers 
to employment faced by 
adults with epilepsy. 
Single focus group; 
Form of thematic 
analysis  
Sample size: n= 14; Sample: 
Six males and eight female 
adults with epilepsy; Age: 





Paschal et al. 2005 Stigma and safe 





To explore the attitudes 
and behaviours of a 
minority group, 
African-American 
women with epilepsy 
Individual unstructured 
ethnographic interviews; 
unspecified form of 
thematic analysis 
Sample size: n=10; Sample: 
African-American women 
with epilepsy; Age: 29-58 
years  
Setting:  Specialist 
and primary care 
centres, Midwest 
USA (Wichita) 
Birbeck et al. 2008 Women's experiences 
living with epilepsy in 
Zambia 
To identify relevant 
areas of the lives of 
people with epilepsy 
that might be relevant to 
consider in future 
quantitative studies. 
Focus groups of women 
with epilepsy; 
Unspecified form of 
content analysis, main 
themes identified 
Sample size: Six groups of 
8-15 participants; Sample: 
Women with epilepsy; Age: 
Adult women 
Setting: Zambia, 
urban clinic and 
rural (Tonga) region 
Kilinc & 
Campbell 
2009 It shouldn't be 
something that's evil, it 
should be talked about: 
a phenomenological 
approach to epilepsy 
and stigma 
To explore the 
experience of stigma for 
adults with epilepsy 




undertaken six to twelve 
months apart; Analysed 
using phenomenological 
analysis  
Sample size: n= 52 ; 
Sample: Adults with 
epilepsy ; Age: 18+  
Setting: Community 
setting in UK 
Räty et al. 2009 Epilepsy patients' 
conceptions of epilepsy 
as a phenomenon 
To explore the concept 
of epilepsy and the 
emotions related to this 





Sample size: n=19; Sample: 
People with epilepsy (7 









2011 Patients' perceptions of 
living with epilepsy: A 
To describe how 
patients with epilepsy 
Individual interviews; 
analysed by the 
Sample size: n=19; Sample: 
People with epilepsy (7 
Setting: Sweden, 
recruited from 









men, 12 women); Age: 20-
65  
clinics (county and 
private) 





To explore young 
adult’s experiences of 
living with epilepsy and 
subjective cognitive 
decline 
Focus groups (two made 
up of women with 
epilepsy and two of 
men); Analysed using 
Content analysis  
Sample size: n=14; Sample: 
Young adults (7 males and 7 






2011 Women's perspectives 
on epilepsy and its 
sociocultural impact in 
South Western Nigeria 
To explore the 
sociocultural aspects of 
epilepsy for women in 
Southwest Nigeria who 
already face gender 
based marginalisation 
Six focus groups: three 
in urban areas, three in 
rural areas; Analysed 
using content analysis 
Sample size: Six focus 
groups of 8-15 women; 
Sample: Women with 
epilepsy in Southwest 
Nigeria (mostly of the 
Yoruba population); Age: 
Adult women 
Setting: rural and 
urban setting in 
Southwest Nigeria 
Chung et al. 2012 Quality of life in 
epilepsy (QOLIE): 
insights about epilepsy 
and support groups 
from people with 
epilepsy (San Francisco 
Bay Area, USA) 
To investigate the 
perceived quality of life 
in people with epilepsy 
who attend support 
groups compared to 
those who do not.  
Six focus groups: three 
including people with 
epilepsy who attend 
support groups and three 
who do not; Content and 
interpretative qualitative 
analysis by the constant 
comparative method  
Sample size: n= 36 (18 who 
attended support groups, 18 
who did not); Sample: Male 
and female adults with 
epilepsy; Age: 24-65+  
Setting: Community 
based, San Francisco 
Bay, USA 
Jacoby et al. 2014 Exploring loss and 
replacement of loss for 
understanding the 
impacts of epilepsy 
onset: A qualitative 
investigation.  
To gain an in-depth 
understanding of the 
lived experience of loss 
for people with epilepsy 
and to explore the 
relationships between 
different influences 
mediating loss and 
contributing to overall 
quality of life.  
Individual interviews; 
analysed using Constant 
Comparative method 
Sample size: n=67; Sample: 
Adults with epilepsy; Age: 
24-65 years 
Setting: Community 
setting in UK 
Sonecha et al. 2015 Perceptions and 
experiences of epilepsy 
among patients from 
To explore perceptions 
and experiences of 
epilepsy among black 
Individual semi-
structured interviews; 
analysed thematically  
Sample size: n = 11; 
Sample: Black African and 
Caribbean people with 
Setting: UK 
Recruited via South 
London hospitals 
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black ethnic groups in 
South London 
African and Caribbean 
people in South London 
epilepsy (6 male, 7 female); 
Age: 22-79  
Sleeth et al. 2016 Felt and enacted stigma 
in elderly persons with 
epilepsy: A qualitative 
approach 
To qualitatively assess 
the effects of stigma 
upon the quality of life 





specified form of 
thematic analysis 
Sample size: n=57; Sample: 
Older adults with epilepsy 













experiences of social 
inclusion in people with 
epilepsy in Slovenia 
Individual semi-
structured interviews; 
Analysed by content 
analysis using coding 
frames  
Sample size: n=11; Sample: 
Adults (8 women, 3 men) 
with epilepsy; Age: 27-64 
years  
Setting: Community 
setting in Slovenia 
Keikelame & 
Swartz 
2016 "The others look at you 
as if you are a grave": a 
qualitative study of 
subjective experiences 
of patients with 
epilepsy regarding their 
teatment and care in 
Cape Town, South 
Africa.  
Describe the subjective 
experiences of how 
people with epilepsy in 
an urban township in 
Cape Town understand 
their illness.  
Individual semi-
structured interviews; 
Analysed using thematic 
analysis.  
Sample size: n= 12; Sample: 
People with epilepsy in 
Cape Town (8 males, 4 
females); Age: >18 years  
Setting: Community 
based in urban 
township in Cape 
Town, South Africa. 
Collard & 
Ellis-Hill 
2016 ‘I'd rather you didn't 
come': The impact of 
stigma on exercising 
with epilepsy  
To explore the barriers 
to exercise for people 
with epilepsy. To 
provide a deeper 
understanding of how 
stigma is felt and 
enacted with a view to 
considering how it can 
be reduced.  






Sample size: n=11; Sample: 
People with epilepsy ; Age: 






2017 Becoming comfortable 
with "my" epilepsy: 
Strategies that patients 
use in the journey from 
To understand how 
people become 




Sample size: n=49; Sample: 
People who felt comfortable 
with their epilepsy; Age: 
>18 years  
Setting: Community 
setting in Ireland 
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diagnosis to acceptance 
and disclosure 
they constructed their 
epilepsy. 
Crooks et al. 2017 Mind the gap: 
Exploring information 
gaps for the 
development of an 
online resource hub for 
epilepsy and depression 
To identify current gaps 
and barriers to current 
online resources 
designed for people 
with epilepsy and 
depression.  
Individual interviews; 
analysed by content 
analysis 
Sample size: n=10; Sample: 
People with epilepsy and 
depression; Age: 27-53 
years 
Setting: Recruited 
via local epilepsy 
registry in Canada 
Yennadiou. & 
Wolverson 
2017 The experience of 




To explore the lived 
experience of epilepsy 
in later life through 
older peoples' appraisal 
of their condition.  
Individual interviews; 
analysed using IPA 
Sample size: n=10; Sample: 
Older adults with epilepsy; 
Age: >65 years  
Setting: Recruited 
from a Neurological 
Department in North 
of England, UK. 
Kılınç et al. 2017 The experience of 
living with adult-onset 
epilepsy 
To explore the 





analysed suing IPA 
Sample size: n=39; Sample: 
People with epilepsy onset 
>18 years; Age: >18 years  
Setting: Recruited 
via epilepsy charity 
and support group in 
UK.   
Raffaele et al. 2017 Men with adult onset 
epileptic seizures 
What characterises 






Sample size: n=5; Sample: 
Men with adult-onset 
epilepsy that had undergone 
temporal lobectomy 
neurosurgery; Age: 24-45 
years  
Setting: Recruited 




2018 I wonder if I did not 
mess up....: Shame and 
resistance among 
women with epilepsy 
in Cape Town, South 
Africa 
To provide and in-depth 
understanding of the 
ways in which women 
with epilepsy 




Analysed using thematic 
analysis.  
Sample size: n= 12 (4 
participant responses related 
to the research question); 
Sample: People with 
epilepsy in Cape Town (8 
males, 4 females); Age: >18 
years (mean age males 47 
years, mean age females 37 
years)  
Setting: Community 
based in urban 
township in Cape 
Town, South Africa. 
Raffaele 2018 A qualitative study 
exploring family life in 
men  
What characterises 




Sample size: n=5; Sample: 
Men with adult-onset 
epilepsy that had undergone 
Setting: Recruited 
via epilepsy charities 
in Australia 










2018 A life with seizures: 
Argentine patients' 
perspectives about the 
impact of drug-resistant 
epilepsy on their lives 
To add information 
about patients' 
perspectives of drug-
resistant epilepsy from 
a developing nation.  
Semi-structured 
interviews; analysed 
using thematic analysis 
Sample size: n=20 (12 men, 
8 women); Sample: Adults 
with drug-resistant epilepsy; 
Age: 22-52 years 
Setting: Recruited 
from hospital clinics 
in Argentina 
Molavi et al. 2019 The experiences of 
Iranian patients with 
epilepsy from their 
disease: A content 
analysis 
The experiences of 
patients with epilepsy 
regarding stigma.  
Semi-structured 
interviews; analysed 
using content analysis 
Sample size: n=22; Sample: 
Adults with epilepsy; Age: 
>20 and <60 years  
Setting: Recruited 
from a neurology 
clinic in Iran. 
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Table 3: Critical Appraisal of the Included Studies 



































Was there a clear 
statement of the aims of 
the research? 




Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the research design 
appropriate to address 
the aims? 
2 3 3 3 3 3 3 1 3 3 2 1 
Was the recruitment 
strategy appropriate to 
address the aims? 
2 3 3 2 2 3 3 2 2 3 1 2 
Were the data collected 
in a way that addressed 
the research issue? 





1 2 1 1 1 1 1 1 1 2 1 1 
Have ethical issues been 
considered? 
2 2 3 1 3 2 2 2 3 3 2 2 
Was the data analysis 
sufficiently rigorous? 
2 2 2 3 2 3 3 2 2 3 2 2 
Is there a clear statement 
of findings? 
3 3 2 3 3 3 3 2 2 3 3 3 
How valuable is the 
research? 
3 3 2 3 3 3 3 3 2 3 3 3 
Total Score 17 21 18 18 19 20 21 15 17 23 16 16 
1 = weak, 2 = moderate, 3 = strong 
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Was there a clear 
statement of the aims of 
the research? 




Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Was the research design 
appropriate to address 
the aims? 
3 2 2 3 2 3 3 2 3 2 2 2 
Was the recruitment 
strategy appropriate to 
address the aims? 
2 3 2 2 2 3 2 2 3 2 1 2 
Were the data collected 
in a way that addressed 
the research issue? 





1 3 2 1 1 1 3 1 3 2 1 1 
Have ethical issues been 
considered? 
2 3 2 3 1 2 2 2 3 2 1 2 
Was the data analysis 
sufficiently rigorous? 
3 3 2 3 3 3 2 3 3 2 2 2 
Is there a clear statement 
of findings? 
3 3 3 3 3 3 3 3 3 3 3 2 
How valuable is the 
research? 
3 3 3 3 3 3 3 3 3 2 3 3 
Total Score 20 23 19 21 17 20 21 19 24 18 15 17 
1 = weak, 2 = moderate, 3 = strong 
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Database = 1109 
Records identified 
through PubMed 
Database = 1173 
Records identified through 
CINAHL Database = 197 
Records screened = 2877 
Records excluded = 2814 
Duplicates = 650 
Not meeting inclusion/exclusion criteria 
= 2164 
• Not human participants  
• Not relating to epilepsy 
• Not qualitative research 
• Not new research e.g review 
• Not peer-reviewed research 
• Not specific to stigma 




Articles eligible for 
inclusion in review = 24 
Excluded = 50 
• Full article not available = 2 
• Not original/peer reviewed research 
= 2 
• Not written in English = 2 
• Not qualitative research or no direct 
quotes = 8 
• Included other populations e.g. 
carers, healthcare professionals, 
children, other conditions = 24 
• Stigma not major theme = 12 
Full text articles assessed 
























Database = 398 
Additional articles 
identified through hand 
searching = 11 
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Appendix 1-A: Definitions of Epilepsy 
 
Conceptual definition of seizure and epilepsy (2005)1 
 
An epileptic seizure is a transient occurrence of signs and/or 
symptoms due to abnormal excessive or synchronous neuronal 
activity in the brain. 
Epilepsy is a disorder of the brain characterized by an enduring 
predisposition to generate epileptic seizures, and by the 
neurobiologic, cognitive, psychological, and social consequences 
of this condition. The definition of epilepsy requires the 
occurrence of at least one epileptic seizure. 
Operational clinical definition of epilepsy (2014)2 Epilepsy is a disease of the brain defined by any of the following conditions 
1. At least two unprovoked (or reflex) seizures occurring >24 h apart 
2.One unprovoked (or reflex) seizure and a probability of further seizures similar to the general 
recurrence risk (at least 60%) after two 
unprovoked seizures, occurring over the next 10 years 
3. Diagnosis of an epilepsy syndrome 
Epilepsy is considered to be resolved for individuals who had an age-dependent epilepsy 
syndrome but are now past the applicable age or those who 
have remained seizure-free for the last 10 years, with no seizure medicines for the last 5 years. 
 
1 Fisher, R. S., et al. (2005). "Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International 
Bureau for Epilepsy (IBE)." Epilepsia 46(4): 470-472. 
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Epilepsy Epilep* or Seizure(s) PsycInfo DE "Epilepsy" OR DE "Epileptic Seizures" OR DE "Seizures" 
Pubmed "Seizures"[Mesh] OR "Epilepsy"[Mesh] 
CINAHL  
MH "Epilepsy" OR MH "Seizures" 
Scopus n/a 
Stigma Stigma or discrimination or “social 
discrimination” or “social perception” 
“social adjustment” or stereotyp* or 
attitude or prejudice or ignoran* or 
shame or disgrace or dishonour or 
judgement or attitude  
PsycInfo DE "Physical Illness (Attitudes Toward)" OR DE "Health Attitudes" 
OR DE "Discrimination" OR DE "Attitudes" OR DE "Prejudice" OR 
DE "Social Acceptance" OR DE "Social Approval" OR DE "Social 
Discrimination" OR DE "Social Perception" OR DE "Stereotyped 
Attitudes" OR DE "Stigma"  
Pubmed "Social Stigma"[Mesh] OR "Shame"[Mesh] OR "Prejudice"[Mesh] 
OR "Stereotyping"[Mesh] OR "Social Discrimination"[Mesh] OR 
"Social Behavior"[Mesh] OR "Attitude"[Mesh] OR "Attitude to 
Health"[Mesh] OR "Social Adjustment"[Mesh] OR "Social 
Perception"[Mesh] OR "Taboo"[Mesh] 
CINAHL MH "Stigma" OR MH "Social Adjustment" OR MH "Social 
Attitudes" OR MH "Social Norms" OR MH "Social Behavior" OR 
MH "Social Conformity" OR MH "Social Inclusion" OR MH "Social 
Values" OR MH "Stereotyping" OR MH "Attitude" OR MH 





qualitative or ethnograph or experience 
or experiences or perception or 
perceptions or semi-structured or 
semistructured or “semi structured” or 
unstructured or in-depth or indepth or 
face-to-face or structured or guide or 
PsycInfo DE "Grounded Theory" OR DE "Interviewing" OR DE "Qualitative 
Research" OR DE "Questioning" OR DE "Interview Schedules" OR 
DE "Interviews" OR DE "Structured Clinical Interview" OR DE 
"Feedback" OR DE "Life Experiences" OR DE "Experiences 
(Events)"  
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guides or interview or interviews or 
discussion or questionnaire or 
questionnaires or focus group or focus 
groups or survey or surveys or thematic 
or grounded theory or interpretative or 
narrative or case study or observation or 
phenomenology or phenomenological or 
feedback  
  Pubmed "Ethnology"[Mesh] OR "Grounded Theory"[Mesh] OR "Surveys and 
Questionnaires"[Mesh] OR "Narration"[Mesh] OR "Case Reports" 
[Publication Type] OR "Feedback"[Mesh] OR "Qualitative 
Research"[Mesh] OR "Focus Groups"[Mesh] OR "Interviews as 
Topic"[Mesh] OR "Interview" [Publication Type] OR "Interview, 
Psychological"[Mesh]  
  CINAHL MH "Qualitative Studies" OR (MH "Ethnographic Research" OR 
MH "Ethnological Research" OR MH "Grounded Theory" OR MH 
"Phenomenological Research" OR MH "Phenomenology" OR MH 
"Semi-Structured Interview" OR MH "Interview Guides" OR MH 
"Structured Interview" OR MH "Unstructured Interview" OR MH 
"Unstructured Interview Guides" OR MH "Structured Interview 
Guides" OR MH "Interviews" OR MH "Life Experiences" OR MH 
"Feedback" OR MH "Narratives" OR MH "Open-Ended 
Questionnaires" OR MH "Life Histories" OR MH "Biographies" OR 
MH "Surveys" OR MH "Survey Research" OR MH "Focus Groups" 
OR MH "Vignettes" 
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Appendix 1-C. Summary of Relevant Findings of Each Individual Study 
Study Details Summation of Findings 
Bishop, 2002 Applying for a job as a person with epilepsy: overt employer decisions, psychological impact of doubt, fear of disclosure, frustration about what to 
disclose. Maintaining employment: covert dismissal, hiding epilepsy, epilepsy a deterrent, empathy for witnesses. Factors that enable employment: 
supportive and knowledgeable employers and colleagues. 
Paschal et al., 2005 Financial resources: accessing and adhering to medication and treatment, impact of transport and dependence on others, affording medication, 
epilepsy putting into poverty. Knowledge about epilepsy: misconceptions (drug abuse), need to educate family, relationships ending, more stigma 
toward convulsions, mistaking symptoms due to lack of education and not seeking help. Patient-provider communication: better care received from 
tertiary than primary care, unaware of additional care, dissatisfied with primary care, wanting more than medical care. Social networks and social 
support: support increasing access to transportation and finance (for medication), improved adherence to medication, family views of surgery, 
minimal community support (including church), not disclosing epilepsy, wanting church to educate and pray about epilepsy similar to other 
conditions.  
Birbeck et al., 2008 Seizure worries: Shame caused by inadvertent taboo breaking (revealing themselves, indication of husband's regard, urinary/faecal incontinence), 
accidental injury, intentional injury, fear of sexual assault. Family response to the PWE: supportive families or extreme rejection (physical abuse, 
in urban regions "sent back to the village"). Role fulfilment: Marital relationships (difficulty finding partner if epilepsy developer prior, married 
women abandoned or feared abandonment, lost children, sexual rejection leading to poverty and humiliation); Childbearing and rearing (fear 
children taken, prenatal or paediatric injury leading to ambivalence); Employment (seizure worries placed limitations, rejected if condition known, 
employment terminated as result of seizure); Social role in community (forced disclosure as result of seizure, social rejection and isolation, 
ridicule).  
Kilinc & Campbell, 2009 Misconceptions vs ownership: public negative misconception as mentally ill or using substances, public lack of awareness leading to not feeling 
'normal', lack of own knowledge prior to diagnosis, impact of previous experience, reducing uncertainty of seizures and making adjustments. 
Avoiding vs sharing: hidden illness, concealing through avoidance and withdrawal, impact of seizures on others, disconfirming negative 
consequences of seizures, concealment contributing to public misconception, disclosure. Embarrassment vs normalising: confidence, seizures 
drawing attention, engaging in society, impact on identity, need for education. 
Räty et al., 2009 Illness/ Condition related to physical disturbances: chronic illness within the brain, condition associated with seizures, happy could be treated, not 
dangerous, hope might disappear, disappointment at seizures returning. Mental disturbance related to lack of capacity: something wrong in the 
brain/head, "disgusting", "queer", fear of exposure, anxious about social events, shame at not being entirely sane, not satisfactory member of 
society, denial of epilepsy. Handicap related to psychological and/or social aspects: a worry and restriction (including work), impact on 
relationships and childbearing, sorrow as result of obstacles to partnership, pregnancy and parenthood, guilt at suffering of others, shame and 
feeling of lower human value. Identity related to being epileptic: internalized, separate category of people, being abnormal, shame at not being 
normal and causing suffering to others by existing. A punishment: epilepsy result of wrongdoing and searching for explanations, sorrow and guilt 
at having done wrong. 
Räty & Wilde-Larsson, 2011 Living with epilepsy means living a normal life - gaining and maintaining control: Accepting the person with epilepsy (accepting as part of daily 
life, not letting epilepsy rule, disclosing epilepsy so not to fear seizures, need for supportive family); Taking responsibility (listening to signs of a 
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seizure and preparing so not to injure self or others, protecting family from harm by education, positive effects of epilepsy reducing feeling 
different and feeling normal, changing values becoming more understanding to own and others difficulties). Living with epilepsy means living with 
focus on the condition - conflict and avoidance or resigning to fate: Struggling with stigma, prejudice and loss of control (restrictions on life and 
giving up dreams, fearing foetal damage, increasing seizures, avoiding situations of disclosure, being observed and controlled by others including 
family and work, not having the same rights); Physical fears (injury or side-effects of medications); Psychological fears (being seen as different, 
judged or seen as different, need for concealment and avoid exposure); Social fears (being dependent and a burden, other’s attitudes and 
knowledge, becoming isolated). Giving up hope of recovery, accepting loss of control: building and losing hope of seizure cessation, fear of 
exposure, vulnerability and mercy of others during seizures, nightmares about what might happen. 
Gauffin et al., 2011 Affecting the whole person: Personal development and fulfilment (developing a different personality, difficulties making friends and meeting 
partners, lifestyle adjustments, need to plan, giving up on dreams, driving restrictions and reliance on others, restrictions, life requiring more effort, 
impact on academic success, fatigue, impact on self-esteem); Limitation of potential and responsibility (not allowed, others enforcing restrictions 
due to ignorance, alienation, difficulty explaining and others not understanding symptoms of epilepsy, mistaken for mentally ill, embarrassment). 
Influencing daily life: Memory (forgetting leading to embarrassment, impact on relationships and work, impact of seizures and medication); 
Memory ever-present (more difficult than intermittent nature of seizures, decline); Overcoming memory using strategies (using aids, reminders and 
routine, remembering medication). Affecting relationships: Family and friends (affecting whole family, family taking care, impact on other’s work, 
sustaining friendships, impact of memory difficulties, not disclosing epilepsy, requiring support for seizures, mutual friendship, disregarded); 
dependence on others (dependence on relatives, close relationships, asking for help, frustration, fear of separation); Guilt (causing family problems, 
impact on children, scaring children, keeping promises). Meeting ignorance in society: not helping with seizures, not recognising symbol for 
epilepsy, teaching others. 
Komolafe, et al., 2011 Perception about epilepsy: denial of epilepsy, supernatural or contagion causes, traditional/spiritual treatments before western care, costs of care. 
Family attitudes and social relationships: supportive vs rejecting, patrilineal distancing, concealment, social isolation, avoiding forced disclosure. 
Economic consequences: impact on education and future potential, employment restrictions, no financial contribution. 
Marital prospect and relationships: non-disclosure, separation or divorce, rejection/abuse from relatives, ceased financial assistance, poverty, turn 
to prostitution. Role fulfilment: difficulty being wives or mothers, limited roles due to fear of injury from seizures, impact on fertility, fear of 
infecting or injuring their children. Vulnerability or abuse: physical and sexual abuse, part of treatment, sexual assault during seizures, rituals. 
Chung et al., 2012 Barriers to employment: losing employment as result of seizure, discrimination at work. Invisibility/need to prove: providing deserving of aid, 
difficulty gaining financial assistance. Stigma toward people with epilepsy: negative attitudes, social rejection, rejection after disclosure, 
termination of employment, lack of knowledge in public sector workers, concern regarding caring for someone having a seizure. Psychological 
burden: medication for depression, lack of fulfilment, loneliness, difficulty maintaining relationships and limited social interaction, shame, 
frustration and guilt, support groups allowing positive coping strategies and increase social interaction. Restricted activities and socialisation:  
support groups allow opportunity to safely converse without stigma. Social security and income: dilemma regarding aid or employment, impact on 
self-esteem and contribution to society, sustainability of financial support, unpredictable termination of employment. Value of support groups: gain 
knowledge, improve coping, build relationships. 
Jacoby et al., 2014 Explaining QOL impacts: the linkage between psychological and social losses: Psychological loss following seizure reoccurrence due to intrusion 
including loss of control, fear, anxiety, embarrassment, vulnerability and stigma. Social consequences such as loss of job, social activities and 
family roles. Externally enforced decisions such as family member decisions. Withdrawal behaviours in an attempt to minimise harm based on 
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previous experience. Restoring 'normality' and regaining good QOL: Seizure control restoring normality and peace of mind via regaining self-
confidence and former social and psychological status. Factors exacerbating loss: Seizure factors. Others’ perceptions and responses to epilepsy 
and seizures, misperceptions and abuse. Public reaction to epilepsy as lack of empathy. Others fear and lack of knowledge. Decision to withdraw. 
Employment factors. Factors limiting loss: Social and contextual factors limit loss. 'Resources' included personal psychological strategies and 
practical and emotional support from others. Empathy from others. 
Sonecha et al., 2015 Beliefs about cause: African beliefs in supernatural causes (spirit possession), contagious disease (malaria type, airborne or sexually transmitted), 
related to stigma and shame and rejection of others. Caribbean belief that born with epilepsy, chronic condition and not necessary to conceal, 
generational differences (older beliefs similar to African). Felt and enacted stigma: African born participants experienced persecution and 
discrimination, lack of care and social rejection, supernatural belief of self, social outcasts, impact on partnership, abuse as result of seizures, 
continued shame, stigma and social restriction. Caribbean not experienced discrimination, no impact on relationships, but embarrassment at 
seizures and impact on work so concealment when applying. Managing fits and social restrictions: Caribbean fear of seizures leading to avoidance 
and isolation, unpredictability being disabling, restricted activities and isolation. African restricted relationships, family, driving and occupation. 
Mlinar et al., 2016 Physical consequences: draining seizures, injury, recognising triggers leading to control, avoiding situations leading to seizures. 
Emotional consequences: fear (reactions of friends, epilepsy worsening, unpredictability) leading to uncertainty about unpredictability of future, 
self-confinement and social isolation, scaring others. Social consequences: disclosure impacting on social network, loneliness, rejection, 
employment implications, discrimination at work, impact on relatives, difficulty finding a partner, empathy for others with health concerns. 
Manging epilepsy information and social contacts: Strategies (concealment, uncontrolled disclosure, hiding seizures, disclosure in close 
relationships or to enable help, fear or disclosure and non-disclosure with partners and employers, regrets of disclosure vs surprised by positive 
reactions). Experience (low self-worth, trusting others, others’ fearing epilepsy, hurt at others' responses, distress as result of epilepsy, 
powerlessness, desperation, insecurity, loneliness, self-confinement, disassociation, fear, dependence on others, anxiety, shame, feeling different, 
inferior, guilt from reliance on others, life changed, loss of autonomy, relatives dominance). 
Sleeth et al., 2016  Felt Stigma: experiencing stigma in daily life, reactions (including fear) of others (particularly to tonic clonic seizures), stereotypes, affecting work 
and social life, not disclosing, perceived connection with mental state, not experiencing stigma. Enacted stigma: rejection from others, exclusion 
from social events, overt discrimination, worse in earlier life, others being more supportive. Effects of stigma: lack of disclosure, others not 
disclosing (including parents), refusing epilepsy diagnosis, avoiding terminology because of stigma, stigma not impacting on life. Reasons for 
stigma: lack of knowledge, belief epilepsy is contagious, negative stereotypes from previous experience. Addressing stigma: community and 
patient education to increase knowledge (including explaining it is not contagious or harmful to others), teaching others how to live with stigma to 
mitigate adverse effects. 
Keikelame & Swartz, 2016 Difficulties on routine clinical visits: Access to appropriate care inhibited. "You are not told anything". Need to be educated to understand. 
Professionals too rushed to listen. Lack of interpreters. Perceived Health care professionals (HCP) factors affecting care: HCPs show lack of 
empathy, respect, interest and poor listening, training. Disrespectful treatment and lack of required information. Counselling and information 
needs: Insufficient information about medication and side-effects, sexual problems and pregnancy. Need for support with how to cope with 
epilepsy and impact on socio-economic circumstances. 
Collard & Ellis-Hill, 2016 Disclosure to those in authority: Feeling 'different' outweighed safety aspects.  Disclosure not needed. Fear and experience that disclosure results in 
restriction. Feeling responsible to disclose to protect family. Disclosure to other members: fear of negative impact of disclosure. Hidden illness 
increases stigma. Negative impact of limitations due to epilepsy. Stigma improves with more knowledge. Lack of understanding: "people just don't 
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understand". Hidden illness results in less awareness which results in fear in others and viewed as a "weakness". Negative reactions to disclosure 
such as distancing, increasing fear and stigma. Sharing understanding to decrease stigma: Teaching others and witnessing a seizure has mixed 
reactions. Disclosure improving felt stigma but increasing enacted stigma. 
Pembroke et al., 2017 Meaning of "my" epilepsy: Emotional reaction to diagnosis including felt stigma "I felt like there was something wrong with me" and enacted 
stigma. Due to lack of knowledge about epilepsy. Need to adjust life as it "dominate(s)". Reluctant to acknowledge diagnosis. Strategies: Need to 
manage emotions by learning about epilepsy, meet others with epilepsy and talk about it with someone to gain confidence to practice telling. 
Being comfortable with "my" epilepsy: A way of interpreting epilepsy diagnosis. Not allowing to alter self-image "it's part of who I am but it's not 
who I am". Being selective about who to tell. Realising not alone to aid positivity and feel no shame. 
Crooks et al., 2017 Fear and anxiety: Not understanding epilepsy. Fear of seizure in public due to public perceptions and stigma. Assuming seizure due to drug 
withdrawal. Isolation due to staying at home for fear of stigma. Impact on daily living such as driving and employment. Losing yourself: Lack of 
control. Loss of independence and role. Feeling a burden. Health journey and support: Support from family 'critical'. Peer support so not to feel 
alone. Having understanding employers. Being positive and accepting. Seeking information: Sought information primarily from health providers 
but also online and from community organizations. Short healthcare visits made getting information needed difficult. HCP viewed as more credible 
but also didn't know where else to get information. Online forums helpful for sharing experience but not reliable. Not being able to remember log-
in information. Importance of credibility of online information. Epilepsy organisations don't promote events sufficiently. Opportunities and filling a 
gap: Desire for information to share with others to improve empathy. 
Yennadiou & Wolverson, 
2017 
The power of epilepsy: 'It's terrible… it's awful': Distressing and traumatic experiences as result of physical consequences of seizures, concern for 
the fear caused in others. They say you can live a normal life but you can't': The impact of society's attitudes: Socially stigmatising condition. 
Negative lay beliefs result in negative attitudes and ignorance from others. Feeling ostracised and isolated. Feeling discriminated and excluded. 
Keeping their diagnosis concealed to avoid shame and exclusion. Own fragmented understanding of epilepsy. Concealment feeds stigma "I don't 
speak about it so maybe that's the problem". Loss of control: Epilepsy takes over life. Seizures take over the body. Multiple restrictions due to 
epilepsy, not going out alone or avoiding risky situations. 
Kılınç et al., 2017 The ripple effect: Epilepsy is "life changing" affecting all areas of life. Loss of independence, inability to drive and choose activities to engage in. 
Feeling restricted by externally imposed decisions and need for supervision. Benefit of learning about own epilepsy and strategies to put in place to 
manage. Re-evaluating the future: Epilepsy changed life for the better, "things that I've gained" by adapting plans for the future. Easier with 
diagnosis earlier in adulthood. 
Raffaele et al., 2017 Threat minimisation, self-blame, and social isolation: Contending with many threats to personal functioning as a result of social role 
marginalisation. Anxiety about relationships. Threat from poor treatment from healthcare providers. Attempting to manage by living as normal life 
as possible, "as though nothing has happened", hiding epilepsy, relocating. Self-isolation to minimise negative social judgement. Self-blame.   
Cognitive reconstruction: Trying to make sense of their recovery and what was important for self-management. Returning to valued activity. 
Supporting others in similar circumstances. Emotional acceptance and wish fulfilling fantasy: self-acceptance improves well-being. Seeing self as a 
survivor. Using humour. Hoping life will improve. Self-blame: over-loading partner with decisions. Impact on forming relationships. Relationship 
between self-blame and self-isolation. Not living up to others’ expectations for recovery.   
Keikelame & Swartz, 2018 Processes of shame of living with epilepsy: Disappointment and regret due to disruption of life. Guilt, anger and shame at burdening others and 
affecting their relationships "dying might be easier than hurting people". Not being able to fulfil role as mother/grandmother. Shame at 
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incontinence which impacts relationships. Resistance strategies against discrimination: Ability to devise individual strategies to resist injustice, 
prejudice and abuse. Retaliating as strategy against unfair treatment from spouse as result of epilepsy. Fighting back. 
Raffaele, 2018 Role marginalization: exclusion from normal life. Siblings embarrassed and minimising contact or isolating which affected happiness. Parents not 
showing care or concern. Spouse embarrassed to socialise with me. Role dependency: Undue reliance on others. Reduced decisional role in family 
resulting in enjoyed dependency and happiness. Others overprotecting. Having to rely on others, particularly for transport experienced as negative. 
Financial dependence resulting in loss of relationship. Not being able to work affecting self-identity. Role Enmeshment: Treated by spouse like a 
child, particularly for emotional support. Not being able to maintain parent role due to diminished responsibility. 
Sarudiansky et al., 2018 Characteristics of the illness: unpredictability of seizures impacting on life "I can't do anything". 
Interactions with the healthcare system: not having equal access to healthcare and benefits. Doctors not caring. Family members taking to 
traditional healers. Beliefs about the illness: Medical illness and cause vs 'a defect' and feeling ashamed or anger at having epilepsy. Psychological 
or supernatural causes "something bad you have done". Beliefs about how other people perceive them: Others prejudiced against them. Called 
"lazy" or "crazy". Feeling a burden to others. Others over-protective and feeling dependent. Whether to reveal illness, only to minimise risk. 
Importance of social support for emotional support and navigating healthcare. Self-perception: Accepting epilepsy influences disclosure. Feeling 
different from others. Not living up to societal expectations. Limiting life achievements such as marriage, parenting or employment aspirations. 
Not being able to financially support family. Lack of independence and autonomy. Hopeful for a cure.  Impact of the illness on activities: 
Restricted in employment and education which impacts on economy and autonomy. Restrictions on activities. 
Molavi et al., 2019 Need for support: Those supported by family experienced more positive reactions from others, continued education and positive mood. Support of 
important people e.g. doctors, teachers, employers increased quality of life. Those without support experienced many problems. Desire for 
increased public knowledge, reduction in superstitious beliefs, fewer presentations of fear in media, supported through early education. 
Defence mechanisms: Trying to hide illness, due to fear of being labelled and deprived. Emigrating where no-one knew them and returning home 
for family support. Family shame: "my mother and father tried to hide my disease". Superstitious beliefs: Belief of being 'damned' and a 
punishment for guilt and need for faith healers. Negative feelings: Feelings of shame, guilt, regret and fear. Frightened to be alone, not being 
accepted, effect on their lives and their children getting the illness. Resulted in depression, low confidence and isolation. Experiences of rejection, 
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Appendix 1-D. Process of synthesis and emerging themes and concepts 
Relevant studies (First author) Key themes, first iteration Key themes, final 
iteration (second-
order constructs)  
 






Paschal, Kilinc, Gauffin, Komolafe, 
Sonecha, Sleeth, Jacoby, Pembroke, 
Crooks, Collard, Molavi  
Beliefs about cause/public misconceptions/negative perceptions 
about epilepsy 
Ignorance/lack of knowledge about epilepsy/lack of 
understanding 
Mental illness/intellectual impairment/lack of capacity 








epilepsy result in 
discrimination and 
rejection 
Sonecha, Birbeck, Raty, Raty & Wilde-
Larsson, Collard, Yennadiou 
Different from society/societal expectations 
Taboo/strange/abnormal 
Different from society Different from 
society 
Birbeck, Chung, Komolafe, Paschal, 
Mlinar, Collard, Raffaelle, Sarudiansky, 
Molavi 
Experiencing rejection/abandonment/relationships ending/being 
avoided/distancing/disregarded 
Rejected from society Experiencing 
discrimination and 
rejection 
Birbeck, Komolafe, Sonecha, 





Raty, Raty & Wilde-Larsson, Chung, 
Birbeck, Sleeth, Yennadiou, 
Sarudiansky 
/Own understanding 




Internalised stigma Internal attributions 




Sonecha, Chung, Raty, Mlinar, Gauffin, 
Pembroke, Collard, Sarudiansky 
Self-perception  
Feeling different/abnormal/’yucky’  
Feeling of lower human value/low self-worth/disgusting 
Feeling different 
Sonecha, Chung, Raty, Mlinar, Gauffin, 
Yennadiou, Keikelame, Sarudiansky, 
Molavi 





Raty, Raty & Wilde-Larsson, Gauffin, 
Komolafe, Sleeth, Mlinar, Raffaelle, 
Jacoby 
Fear of harming others/injuring others/responsibility for others 
Scaring others/ 
Risk to others 
Komolafe, Raty & Wilde-Larsson, 
Mlinar, Gauffin, Sonecha, Sarudiansky, 
Yennadiou, Crooks, Collard, Molavi 
Fear of rejection//fear of assault/fear regarded stupid/fear of 
others’ reactions 
Fear of others’ 
reactions 
Fear of stigma 
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Relevant studies (First author) Key themes, first iteration Key themes, final 
iteration (second-
order constructs)  
 






Chung, Paschal, Raty, Gauffin, 
Komolafe., Sonecha, Mlinar, Jacoby, 
Raffaelle, Keikelame, Sarudiansky, 
Molavi 
Difficulties with relationships/effect on relationships/loss of 
relationship/fear of rejection 
Role fulfilment: Marital relationships/unable to marry/fear of 
divorce/losing parent role 





Impact of stigma on 
everyday life and 
associated reliance 
on others 
Komolafe, Gauffin, Birbeck, Raty, 
Keikelame, Raffaelle 
 
Fear of pregnancy/not able to parent/parenting/feeling a bad 
mother/not providing children/fear of harming baby 
Role fulfilment: 
parenting 
Sleeth, Birbeck, Bishop, Raty, Gauffin, 
Mlinar, Jacoby, Raffaelle, Sarudiansky, 
Molavi 
 
Applying for employment/maintaining employment/limited 
opportunities 
Losing work/losing job 




Bishop, Chung, Pachal, Mlinar, Raty & 
Wilde-Larsson, Jacony, Kilinc, Crooks, 
Raffaelle 
Diminished life/not being whole/daily restrictions/can’t do what 
others do/impact on daily living/multiple restrictions 
Unable to drive 
Restrictions on daily 
living 
Impact of epilepsy 
and stigma 
Chung, Gauffin, Raty, Yennadiou, 
Kilinc, Sarudiansky 
Not providing/not contributing/financial implications/unequal 
rights/not meeting potential 
Not contributing 
Chung, Birbeck, Klinic, Raty & Wilde-
Larsson, Crooks, Yennadiou, 
Keikelame, Raffaelle, Sarudiansky,  
Relying on others/feeling a burden/requiring support/not wanting 
to be dependent/burdening others 
Relying on others  Dependence on 
others 
Kilinc, Chung, Sleeth, Mlinar, Raty, 
Gauffin, Jacony, Kilinc, Pembroke, 
Crooks,  
Loss of control/lack of autonomy 
Externally enforced decisions/family decisions/external 
restrictions 
Feeling powerless/feeling restricted/infantilising/other over- 
protective 
Lack of independence 
Sleeth, Pembroke, Raffaelle, Kilinc, 
Keikelame, Molavi 
Refusing diagnosis/rejecting epilepsy/avoiding the ‘E’ word/not 
understanding own epilepsy 
Accepting epilepsy 
Denial of epilepsy Concealment Attempts to manage 
stigma through 
concealment and 
avoidance Gauffin, Komolafe, Sleeth, Sonecha, 
Mlinar, Klinic, Raty & Wilde-Larsson, 
Chung, Bishop, Padchal, Yennadiou, 
Sarudiansky, Raffaelle, Molavi, Collard 
Hiding epilepsy/not disclosing/keeping epilepsy 
secret/concealment/not telling employers 
Choosing when to disclose/choosing who to tell/practicing 
telling/avoid explaining 
Fear of others knowing/disclosure resulting in discrimination 
Being open about epilepsy 
Don't disclose epilepsy 
diagnosis 
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Relevant studies (First author) Key themes, first iteration Key themes, final 
iteration (second-
order constructs)  
 
Core Concept, first 
iteration 
Chung, Birbeck, Klinic, Raty & Wilde-
Larsson, Sonecha, Komolafe, Mlinar, 
Jacoby, Crooks, Yennadiou, Raffaelle 
Social withdrawal/self-isolation /avoid relationships/choosing 
friends 
Avoiding exposure/preventing judgement/pretending to be 
normal/ fear of forced disclosure/hiding seizures 




Birbeck, Komolafe Paschal, Sleeth, 
Mlinar, Chung, Bishop, Raty & Wilde-
Larsson, Molavi, Keikelame, Pembroke, 
Crooks, Sarudainsky 
Receiving support/supportive family/needing family 
support/support groups/supportive employers/supporting each 
other 
Support Support as 
protective 
Support from others 
is beneficial but 




Raty & Wilde-Larsson, Kilinc, Jacoby, 





Chung, Gauffin, Sleeth,Paschal, Raty & 
Wilde-Larsson, Kilinc, Molavi, Sleeth, 
Crooks, Yennadiou,  
Educating others/increased awareness/need for 
understanding/ignorance/incorrect information 
Church as source of education/education means 
acceptance/schools should educate 
Media misrepresentation 
Educating others  
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SELF-DISGUST IN EPILEPSY  2-2 
 
Abstract 
Aim: To illustrate the experiences of self-disgust in people with epilepsy and their 
understandings about this. 
Design: A qualitative study informed by thematic analysis. 
Method: Ten adults with epilepsy and uncontrolled seizures were recruited online and 
participated in a telephone semi-structured interview. 
Results: Three themes illustrated the development and experiences of self-disgust in adults 
with epilepsy and uncontrolled seizures, and how participants attempted to manage this. The 
first theme described the development of self-disgust as a result of the physical 
manifestations of seizures but also the experiences of others’ disgust reactions to seizures and 
an expectation of rejection. The second theme described the enduring and often, unescapable 
experiences of self-disgust, which could be experienced despite the physical reality of 
seizures. The third final theme illustrated how participants attempted to manage experiences 
of self-disgust, particularly through avoidance. 
Discussion: This study was the first to explore qualitatively the experiences of self-disgust in 
people with epilepsy. People with epilepsy experience disgust in reaction to the physical 
symptoms of seizures and these disgust-based feelings appear to become internalised 
following others’ disgust reactions. Avoidance as a strategy to manage self-disgust can be 
protective but may inadvertently maintain self-disgust. 
 
Highlights 
• The present study explored the experiences of self-disgust in adults with epilepsy 
• People with epilepsy experience disgust in reaction to the physical symptoms of 
seizures 
• People perceive disgust reactions from others in response to their epilepsy and 
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seizures which become internalised 
• These findings highlight the activation of self-disgust in response to epilepsy and 
seizures but which appeared enduring 
• Participants with epilepsy describe avoidance as a means of managing self-disgust but 
this strategy may not be adaptive 
 
Keywords: Epilepsy, Emotions, Disgust, Self-disgust 
 
1. Introduction 
1.1 Epilepsy and Mental Health 
As with other chronic health conditions, living with epilepsy may impact on the 
mental health of affected individuals [1].  In particular, stress, depression, suicidal ideation 
and anxiety have been reported to be common among people with epilepsy [2].  Individuals 
with poorly controlled seizures are two to three times more likely to be diagnosed with 
depression or anxiety than the general population [1].  Such experiences are important to 
consider in the management of epilepsy as experiences of anxiety and depression are stronger 
predictors of poor quality of life in people with epilepsy than seizures [3]. 
However, living with epilepsy may result in individuals experiencing a range of 
difficult emotions beyond those associated with anxiety and depression. Indeed, individuals 
with epilepsy are subject to high levels of stigma [4].  Recent research has also indicated that 
people with epilepsy are more likely to experience negative self-directed emotions such as 
shame and guilt, [5] which are associated with higher levels and more severe symptoms of 
anxiety and depression, as well as poorer quality of life [6].  In addition, qualitative studies 
exploring the experiences of epilepsy have highlighted the importance of consideration of 
emotions such as embarrassment in the management of the condition [7].  As a result of such 
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emotional experiences, individuals may experience increased social avoidance and poorer 
relationships [8].  Therefore, those interested in helping individuals manage the condition 
should also consider the diverse range of emotional experiences which may otherwise be 
unrecognised.  
1.2 Disgust and Self-disgust 
 One emotion which has recently benefited from a surge of research interest is disgust 
[9].  Far from being ‘the forgotten emotion of psychiatry’ [10] disgust is considered a 
universal human emotion, [11] relevant to a wide range of psychological difficulties.  Most 
psychological models of disgust conceptualise it as a negative but adaptive emotion which, 
via revulsion and rejection, allows for self-preservation through distancing oneself from 
potential contaminants [9].  This particular model describes four distinct disgust elicitors and 
their respective functions: core elicitors such as food and body waste products (e.g., faeces, 
vomit, urine) which protect us from harm and disease; animal-nature elicitors such as sex, 
death and hygiene that protect our ‘soul’ and mortality; interpersonal disgust to allow for the 
avoidance of contact with contaminated others; and moral disgust, elicited by moral 
violations to protect our social status.  However, more recent conceptualisations of disgust 
propose that it can in fact, be triggered by a wide range of sociocultural factors [12]. 
In recent years there has also been increased interest into the transdiagnostic construct 
of self-disgust. Self-disgust is conceptualised as a dysfunctional, rather than adaptive, 
generalisation of the disgust response, directed towards the self [13].  It has been found to 
correlate positively with disgust, as evidenced by the high concurrent validity between the 
Self-Disgust Scale and the Disgust Sensitivity Scale [14].   
Until recently, research into self-disgust was still in its infancy.  Indeed, both in 
research and lay language, experiences of self-disgust have often been described by better 
known self-directed emotions such as shame or guilt, or these may have been used 
SELF-DISGUST IN EPILEPSY  2-5 
 
interchangeably [15], perhaps obscuring the prevalence and importance of self-disgust.  
Others have described self-disgust as a component of self-criticism [16].  However, self-
disgust has now been subject to increased international empirical and theoretical study and a 
recent mixed-methods review examined the clinical utility of self-disgust [17].  
Self-disgust has been conceptually delineated from other negative self‐referent 
emotions such as self‐criticism, low self-esteem and shame, mainly through its 
phenomenological experiences related to disgust and revulsion [12, 18, 19], including the 
visceral and pervasive nature of self-disgust (often experienced as physical feelings of 
nausea), as well as distinct disgust-based appraisals [15].  For example, it is possible for 
individuals to have appraisals that might generate shame or guilt, but not disgust and 
conversely, appraisals that generate self-disgust (such as “I make other people feel sick”) but 
which do not necessarily generate shame [15].  Furthermore, self-disgust is associated with 
psychological and behavioural reactions (such as social withdrawal or attempts to cleanse or 
remove the disgusting self) not evident in other emotions [15, 17].  Shame has theoretically 
been conceptualised as relating to a sense of the whole self as fundamentally flawed, 
defective or inferior, initiating an urge to withdraw and hide the self [20-22].  Shame and 
self-disgust may therefore, have different evolutionary underpinnings [12].  While complex 
relationships exist between self-disgust and other self-directed emotions, [12] self-disgust has 
now been demonstrated to represent a meaningful and coherent construct which can be both 
theoretically and empirically differentiated [17].   
Self-disgust has, therefore, been conceptualised as a distinct emotional schema [12, 
15].  Emotional schemas can be defined as patterns of associations between perception, 
emotion, appraisals and cognition [23].  In self-disgust, disgust is directed towards the self 
and thus involves both disgust-based feelings and cognitive elements [15].  Thus, it is 
postulated that self-disgust schemas likely develop in childhood, perhaps in response to 
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disgust based abuse, whereas self-disgust in adulthood is more likely to be in response to a 
change in  the self or how the self is experienced [12, 24]. 
Increased interest in self-disgust has led to its identification in people with a range of 
mental health difficulties, including individuals with difficulties with depression, body image 
and trauma [17] and thus, have implications for the treatments of such.  Further, the concept 
of self-disgust and its role in adaptation to physical health conditions has been evidenced. 
[25].  Indeed, physical side-effects of cancer treatments, such as nausea or bladder or bowel 
problems, and thus elicitors of core disgust, were associated with increased psychological 
distress and mediated adjustment to cancer treatment [26].  However, it has been proposed 
that self-disgust in physical health conditions might have both beneficial and detrimental 
effects on outcomes [27] and there is, therefore, the potential for further exploration of this 
relationship. 
1.3 Epilepsy, Disgust and Self-disgust 
Self-disgust in relation to epilepsy may be particularly relevant.  Firstly, self-disgust is 
likely to be culturally influenced and determined according to social norms of what is 
appraised as disgusting [13].  Indeed, disgust propensity (proneness to be disgusted) has been 
found to be associated with negative attitudes toward people with cancer [28].  
Given that epilepsy is a disorder associated with very visible behavioural 
consequences of seizures, individuals with epilepsy may have to experience core disgust-
inducing stimuli (such as convulsions, or incontinence) that could result in the activation of 
the self-disgust schema.  Indeed, Reynolds and colleagues [29] propose that the symptoms of 
physical illness mean that exposure to disgust-elicitors is commonplace and, as a result, 
activation of the self-disgust schema is unavoidable.  
Furthermore, the self-disgust schema is likely to develop in response to others’ 
reactions to one’s self and behaviour [12].  Epilepsy remains associated with a range of 
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misconceptions and myths [30] and high levels of illness-related stigma are reported [31].  
For example, epilepsy has been considered to be caused by an “unclean dumb and deaf spirit” 
(p. 12) [32], illustrating negative held beliefs about the nature of epilepsy. Individuals with 
epilepsy may therefore have to confront a wide range of disgust-inducing stimuli, such as 
being perceived as contaminating and being socially stigmatised [33].  Disgust responses 
have been shown to be automatically activated in onlookers due to the perceived risk of 
contamination, despite a genuine lack of such pathogens [34], as demonstrated in perceptions 
of obesity [35].  It is possible, therefore, that self-disgust in epilepsy may be an important 
mechanism involved in the high levels of social avoidance reported in this population [36].  
Parents of children with disfigured faces report avoiding taking their children out in public 
due to anticipated disgust reactions of others [37]. Indeed, disgust-induced social avoidance 
has been evidenced in people with bowel problems. 
1.4 Current Research Question 
The theoretical explanation of whether and how self-disgust might be experienced by 
individuals with epilepsy is yet, unexplored.  Such understanding would provide insight into 
the management of epilepsy and associated psychological distress.   
The current study addresses this gap in the literature by exploring first-hand 
perspectives of people with epilepsy.  Using a qualitative methodology, the primary aim of 
the current study was to explore the experiences of self-disgust in people with epilepsy and 
their understandings about this.  
2. Method 
2. 1 Design 
Qualitative methodologies allow for in-depth exploration of a small sample of 
participants’ experiences  allowing for a richer understanding of subjective perceptions and 
complex experiences [38].  A qualitative approach was chosen as the most appropriate 
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methodology to address the research question as it would provide  opportunity to explore 
participants’ experiences of self-disgust in epilepsy, an area which has yet to be researched. 
Thematic analysis is an established method of qualitative analysis [38].  It allows for a 
systematic approach to the identification of themes and summarises patterns of data across 
the dataset that are important to a specific research question [39].  Thematic analysis can be a 
useful approach to explore individuals’ experiences of a novel phenomenon and was 
therefore chosen as the most appropriate methodology for the current study. 
2.2 Procedure 
The necessary ethical approval for research carried out within the National Health 
Service (NHS) was received prior to commencement of the study.  Recruitment to the 
research study was via two sources: a single-centre NHS epilepsy service and a leading 
national epilepsy charity.  Recruitment was promoted by staff and by electronic media such 
as the charity’s website, social media and email, as well as more traditional routes such as 
newsletters and word of mouth.  Potential participants were invited to complete a consent 
form, provide demographic details and complete the Self-Disgust Rating Scale (SDS) [14] 
either online or via post.  Participants were made aware that a proportion would be invited to 
further take part in an in-depth qualitative interview and consent for this was gained at the 
time. 
To identify participants for whom self-disgust might be most relevant, those with the 
highest scores on the SDS were invited to interview.  Scores on the SDS can range from a 
possible score of 12 to 84.  Only participants who scored greater than 31 were considered for 
inclusion in the interview element of the research.  This represented a score of more than one 
standard deviation above the mean according to a previous non-clinical sample (M = 29.8, 
SD = 1.2)[14].  This is consistent with an approach adopted in a study exploring self-disgust 
within a different population [15].  As specified in the approval of the study, interviews could 
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take place face-to-face or over the telephone.  Due to practical restrictions and participant 
preference, all interviews took place over the telephone.  Prior to the interview taking place, 
all participants were informed  that they could stop the interview at any time and  could 
withdraw their data from the study up to two weeks following the interview.  At the end of 
the interview the researcher ensured that the participants were not feeling distressed and 
debrief information was provided, including details of where to seek further support if 
required.  
Interviews were conducted according to a semi-structured schedule (see Appendix 2- 
A).  This was based on a previous study which qualitatively explored the experiences of self-
disgust in females with depression [15], but which was adapted for the current research study. 
This allowed for discussion of background to epilepsy and seizures, experiences of emotions 
including self-disgust, as well as the relationship between them.  Although the interviewer 
followed the schedule, interviews were led by the participants and how they discussed their 
experiences in line with the research question.  Therefore, parts of the schedule may have 
been elaborated on if it was believed by the researcher to be important to the participant.  
This is consistent with data collection methods appropriate for thematic analysis [14]. 
 
2.3 Participants 
Forty-three participants completed the SDS and consented to take part in the research. 
All did so via the online source.  The median score on the SDS was 50 (IQR = 43-59).  A 
total of 38 participants (88%) scored above the chosen cut-off, suggesting high rates of self-
disgust compared to a normative sample [14]. Of these, 10 participants took part in a follow-
up in-depth interview.  Participants were allocated pseudonyms chosen by the researcher to 
maintain anonymity.  The size of the sample reflected the qualitative thematic approach taken 
in which the in-depth exploration of the experiences of a small number of participants is 
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preferential [40] and is consistent with the number of participants recruited in other published 
research using thematic analysis [41]. 
Participants were aged 16 years or over (and thus expected to be under the care of 
adult healthcare services) and self-identified as having received a diagnosis of epilepsy and 
experienced at least one seizure in the last twelve months.  Participants were required to 
speak English, as it was preferred that the speaker and interviewer be fluent in the same 
language, and did not have communication or learning problems of sufficient severity to 
prevent providing informed consent or taking part in an in-depth interview.  Information on 
participant demographics was collected from the participants at the time of consent and 
included age, gender, type of epilepsy diagnosis, and duration since this diagnosis was 
received. 
Participant demographics are displayed in Table 1.  The median participant age was 
30 years (IQR = 26-43).  The median duration of epilepsy was 10 years (IQR = 3-20). 
- Insert Table 1 about here - 
2.4 Data analysis 
The analysis conducted in this study was consistent with the six-stage approach to 
thematic analysis described by Braun and Clarke [38].  This approach allows for a flexible 
but systematic way of gathering, analysing and conceptualising qualitative data but which 
also encourages the researcher to be reflexive and make their epistemological and other 
assumptions explicit.  The approach involves six phases: 1. Familiarising with the data. 2. 
Generating initial codes. 3. Searching for themes. 4. Reviewing Themes. 5. Defining and 
naming themes. 6. Producing the report.  For additional guidance, a practical example of 
conducting trustworthy thematic analysis was consulted [42].   
An inductive approach to the analysis was adopted. This aimed to analyse the data in 
a way that was strongly linked to the data itself rather than trying to fit this within a pre-
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existing framework or the researcher’s preconception [43].  In line with guidance, interviews 
were transcribed verbatim by the researcher, which aided becoming familiar with the data.  
All transcripts were re-read and initial thoughts about the dataset were noted in a reflective 
log.  Codes were then derived directly from the data, working systematically through all 
transcripts, giving equal attention to each [38].  Important sections of text were highlighted, 
and labels attached.  Codes were derived at the semantic level, to reflect the explicit data 
itself, as opposed to the latent level which aims to describe concepts and assumptions which 
might be underpinning the data [38].  All codes and associated text were collated in a 
spreadsheet and organised into themes by considering the relationships between them.  
Initially a ‘miscellaneous’ theme was held so that potentially relevant data was not 
prematurely abandoned [44].  Initial themes were revised by revisiting the transcripts and 
refining codes, and the development of themes was carried out by reconsidering the 
relationships between them.  At this stage, themes can be refined, combined, separated or 
abandoned [44].  The interpretation of themes continued during the writing of the report until 
the final distinct and separate themes were identified and named.  
2.5 Reflexivity 
Many quality appraisal tools and criteria can often not be suitably applied to 
qualitative research [45].  Instead, to demonstrate trustworthy findings, qualitative research 
and, specifically thematic analysis should be conducted and reported in a rigorous manner 
[42].  It is, therefore, recommended that qualitative researchers consider issues such as 
sensitivity to context, rigour, coherence and transparency [46].  Therefore, to demonstrate 
credibility, these criteria were considered throughout, facilitated by the use of a reflective log.  
Thematic analysis is not tied to a particular epistemological position and so is a 
method that can be flexibly adopted and carried out in accordance with to an individual 
researcher’s stance.  However, it is recommended that this is made explicit, so that the 
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potential influence on the analysis is clear and readers can be assured that findings are 
coherent and consistent with this position [47]. 
The epistemological position of the researcher was that of critical realist.  Critical 
realism is ontologically realist.  It differs from both positivism (reality is only that which can 
be empirically known) and constructivism (reality is constructed only through human 
knowledge or discourse) [48].  A critical realist approach to research therefore, assumes that 
data is ‘real’ but that interpretation is needed in order to access the underlying structures of 
this [49].  Thus, it assumes that an independent reality exists but that this operates 
independently of our awareness or knowledge of it and thus, can only be fallibly known [50] 
or ‘imperfectly apprehendable’ [51]. As such, from a critical realist perspective self-disgust 
was assumed to exist as a ‘real’ construct but that current explanations of this are fallible. 
Thus, attempts to understand ‘real’ experiences of self-disgust from participants accounts of 
such, through interpretation based on these existing theories, would also be fallible.  
In line with this approach and following guidance on conducting thematic analysis 
[44], it was considered  important to reflect on the preconceptions and knowledge of the 
researcher and the potential impact of herself on the data collection and analysis. 
Assumptions were likely to be influenced by the researcher’s prior clinical experience of 
working with this population and awareness of the self-disgust literature.  Furthermore, it is 
acknowledged that identification of participants using the SDS may have further impacted on 
participants’ expectations of the research and thus, demand characteristics were important to 
consider.  
Within thematic analysis, researcher judgement is required to decide on themes as 
part of the analysis. Thus, a critical realist approach acknowledges the inevitable and 
inescapable impact of the researcher’s experiences, beliefs and assumptions on the data [38].  
As such, the researcher assumed that themes did not passively ‘emerge’ from the data but that 
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these were actively constructed, according to the researcher’s assumptions and informed by 
the literature [52].  However, in attempts to remain consistent with the inductive approach 
and limit the impact of such factors on the interpretations made, the researcher, attempted to 
remain aware of her influence at all stages of the research.  Steps were taken to mitigate 
against this as much as possible through the use of a reflective log and discussion in 
supervision with a more experienced researcher.  Notes were made to track reflections and 
lines of enquiry following individual interviews and the analysis process [53]. Use of 
language was also considered, for example, attempting not to ask leading questions during 
interview and taking care not to take examples out of context during analysis.  To support 
this, all themes were evidenced by direct quotes.  Further, an audit trail of the analytic 
process is provided, allowing readers to judge the reliability of interpretations, by the 
possibility of tracing the development of themes from raw interview data, to theme 
identification and the final presented themes. 
3. Results 
Three key themes were identified from analysis of the data: Being an outsider: “The 
feeling of being a bit of a freak”; The unescapable presence of self-disgust: “it’s a niggling 
feeling that something’s not quite right”; Preventing exposure: “Living a protected life”. 
These are further discussed, and illustrative quotes are provided to support the author’s 
interpretations. 
3.1 Being an outsider: “The feeling of being a bit of a freak” 
In this first theme, participants described the difficulty in experiencing the physical 
symptoms of seizures were found to be disgusting. Participants described others’ disgust 
responses to seizures as being inevitable and thus the difficulty experienced in others 
witnessing them.  Subsequent negative reactions of others led participants to feeling 
stigmatised, internalising disgust and anticipating further negative appraisals and rejection. 
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All participants described the physical symptoms of seizures which they experienced 
as unnatural, dangerous, and posing threat to health as one participant explained: 
my whole body goes really rigid, really straight, then I start the jerks. Then I start 
slavering and loads of foam are coming out of my mouth. They say I make piggy type 
noises. I wee myself as well, which is the worst bit, and then I just move around all 
over the floor and smack my head on the ground usually, cause quite a few injuries 
and blood and bite my tongue, things like that. And my eyes, it’s really freaky 
because I don’t close my eyes for some reason. My eyes stay wide open and I’m just 
staring into nowhere, like into space (Gemma) 
Gemma’s description details the numerous disgust-inducing symptoms associated 
with seizures including core and animal-nature disgust elicitors.  Furthermore, symptoms of 
seizures also appeared to result in moral disgust responses, thus feeling degraded, inferior and 
of low social status: “I feel disgusted in myself, I mean I wee myself when I fit, for goodness 
sake, it cannot get much lower than that” (Gemma).  While social comparisons are often 
associated with stigma in epilepsy [4] and related to other self-directed emotions, such as 
shame and self-criticism [54], here it appeared that seizures were also associated with the 
activation of a stronger disgust response.   
Due to their disgust-inducing nature, participants described expecting their seizures to 
be appraised as “not attractive” (Laura) to others.  Therefore, experiencing seizures in public 
could be particularly difficult: “like it happened in [UK supermarket] that one time and that 
was mortifying, I was just like, uh, it was just disgusting in the middle of the aisle and people 
coming up cleaning after myself, the blood and the wee and, uh, it’s just embarrassing” (Sue).  
As Sue explains, others witnessing the physical symptoms associated with seizures, 
particularly others being in contact with her bodily fluids, due to their potential contaminating 
nature, could trigger feelings of social embarrassment and disgust.   
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Participants therefore reported a fear of others witnessing seizures and appraising 
them as disgusting: “when I have a seizure and stuff I worry about, I feel like other people 
would be disgusted” (Laura).  This seemed driven by a desire to prevent others’ perceptions 
of them being associated with their epilepsy which they felt would endure: “I don’t want 
them to have to see me as person who fits, I want them to see the person before all of these 
fits, because then they’ll just associate me as disgusting, and they’ll just not get the disgusting 
images out of their heads” (Katie). 
Indeed, participants reported receiving negative feedback from others regarding 
seizures, having been told they appeared “scary” (Sue), “disturbing” (Neil) and “horrifying” 
(Gemma) to witness.  Therefore, the distress and fear that could be provoked in others at 
seeing seizures could result in extreme reactions; as one participant explained: “I was told 
that the girl had stood up and screamed, and one girl had even jumped over the desk to get 
out of the room because she’d had such a fright” (Harriet).  One participant explained how 
these reactions had the potential to make her feel monstrous: “it sort of makes you feel a bit 
like when you’re having a fit, you know, you look like a monster” (Anne) and in turn feeling 
‘dirtied’ and thus, disgusted in herself due to the impact on others: “it makes you feel more, I 
don’t know, sort of, dirty if you like and it makes you appreciate the effect you have on, the 
bad effect you have on people” (Anne).  As the common behavioural response to disgust is 
rejection [15, 55], many participants also described being avoided by others as a result of 
seizures; as one participant described: “there are times when you have a seizure and people 
don’t help you, which is quite horrible, like, they avoid you” (Helen).  
Participants therefore described that, over time, experiencing the symptoms of 
seizures, learning of others’ disgust reactions and experiencing discrimination led to “feeling 
different” (Katie), stigmatised and therefore, an outsider of society: “it’s from those 
conditions that the feeling of being a bit of a freak comes” (Clare).  As a result, perceptions 
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regarding others’ disgust-based appraisals and responses towards seizures could become 
internalised as described by one participant: “it’s other people’s perceptions of me that makes 
me feel disgusted in myself” (Emma).  Moreover, these emotional experiences appeared to be 
new as a result of developing epilepsy and distinct from existing beliefs or difficult emotions 
experienced in the past: “with these fits it is a completely different feeling to what normal 
feelings I had up until, prior to that” (Helen).  It appeared, therefore, that self-disgust was 
activated by the development of epilepsy and the internalisation of negative appraisals and 
responses from others. 
 Therefore, participants described anticipating further disgust responses from others. 
For many, these responses were appraised as understandable: “just the visual of the vomiting, 
the gurning, um, like the stiffening of the limbs, the jerking. I would have a fright if 
somebody took ill in front of me in that way” (Harriet).  Thus, participants described further 
rejection was to be expected: “why would a lad want to be with me and like, share a bed with 
me when I do things like this?” (Katie).  However, participants also described the on-going 
realisation of such, as distressing: “yeah I know I look disgusting when it’s happening, and I 
already feel disgusting so I don’t need them to kind of, point it out” (Gemma).  While some 
participants spoke of others reacting positively to their seizures, these were usually confined 
to close family and friends with whom they had existing secure relationships and who 
perhaps had improved understandings about epilepsy.  
3.2 The unescapable presence of self-disgust: “it’s a niggling feeling that something’s 
not quite right” 
In this subsequent theme, participants described the enduring nature of self-disgust 
due to the uncertainty of epilepsy.  Separation of disgust towards the ‘epileptic body’ from 
the ‘whole self’ was described by some participants, which appeared protective, but which 
was jeopardised by the risk of further seizures.  
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 All participants described the difficulty of living with a condition over which they 
felt they had limited control and as such, described a persistent sense of unease: “it’s a 
niggling feeling that something’s not quite right” (Harriet).  
Participants described self-disgust as enduring, beyond acute seizures themselves. 
Indeed, it appeared that self-disgust could also be activated through memories or reminders 
about epilepsy without the physical reality of a seizure.  Such cognitions alone could re-elicit 
the physiological responses associated with self-disgust: “it makes me feel sick, physically 
sick when I think back to that time [referring to a seizure]” (Helen).  Furthermore, the risk of 
further seizures and anticipated responses in others could maintain feelings of self-disgust: 
“there’s always a fear and that fear is always gonna be that if it does happen it’s gonna be 
horrible” (Sue).  As such, one participant described the psychological impact of the 
unescapable presence of epilepsy, rather than the physical symptoms, as resulting in specific 
physiological experiences of sickness and nausea which appeared enduring: “a lot of the time 
it [having epilepsy] just makes us feel really sick, like nauseous” (Katie).  
Moreover, due to the uncertain nature of the condition, participants described the 
inevitable further negative impact of seizures on others.  Participants described negative self-
directed emotions in response to the impact of their epilepsy on others, as one participant 
described: “I just feel so frustrated and angry and disgusted with myself that I’m letting other 
people down” (Clare).  For those participants who were parents, the potential to expose their 
children to the distressing experience was associated with a deep sense of shame, due to their 
perceived increased vulnerability; as Sue described: “it’s not something a child, should see”. 
One participant described feelings of self-disgust resulting from the distress caused as a result 
of the care required from others during seizures: “I feel disgusted that if I have a seizure then 
people will have to do that [referring to others offering first-aid during a seizure] and I’ve 
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called on them to do that” (Neil).  The potential impact on others’ lives was, therefore, also 
internalised: “I’m disgusted with me because of what I’ve done to other people” (Neil).  
Interestingly, some participants described a psychological distinction between 
feelings of self-disgust directed towards the self and the body.  This appeared more tolerable 
and prevented penetration of self-disgust towards the ‘whole self’ as Helen described: 
Disgusted at my body, just revolted at its weakness, just disgusted at it’s pointless, the 
fact that it couldn’t even do a short walk, what was the point in it, what was the point 
of it even existing, that’s what I kept thinking, not me existing, but it existing 
Thus, many participants described feeling “betrayed” (Harriet) by their body. One 
participant described this negative affect as being directed specifically at their brain as 
dysfunctional: “anger at my brain because that’s where it’s coming from… I feel angry at that 
and frustrated and disgusted and think why it’s not working in the way it should do” 
(Harriet).  Thus, participants described the desire to remove or distance from the epileptic 
body, but which was not possible due to ongoing physical symptoms of seizures.   
However, this separation between the epileptic body and the self, did not appear 
possible for all participants.  While epilepsy appeared to be the trigger for feelings of self-
disgust, this could also become generalised to feelings of self-disgust towards the whole self:  
I’m always thinking, I’m a weirdo, I’m a freak, there’s so many words and feelings 
that I can use to describe myself because, only because of the epilepsy, not in myself, 
just associated with the epilepsy, and I’m horrible, I’m disgusting, I’m freaky, all of 
this that and the other (Gemma) 
Gemma’s use of the first person “I” suggests disgust is directed to her entirety. 
Interestingly, Gemma was one of the most recently diagnosed participants and this difference 
may reflect lack of time to adjust to living with the condition.  It might therefore be 
hypothesised that this distinction becomes an effective coping strategy with time.  
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However, even when this separation was available to participants, this was constantly 
jeopardised by the inevitability of further seizures which could result in an inconsistency 
between how one viewed the self and how others might perceive them: “it’s changing the 
view that I’m presenting to the outside world and I’ve actually got no control over it” (Clare). 
Therefore, participants’ lack of control over their bodies appeared to maintain self-disgust 
due to feelings of hopelessness and futility.  
3.3 Preventing exposure: “Living a protected life” 
This theme illustrates how participants attempted to manage their difficult feelings of 
self-disgust. Participants described radical steps to avoid further public exposure of epilepsy 
to protect themselves and others.  Participants also described altered self-care behaviours. 
Participants described the main way of managing the negative emotional impact of 
epilepsy, including self-disgust as being through avoidance.  Disgust responses of avoidance 
and rejection are described to be an adaptive response that protect us from harmful 
contaminants [9].  Indeed, participants frequently described disgust in response to the 
physical nature of seizures and a desire to distance themselves from the situation:  
All I want to do is get up, no-one will let us stand up. They want to call [an] 
ambulance. Everyone kind of takes over and I just think ‘oh my goodness I’m putting 
everyone else out’ and I just feel really disappointed in myself, disgusted. I just feel 
vile. I literally just want to get up and get out of that room where I am, but obviously I 
can’t stand up straight away after it, so I’ve got to bring myself round fully (Gemma) 
However, this quote also describes Gemma’s desire to remove herself from others 
who were present and caring for her.  As such, avoidance may also be used in attempt to 
manage the fear of stigma, shame and the perceived distress caused in others, which might be 
associated with interpersonal disgust.  However, due to the nature of seizures, behavioural 
avoidance strategies were often not possible or ineffective. 
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Avoidance was therefore also used in attempts to hide further seizures from others.  
This appeared to be as a result of avoiding “the risk of these things happening publicly” 
(Clare) and thus limiting the resulting negative reactions of others.  One participant 
specifically described this being in an attempt to avoid the anticipated disgust response of 
others: “I hide myself away, so people don’t witness me being so vulnerable and like, 
disgusting and vile and horrible” (Gemma).  Other participants described hearing distressing 
stories of people being filmed during a seizure and humiliated on social media. Similar to that 
described in response to health-related shame and stigma [56], the fear of this happening 
prompted further social avoidance.  
Furthermore, perhaps in response to the anticipated disgust and distress caused to 
others as a result of witnessing a seizure, participants also described social avoidance as a 
strategy to protect others:  “it’s just easier for everyone and I don’t have to freak out my 
friends and they don’t have to deal with it” (Anne).  Despite this potentially leading to 
feelings of loneliness, Anne viewed this as “the lesser of two evils”.  Moreover, participants  
described purposeful attempts to avoid social interaction with people who were familiar to 
them: “in a way I’d prefer to take ill in front of strangers than in front of the people I know 
and that care about me, I suppose. Because you have to face those people again.” (Harriet). 
Potentially, avoidance was, therefore, seen as a protective mechanism to maintain 
relationships with others.  
Participants also described avoidance of places where they had experienced seizures 
as well as other people who had witnessed them.  This often led to participants taking radical 
steps to avoid these situations and participants reported leaving jobs or ending relationships 
in an attempt to prevent having to face these situations due to the potential to re-activate 
negative emotions such as  shame and self-disgust: “the thought of having to face people 
when you’ve wet yourself in front of them is just, it’s a really horrendous feeling” (Helen). 
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One participant described the visceral feelings of sickness as a result of having to return to 
the environment in which she had experienced a seizure: “it was just the feeling of being, you 
know, the wanting to be sick as I walked into the office because I didn’t know what I would 
be facing” (Sue). 
Interestingly, some participants also expressed overt attempts to avoid having to 
witness their own seizures.  Participants described the videoing of seizures, often for medical 
professionals, but not wanting to view the recordings: “I wouldn’t like to see it… I just think 
it would be disgusting to watch” (Katie).  However, for some this lack of knowledge 
increased distress: “it’s the not knowing what I look like as well that affects us, cause all I 
know is what people describe, what I look like, but I can’t actually see it for myself” 
(Gemma).  Again, it appeared that those who had developed epilepsy more recently, and 
therefore had less time to adjust, found this more difficult than others.  In contrast, one 
participant who had experienced epilepsy for many years reported feeling more comfortable 
with the appearance of seizures: “now I know what they look like and I can prepare for that 
and I can explain to people what will happen” (Neil). This appeared to result in an improved 
sense of control.   
Participants described altered self-care behaviours.  These were described in attempt 
to limit further seizures, and thus, the distressing and potentially disgust-inducing 
experiences. Such strategies were therefore viewed as protective, as Clare described: “you 
live a protected life, you protect yourself… I will never book in something every day of the 
week. It’s one way that I cope”. However, participants spoke of this also resulting in negative 
feelings due to living a restricted life.  
In contrast, however, some participants also spoke of feelings of self-disgust leading 
to lack of self-care.  This often resulted in engaging in behaviours which appeared to 
reinforce the belief that the self was disgusting, for example not showering or brushing their 
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teeth: “I just feel like I’m not worth it and I’m so gross anyway. I’m just a freak” (Anne). 
This appeared to be associated with the belief that their disgust was unchangeable due to the 
chronicity of epilepsy, and thus attempts to present themselves more positively were futile. In 
this way, self-disgust and lack of self-care appeared to develop into a cycle in which one 
maintained the other. 
However, in an attempt at self-affirmation, some participants spoke of information 
about epilepsy being helpful.  Participants described this knowledge about the medical nature 
of epilepsy as relieving some of the self-disgust and shame often associated with having the 
condition, perhaps contributing to the separation between the self and the body previously 
described:  “after all this time I know that’s what it does, I can’t stop it… it’s electrical 
activity that just takes over” (Neil).  This was perhaps related to the individual’s duration of 
epilepsy in which those who had epilepsy for a longer time were more able to accept the 
nature of the condition and thus generate increased feelings of self-compassion.  For others, 
receiving support and compassion from friends, family or even pets appeared reassuring and 
protective against some of the difficult feelings associated with epilepsy, including self-
disgust. 
4. Discussion 
This is the first study specifically to consider experiences of self-disgust in people 
with epilepsy.  As well as other self-directed emotions that have previously been described in 
this population such as shame and stigma [4], interviews with participants demonstrated 
experiences of self-disgust associated with epilepsy and uncontrolled seizures. The findings 
presented three key themes. The first theme described participants’ own reactions and their 
perception of others’ reactions to their seizures which led to feelings of disgust directed 
towards the self.  Subsequently, the second theme illustrated the enduring and often, 
unescapable experiences of self-disgust, which could be elicited despite the physical reality 
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of seizures.  The final theme described how participants attempted to manage their difficult 
feelings of self-disgust, predominantly through avoidance, in attempts to protect themselves 
and others. 
4.1 Disgust and self-disgust in epilepsy  
Consistent with the psychological model of disgust as an adaptive emotion to protect 
us from harm and disease [9], participants described disgust being elicited within, as a result 
of the physical presentation of seizures and associated symptoms of such, including body 
waste products.  Similarly, participants also described the detection and anticipation of 
similar disgust responses in others’ reactions to their seizures.  Participants further 
internalised others’ negative appraisals and disgust responses to their seizures and as a result, 
anticipated further avoidance and rejection.   
While disgust elicitors may be viewed as having an adaptive mechanism [9], self-
disgust is conceptualised as a dysfunctional generalisation of the disgust response, directed 
towards the self [13]. In this study, activation of disgust responses was described in response 
to seizures.  This may be, perhaps beneficial for a period of time, to remove participants from 
danger or as a protective mechanism from others’ disgust responses. However, it appeared 
that participants internalised these reactions and that self-disgust remained active, beyond 
acute seizures.  Indeed, in this study, participants described a persistent and enduring sense of 
self-disgust which was described as ‘always in the background’.  This was associated with 
visceral experiences of sickness and nausea distinct to self-disgust [17].  However, this 
feeling could also fluctuate over time, as it was intensified by triggers including further 
seizures or reminders of epilepsy, consistent with previous qualitative descriptions of self-
disgust [15]. 
Interestingly, due to the unpredictable nature of epilepsy, participants described the 
lack of control over seizures resulting in feelings of self-disgust as unescapable.  Such a 
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finding may be explained by the theoretical perspective of self-disgust as an emotional 
schema.  Emotional schemas represent interactions between perception, emotion, appraisal 
and cognition [23] and are hypothesised to be persistent at some levels of consciousness [57]. 
Thus, participants described a self-disgust emotional schema which was enduring in the 
background, but which could also be triggered by congruent experiences.  
While it has been proposed that self-disgust is likely developed in childhood [13], in 
the current study no differences were apparent in self-disgust experiences due to the age of 
onset of epilepsy. However, it has more recently been argued that dysfunctional self-disgust 
schemas can, in fact, be created in adulthood, particularly in those with a latter onset of 
chronic, debilitating physical conditions [15].  Indeed, in this study, participants indicated 
that the self-disgust schema was not only activated by seizures but,  initiated and 
demonstrated in response to epilepsy, whether this developed in childhood or adulthood.  
Furthermore, the majority of participants in the study did not identify previous feelings of 
self-disgust or of having experienced epileptic seizures in others.  This provides further 
evidence for the activation of a self-disgust schema only initiated in response to personal 
experiences of epilepsy. 
Self-disgust also appeared to be elicited by the perceived ‘disgusting’ dysfunctional 
body or brain.  In attempts to tolerate this, participants described a psychological distinction 
between the ‘epileptic body’ and the ‘whole self’.  This is consistent with the psychological 
reactions to self-disgust described in other populations. Indeed, attempts to dissociate the 
‘disgusting’ self from the rest of one’s identity have been described in people with eating 
disorders [18] and in women with depression [15].  Viewing epilepsy as a dysfunctional brain 
or body, while having an internal focus, allowed some participants to externalise the blame 
from their self.  This, could in time, allow for acceptance of the lack of control associated 
with condition.  This is consistent with previous literature in the development of an altered 
SELF-DISGUST IN EPILEPSY  2-25 
 
sense of self necessary to adjust to  having a long-term health condition [58].  It is proposed 
that only when all other plausible explanations are considered and exhausted, and with 
repetitive experiences in daily life, can an altered sense of self around illness be accepted. 
However, studies focusing on the locus of control in epilepsy suggest that those who attribute 
their epilepsy to external factors might in fact show poorer psychological functioning than 
those who accept internal triggers [59].  While for some this distinction between disgust at 
the ‘whole self’ and the altered ‘epileptic body’ appeared protective, it may explain why this 
was not sufficient to prevent prolonged distress and enduring feelings of self-disgust.  
Further, due to the neurological and therefore, internal nature of epilepsy, the inability to 
avoid the body could in turn reinforce feelings of self-disgust. 
The dominant approach to managing self-disgust described by the participants in this 
study was that of avoidance.  Social avoidance strategies have been well documented in 
response to epilepsy related stigma [4].  Participants described engaging in behaviours that 
they felt were protective, both to prevent further seizures, but also in preventing exposure of 
their epilepsy that might be distressing to others.  It has been proposed that disgust may have 
a causal link to stigma seen in health conditions such as cancer [28].  Indeed the protective 
function of self-disgust has been suggested  [60].  Theoretically, social avoidance in cancer 
has been proposed to have beneficial effects both in the short and longer term, [29] for 
example in the maintenance of relationships.  However, differences between health 
conditions in terms of elicitors of disgust are of important note.  Further exploration of the 
relationship between stigma, disgust and avoidance in epilepsy would, therefore, be of 
interest.  
Furthermore, avoidance may not always be the most effective coping strategy. Indeed, 
it is proposed that avoidance rather than problem-solving coping may be associated with 
poorer psychological adjustment to epilepsy [61].  Moreover, the mediating impact of self-
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disgust on loneliness and depression has been described [62].  In the current study, 
participants’ social avoidance could also be associated with social isolation.  Therefore, self-
disgust driven avoidance may in fact, maintain distress, similar to that seen in anxiety 
disorders [63]. 
4.2 Limitations 
This study has a number of limitations which should be considered within the 
interpretation of the results reported here. 
Due to practical restrictions and participants’ preference, all participants took part in 
telephone interviews. As disgust is associated with distinct visceral qualities, often indicated 
by facial expression, it is possible that the researcher was unable to pick up on more subtle 
indications of disgust.  Future research may be interested in whether such face to face 
interviews allow for the identification of additional factors when exploring the experiences of 
self-disgust. 
All participants included in the study were recruited online rather than via a 
healthcare service. Although participants were informed in the participant information that 
they were only eligible to take part if they had received a diagnosis of epilepsy from a 
neurologist, and confirmed this verbally during interview, due to self-identification it was not 
possible to fully ascertain this information.  For this reason, it is possible that the sample 
reported on here included those with non-epileptic seizures who are likely to have different 
psychological experiences to those with epilepsy [64] and, therefore, may have had different 
experiences of self-disgust.  Future research may benefit from the identification of 
participants via healthcare professionals to ensure a validated diagnosis and consider any 
differences between these populations.  It is, however, recognised that many research studies, 
particularly largescale quantitative studies, may indeed face this challenge [65]. 
Further, a larger proportion of women self-identified and took part in the study than 
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men.  Subtle differences between these groups were identified but which were not explored 
due to the small sample and qualitative approach.  However, higher levels of self-disgust 
have been reported in women [66].  For this reason, quantitative studies may therefore be of 
interest to researchers to explore the impact of gender and other factors on the experiences of 
self-disgust in people with epilepsy. 
4.3 Clinical Implications 
The results from the current study suggest that emotional states such as self-disgust 
could be important to consider  in relation to epilepsy and psychological distress. Therefore, 
assessing for the physiological, behavioural, cognitive and affective states associated with 
disgust may be important to inform interventions for treatments aimed at improving 
psychological well-being in people with epilepsy.  
Current psychological interventions aimed at improving psychological wellbeing in 
people with epilepsy have included cognitive, behavioural, and mindfulness-based 
interventions which have been shown to improve quality of life and psychological well-being 
[67].  However, it is important that healthcare professionals also understand the influence of 
self-directed emotions, including self-disgust, that might lead to behaviours such as 
avoidance in some people with chronic health conditions, including epilepsy.  Therefore, they 
are better placed to recognise and support individuals.  
Descriptions from the current participants suggested that duration of epilepsy was a 
potential factor associated with experiences of self-disgust and subsequent adjustment to the 
condition.  Length of illness can be an important factor in adjustment to physical health 
conditions [68].  Here, it was apparent that those who had been diagnosed with epilepsy more 
recently were less resourced to apply coping strategies.  As such, it may be of increased 
importance to consider self-conscious emotions within those earlier in the adjustment 
journey.  
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Treatments for associated emotions such as guilt and shame have been described, for 
example mindfulness and present moment acceptance [27], compassion-focused therapy [54] 
and exposure therapy directed towards disgust at one’s own body [69].  Indeed it has been 
proposed that emotional components are of key consideration in psychological interventions 
aimed at reducing self-directed emotions [70].  More recently, experimental work has also 
suggested that self-affirmation may be helpful in reducing in-the-moment self-disgust [71]. 
Therefore, interventions that focus on both cognitive and affective processes may have value.  
However, societal factors, such as participants’ perceptions of others’ disgust reactions to 
epilepsy and experiencing discrimination appeared to be key in the development and 
maintenance of self-disgust.  Therefore, similar to recommendations aimed at improving 
stigma towards epilepsy [72],  societal approaches aimed at improving understanding and 
thus, empathy towards those with epilepsy, as opposed to interventions aimed at the 
individual, may also be beneficial.  
 
5. Conclusions 
This study was the first to explore qualitatively the experiences of self-directed 
disgust in people with epilepsy and uncontrolled seizures.  The results suggest that the 
discrete emotion of self-disgust is relevant to people with epilepsy. People with epilepsy 
experience disgust in reaction to the physical symptoms of seizures and these disgust-based 
feelings are hypothesised to become internalised following others’ disgust reactions. 
Avoidance as a strategy to manage self-disgust can be protective but may not always be 
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Table 1: Demographic details of participants 
 
Pseudonym Age (years) Gender Duration Self Disgust 
Scale Score 
Clare 29 Female 8 years 64 
Anne 60 Female 12 years 60 
Neil 62 Male 47 years 62 
Harriet 22 Female 3 years 60 
Laura 31 Female 6 months 57 
Katie 24 Female 13 years 57 
Sam 28 Male 20 years 71 
Gemma 26 Female 1 year 59 
Sue 43 Female 23 years 56 
Helen 30 Female 3 years 49 
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Appendix 2-A. Semi-structured Interview schedule 
 
Introduce myself and explain that the purpose of the interview is primarily to talk about their 
experience of difficult emotions, in particular self-disgust. I will ask a bit about their perspectives on 
having Epilepsy to help me understand their point of view better. 
The interview will be mostly guided by the participant but the guide will be used to structure the 
conversation. Follow-up questions and prompts will be provided when necessary. 
 
1. Brief background about Epilepsy and current situation 
How long ago did your seizures start/ receive the diagnosis? 
What happens / how often do they happen? 
What impact does having epilepsy have on your life currently? Are there activities/situations that are 
difficult as a result of having seizures? 
 
2. Experiences of difficult emotions and self-disgust 
How did you find completing the questionnaire on feelings of self-disgust? Did you notice any 
thoughts or feelings as a result of this? 
Can you tell me about your experiences of self-disgust? I am interested in your personal account. Are 
there any thoughts or feelings related to your experiences? 
Can you tell me about times when you have felt disgusted with yourself? Can you think of any specific 
times in the past? What made you feel self-disgust then? What prompted these feelings? 
How do feelings of self-disgust affect you? Is there anything you do more of/ less of/ differently? 
How do you manage feelings of self-disgust? Is there anything you do to cope with/avoid these 
feelings? Are you able to reduce these feelings? 
How do you feel about your experiences of self-disgust? Are there any other emotions associated 
with this? What thoughts do you have about yourself? 
Is there anything that makes you feel more positive about yourself? I am interested in times or 
situations when you might feel less self-disgusted. Are there times when you are more 
confident? What positive thoughts/emotions do you have in these circumstances? 
 
3. Relationship with seizures 
When did your feelings of self-disgust first emerge? Did you have these before having seizures? 
Have they got more or less over the illness period? Is there any relationship with the course of your 
condition? 
What effects do the feelings have on your condition? What aspects of your behaviour are more 
affected? 
 
4. Debrief and sources of support 
How did you find talking to me today? Check that participant is not feeling negative or upset. 
Is there anything that is concerning you that you would like to discuss with somebody? There are 
sources of support detailed in the information sheet. 
SELF-DISGUST IN EPILEPSY   2-38 
 
Appendix 2-B. Example of coded transcript excerpt. 
I: I see, yeah, ok. So, why do you think it is 
that you want to kind of hide away, what 
thoughts kind of go through your mind 
about hiding away? 
 
P: so that nobody can see us do it, cause I 
don’t 
want people to, I don’t know I just, I, like 
strangers and stuff and them looking at us 
just thinking, look at the state of that, that’s 
disgusting, you look ridiculous, I don’t 
know, it’s just that sort of thing 
 
I: how would that make you feel about 
yourself if you thought people were 
thinking like that then? 
 
P: I’d be mortified I wouldn’t go out, I 
would fit in front of anybody, I’d lock 
myself in a bedroom but, luckily nobody 
actually nobody has said I look disgusting in 
those words as such, but I think sometimes 
people do say things that make us feel like, 
yeah I know I look disgusting when it’s 
happening, and I already feel disgusting so I 
don’t need them to kind of, point it out or 
people say, ah I’ll video it when its happens 
and stuff 
 
I: hmm, what sort of things have people said 
then that have led you to think that way? 
 
P: A lot of the time it’s “you look really 
freaky”, you look really weird, you look 
scary, it looks like you’re no breathing, its 
looks like you’re staring”, a lot of people 
say that they can’t  believe my eyes, that my 
eyes freak them out and, somebody just said 
“you’ve weed yourself, how can you not 
hold your bladder in when you’re doing 
this, there’s a big wet 
patch there now, gonna have to clean it up”, 
or 
things like that. That’s the, the weeing 
myself is the thing that makes me feel most 
disgusting 
 






Avoiding others see seizure 
 
 










Stay at home 
 
 
Others words elicit disgust 
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particular that makes you feels so bad? 
 
P: because it’s not normal, I think, I just 
don’t see it as normal 
 
I: hmm, ok. So, how does it feel when 
people talk to you in that way? 
P: I feel like they’re trying to, because, I 
think it’s because I ask questions though, so 
I don’t help myself. I have to ask them 
because I’m so 
desperate to find out what it looks like and 
what I’m doing, so then I can try and take 
control of it, because all my control is took 
away from us when I fit, so try and regain 
that control, I ask so many questions, but 
then obviously you have to give us honest 
opinions and then, the opinions they give us 
are describing what it looks like and to me, 
if I saw somebody who looks like that it’s 
embarrassing and I just feel frustrated and 
annoyed and dirty and horrible, and I dunno 
 
I: yeah, I can understand, it’s very similar to 
what other people have kind of, described as 
well. And is there anything you can do to 
help those feelings? 
 
P: erm, not a lot, there’s not a lot I can do 
about it other than to, just keep diaries, 
realise when I’m gonna do it, and if I ever 
think I’m gonna do it I got and shut myself 
away and hide away somewhere on me own 
so then I can do it without having to, for 
others to see me looking like that and, 













Asking others for information 
about seizures 
 




How would feel at seeing 
other fit 
 









Hide away to prevent others seeing 
 
 
Avoid others seeing  
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Appendix 2-C. Example of Theme Development: codes and quotes 
Theme Two: The unescapable presence of self-disgust: “it’s a niggling feeling that something’s not quite right” 
Example Codes Example Supporting Quotes 
• Persistent unease 
• Seizure memories re-elicit 
disgust 
• Fear due to unpredictable 
seizures 
• Frustration at lack of control 
over seizures  
• Impact on independence 
• Useless because of epilepsy 
• Disappointment to others 
• Feeling a burden 
• Disgusted with body 
• Betrayed by body 
• Disgust at damaged brain 
• Anger at epilepsy 
• Separation from body 
• It’s a niggling feeling that something’s not quite right 
• I’m just constantly thinking it’s gonna happen 
• A lot of the time it just makes us feel really sick, like nauseous 
• It makes me feel sick, physically sick when I think back to that time 
• Thinking in the back of your mind that there’s something in there that could ruin it for you 
• Disgusted that it might happen at any time and I have no control over that 
• I think the self-disgust comes from a lack of control 
• I don’t want to ruin everything and let people see me like that and disappoint my whole 
family and my boyfriend 
• I don’t contribute to anything because really, I’m just getting in the way all the time 
• I’m disgusted with myself that I’m expecting people to look after me 
• I know straight away that I’ve had a fit and everyone’s staring at us, I feel absolutely 
mortified 
• You feel guilty, you feel sorry. You’re frustrated with yourself that this has happened 
• Disgusted with my body I would say. Betrayed by my body… my body has let me down. 
It’s working against me rather than working with me. 
• It’s wrong that a body can do that to you 
• Its anger at my brain because that’s where its coming from 
• A feeling of separation as well, you feel very separated from your body, or disconnected 
from your body 
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Appendix 2-D. Example of theme development: codes and themes   
Example codes Developing themes/subthemes Final themes 
 
Disgust at symptoms of seizures Disgusting symptoms of seizures 
Seizures aren’t attractive 
 
Being an outsider: “The feeling of being a bit of a 
freak” 
 
Disgust at incontinence 
Sickness and nausea 
Dirty, Unclean 
Seizures scary for others Seizures scary to others 
Experiencing negative reactions from others 
Avoided/rejected 
 
Fear in others faces 
Mortified at others reactions 
Disgust at others seeing 
Negative reactions of others to seizures 
Mistaken as being drunk 
Others reinforce own feelings Internalisation of others disgust 
Not feeling normal Feeling a freak 
Persistent unease Enduring self-disgust 
Triggers of self-disgust 
The unescapable presence of self-disgust: “it’s a 
niggling feeling that something’s not quite right” Fear due to unpredictable seizures 
Frustration at lack of control over seizures  
Seizure memories re-elicit disgust 
Impact on independence Lack of control 
Feeling a burden Useless because of epilepsy 
Disappointment to others 
Feeling a burden 
Disgust at others having to care 
Disgusted with body Disgust with body 
Disgust with brain Betrayed by body 
Disgust at damaged brain 
Anger at epilepsy 
Separation from body 
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Escaping after seizure Avoidance of seizures 
Avoidance of others 
Preventing exposure: “Living a protected life” 
 Trapped by body 
Preventing others witnessing 
Avoiding social situations 
Limited lifestyle 
Avoiding reminders of seizures 
Fear of social media 
Avoiding seeing own seizures 
Protecting self Self-care 
Lack of self-care 
Wanting information Information helpful 
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AUTHOR INFORMATION PACK 3 Feb 2019 www.elsevier.com/locate/yebeh 7
• No open access publication fee payable by authors.
• The Author is entitled to post the accepted manuscript in their institution's repository and make this
public after an embargo period (known as green Open Access). The published journal article cannot be
shared publicly, for example on ResearchGate or Academia.edu, to ensure the sustainability of peer-
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Submission
Our online submission system guides you stepwise through the process of entering your article
details and uploading your files. The system converts your article files to a single PDF file used in
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final publication. All correspondence, including notification of the Editor's decision and requests for
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Peer review
This journal operates a single blind review process. All contributions will be initially assessed by the
editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of
one independent expert reviewer to assess the scientific quality of the paper. The Editor is responsible
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artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your word processor.
Article structure
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered
1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this
numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be
given a brief heading. Each heading should appear on its own separate line.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature
survey or a summary of the results.
Material and methods
Provide sufficient details to allow the work to be reproduced by an independent researcher. Methods
that are already published should be summarized, and indicated by a reference. If quoting directly
from a previously published method, use quotation marks and also cite the source. Any modifications
to existing methods should also be described.
Results
Results should be clear and concise.
Discussion
The Discussion section should explore the significance of the results of the work, not repeat them.
Results and Discussion should be separate and may be organized into subheadings. Avoid extensive
citations and discussion of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand
alone or form a subsection of a Discussion or Results and Discussion section.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae where possible.
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s)
of each author and check that all names are accurately spelled. You can add your name between
parentheses in your own script behind the English transliteration. Present the authors' affiliation
addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-
case superscript letter immediately after the author's name and in front of the appropriate address.
Provide the full postal address of each affiliation, including the country name and, if available, the
e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing
and publication, also post-publication. This responsibility includes answering any future queries about
Methodology and Materials. Ensure that the e-mail address is given and that contact details
are kept up to date by the corresponding author.
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• Present/permanent address. If an author has moved since the work described in the article was
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as
a footnote to that author's name. The address at which the author actually did the work must be
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1. Overview 
In this thesis three papers are presented.  Paper One summarises the systematic search 
for, and review of, qualitative studies examining the individual experiences of stigma in 
adults with epilepsy.  Paper Two provides an empirical report of a qualitative exploration into 
the experiences of self-disgust in adults with epilepsy.  This current final paper offers a 
reflective account of the experience of developing and conducting this research.  It aims to 
discuss the strengths and the limitations of the research project and the potential impact on the 
findings presented.  The plan for dissemination of the findings, implications of the research for 
clinical practice and personal reflections are also discussed. 
2. Strengths and limitations of the research and decisions made 
Throughout the process of this thesis, a number of important decisions were made. 
These decisions had fundamental implications for the research and findings presented.  While 
not at all of these can be discussed in detail, some of the key decisions are presented here 
with discussion regarding the strengths and limitations they implicate for this thesis.  
My interest in this research area stemmed from my clinical experience in working 
with adults with epilepsy prior to my training.  Working into a service specialising in 
providing psychological support to adults with this condition, I developed an awareness of 
the possible psychological impacts of the condition. During my training I became aware of 
the self-disgust literature. The more familiar with this I became, the more I contemplated the 
relevance of this to people with epilepsy.  I therefore approached my academic supervisor 
who is a key contributor to the self-disgust literature as well as a previous supervisor, a key 
contributor to the epilepsy literature.   
I was particularly keen to consider individual understandings and experiences of this 
phenomenon and so a qualitative design was considered. Surveys may have allowed for more 
in-depth investigation of the numeric and demographic details about the phenomenon [1]. 
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However, semi-structured interviews were more likely to provide information about the 
subjective perceptions of individuals’ experiences [2].  In line with my research interest, a 
qualitative interview design was chosen.  However, it was acknowledged that lack of 
previous research meant that it was unclear whether the research question was relevant.  As 
such, it was decided that a quantitative measure would be helpful to identify participants to 
whom the research question might be relevant.  
Another key factor in this decision was the ontological and epistemological 
framework from which the research was considered.  In the current study, the researcher 
adopted a critical realist position and therefore an independent ‘reality’ was accepted to exist, 
but assumed that this can only be fallibly known [3].  Therefore, through a critical realist 
stance, qualitative research may allow for the use of interview and other social research 
methods to explore the interpretations of participants experiences, while also taking into 
account the social context, constraints and resources available to them. The results reported 
here are assumed to be one attempt to explain the phenomena under investigation. However, 
it is acknowledged that other interpretations of participant experiences would have been 
possible, but that these would be no more or less ‘real’ or valid.  Of key importance was the 
acknowledgement of the likely influence of the researcher on the research process.  The 
research presented should therefore, be considered according to my, the lead researcher’s 
own background, experience and assumptions.  It is acknowledged that my previous 
experience working clinically with people with epilepsy and my developing research 
interests, including prior knowledge of the epilepsy and self-disgust literature, would 
inevitably have an impact on the findings.  Expectations that experiencing epilepsy could be 
associated with psychological distress and that self-disgust would be relevant to the 
population, are also of important consideration.  
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A key decision concerning my empirical project was the framework or method in 
which the interview data would be analysed.  Thematic analysis is a method used to identify 
and analyse patterns of meaning across a data set, the aim of which is to illustrate “the most 
salient constellations of meaning present in the data set” [4].  Guidelines for conducting this 
are offered [5].  Similar to that of other modes of qualitative inquiry, thematic analysis 
involves the researcher increasing familiarity with textual data, coding these data and 
grouping these codes to identify themes [6].  Although the flexibility of the approach 
afforded by the absence of a single theoretical framework is often described as a strength, 
critics have questioned the approach, arguing it is a process contained within many 
qualitative methodologies, rather than being an approach in its own right [7].  However, since 
this research was initially conducted, revised guidance has been published for carrying out 
the refined ‘reflexive thematic analysis’, alongside a checklist for evaluating the quality of 
the method [8].  Thus the authors emphasise the importance of the researcher making their 
approach to the method clear, as well as the assumptions underpinning this [9].  Furthermore,  
the active role of the researcher is acknowledged, recognising the inevitable impact of the 
researcher on the data and the need for thoughtful engagement and reflexivity [5]. 
Due to the critical realist position of the researcher and interest into participant 
experiences, Interpretative phenomenological analysis (IPA) could have been a suitable 
methodology to address the research question).  IPA is a methodological framework for 
qualitative research grounded in theories of phenomenology and bound to specific 
epistemological underpinnings [10].  IPA specifically aims to explore how individual 
participants make sense of their lived experience [11].  Although parallels can be drawn 
between the analysis involved in both approaches i.e. the identification of themes, IPA differs 
from thematic analysis in this manner and through the in-depth analysis of data for one 
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participant before progressing to the interpretation of patterns of meaning for the data set as a 
whole [6].   
As this was a novel area of research it was uncertain whether the participant group 
would be homogenous.  Therefore, thematic analysis was chosen for its flexibility in its 
method yet its ability to provide a detailed account of the data.  This method would allow for 
differences across participants to be considered by searching for patterns of meaning across 
the entire data set. 
Grounded theory [12] was also considered as an alternative method of analysis. 
However, the aim was to identify patterns of experience across participants and not to 
construct a theory from this. On this basis, grounded theory was not used in the current study. 
 
Following Braun and  Clark’s [9] guidance for conducting thematic analysis, it is 
important the researcher makes their assumptions and approach to the method clear in order 
to demonstrate trustworthiness.  Important distinctions are the use of deductive versus 
inductive and semantic or latent approaches to coding and interpretation and the 
epistemological and methodological implications of these.  
A semantic approach to coding aims to identify themes from the explicit data itself 
and does not attempt to analyse meaning beyond what has been said.  In contrast, a latent 
approach moves beyond the explicit content of the data and attempts to identify the 
underlying ideas and assumptions that inform this.  A semantic approach was consistent with 
the critical realist position of the researcher and therefore, aimed to limit interpretation of the 
transcript data but instead focused on considering the broader meaning and implications of 
the patterns found across transcripts.  
Deductive, ‘top-down’ approaches to data collection and analysis are directed by 
existing concepts or ideas.  Typically deductive approaches use a more structured interview 
format and coding often uses a pre-existing coding framework to provide detailed analysis 
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directed towards specified topics of interest, informed by the existing evidence base [13].  In 
contrast, an inductive, ‘bottom-up’ approach is one that it is open to hearing about 
participants’ experiences and aims to ground analysis within the data itself.  It is 
acknowledged that the use of the Self-Disgust Scale (SDS) as way of identifying participants 
could have been consistent with a deductive approach to data collection and analysis, 
employing the construct of self-disgust as a conceptual framework.  However, the aim of the 
current research was that of explorative investigation of participant experiences of self-
disgust.  Therefore, a largely inductive approach was taken.  This aimed to avoid analysis 
driven by the researcher’s theoretical interests or pre-conceived analytical frames but instead 
explore patterns of meaning within the data, across datasets.  While it is acknowledged that  
themes do not simply ‘emerge’ from the data [9] and researchers can never entirely free 
themselves from their own experiences and theoretical position [5], attempts were made to 
mitigate this as much as possible.  The researcher was keen to limit the impact of their own 
beliefs and assumptions through the use of supervision and a reflective log whilst making 
their assumptions clear.  
Emotion research relies on the lay public and the academic community sharing 
meanings of emotion terms under investigation [14].  One important consideration during the 
research process was the possible delineation of self-disgust from that of other emotions.  
This has been found to be distinct empirically [15] but may often be described by other, 
better known emotions such as guilt or shame [16].  Indeed, lay understandings of disgust 
have been shown to incorporate a combination of both disgust and anger, whereas the term 
‘grossed out’ may more clearly relate to appraisals patterns that are theoretically distinct to 
disgust [14].  It is therefore argued that researchers need to be hesitant in assuming that 
participants’ understandings regarding disgust are consistent with the researchers.  On 
recruitment to the research study, participants were aware of the purpose of investigation into 
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self-disgust and thus, may have been more likely to describe this in their language than would 
usually be observed [17].  It was therefore of importance that during the research process 
participants’ own interpretations of self-disgust were considered, as well as being aware of 
my own assumptions and understandings about this.  Checking meaning and asking 
participants to elaborate where necessary to help identify experiences, appraisals and 
reactions which help to delineate self-disgust was important.  Furthermore, ensuring not to 
take accounts out of context in the data analysis was of particular importance [18].  However, 
according to the critical realist position of the researcher, it is acknowledged that the findings 
reported here will have been impacted upon by these factors.       
Many of the participants included in the study chose to take part in a telephone 
interview as opposed to a face to face interviews in the participant’s home.  This appeared 
unusual compared to other qualitative studies within this population [19] and phenomenon of 
interest [16].  Telephone interviews have anecdotally been described to be less favoured than 
face to face interviewing techniques due to the impact on rapport building and the lack of 
visual cues and nonverbal contextual data [20].  In the current study this may have particular 
relevance due to the importance of facial expression in recognising and understanding 
emotion [21].  Indeed, disgust may be identified by facial or physiological expressions [22], 
although there is limited evidence for this in self-disgust.  It was therefore acknowledged that 
potentially relevant information from interviews could have been lost due to the lack of non-
verbal communication through body language and facial expression.  
However, it is argued that telephone interviews may in fact allow participants to feel 
more relaxed and report more sensitive data [23].  Indeed, a study using qualitative methods 
described advantages to telephone interviews, including not feeling judged or inhibited, and 
thus, the authors argued that they are a valid first option (as opposed to face to face 
interviews) [24].  Moreover, stigmatised or marginalised groups may feel particularly more at 
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ease during a telephone, rather than face to face interview context and telephone interviews 
may be preferable during discussion of sensitive or embarrassing topics [25].  Therefore, 
while this decision may be viewed as a limitation to the study, it may also be considered a 
strength.  The option of telephone interviews in this study allowed for the possibility of 
participant voices being heard that may otherwise have been missed.  Furthermore, in a 
population in which avoidant coping strategies are common [26], this this may have been 
perceived as less threatening and participants may have felt more able to discuss self-disgust, 
arguably a sensitive topic  
 I was aware that conducting telephone interviews might result in additional 
challenges and I was conscious to try to make interviews as facilitative and flexible as 
possible to meet the individual needs of the participants.  I was particularly aware of the 
additional potential need to adapt my communication style.  For example, not asking multiple 
questions at one time, as this can create difficulty in the participant knowing how to answer 
[27].  Moreover, having epilepsy and taking anti-epileptic medications can be associated with 
cognitive difficulties [28].  Indeed, I felt my training and clinical experience helped me adapt 
my communication style and in a way that facilitated the conversation.  I recognised that with 
each participant and in later interviews I felt more confident in my ability to adapt my 
communication in this way.  
A further challenge of not having face to face contact with participants was my 
decreased ability to recognise and assess levels of participants’ distress during the interviews 
as subtle changes in presentation or evidence of distress was not possible [29].  I was aware 
of the potential emotional impact of the interview on participants [30].  Therefore it was 
important that protocols were in place in order to safeguard the participants [31].  However, I 
was aware that at times I found it challenging to know how much to continue to encourage 
participants to describe distressing experiences while also being mindful of their level of 
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distress.  In discussion with my supervisor I recognised my tendency to avoid pushing 
participants to deepen their descriptions for fear of evoking distress.  I therefore attempted to 
explicitly ‘check-in’ with participants during interviews to ensure how they were feeling and 
whether they would like a break or were happy to continue.  Adopting this approach appeared 
to support participants to feel able to express emotion in a manageable manner and to feel 
able to be open and give more detailed answers.  At the end of the interview, a number of 
participants described finding the interview process beneficial as it had been the first 
opportunity they received to express how they were feeling.  
Due to participants self-selecting to take part in the study, rather than being recruited 
via healthcare professionals, epilepsy diagnoses were not confirmed. It is possible, therefore, 
that some participants who took part in the study experienced symptoms which resembled 
seizures but which might be clinically diagnosed as other conditions, such as non-epileptic 
attacks (NEAs). As participants with NEAs may have different psychological experiences to 
those with epilepsy [32] they may, therefore, have different experiences of self-disgust. 
Indeed, participants with NEAs have been described as experiencing increased symptoms of 
anxiety, low mood, psychosis and post-traumatic stress disorder as well as increased 
likelihood of having experienced abuse or receiving a diagnosis of a personality disorder 
[33], many of which have also been associated with increased experiences of self-disgust 
[34].  
Whether or not to provide frequencies of participants who describe experiences 
relating to certain themes has been debated in qualitative research [35].  While some 
researchers may choose to provide frequencies, others may instead select statements such 
“some or “many”.  After consulting the literature and in line with the assumptions of the 
researcher and approach of analysis, the latter approach was taken as it is argued that 
frequency does not necessarily determine value in qualitative research [36]. 
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3. Future research and implications for clinical practice 
Given the experiences of self-disgust in people with epilepsy described here, it would 
be valuable to understand more about this relationship. This is the first study to investigate 
the relevance of self-disgust in people with epilepsy. Further research would help to 
substantiate the findings here and could provide further insights into the factors involved in 
this relationship.   
Furthermore, despite the rapidly increasing amount of quantitative research  into self-
disgust, qualitative exploration of this has received less attention [34].  Further in-depth 
exploration of this concept in people with other mental health and physical health conditions 
would therefore aid our understandings about this which may also help to inform treatments.   
Psychological interventions have been shown to be beneficial for people with epilepsy 
[37].  However, the current research indicates that such interventions would benefit from the 
consideration of self-directed emotions such as disgust.  In the UK, the NHS five year 
forward strategy [38] recommended the increased provision of psychological support for 
people with long term health conditions.  However, the implication of such services has been 
addressed by existing Improving Access to Psychological Therapies (IAPT) services and, 
therefore, relies on a cognitive behavioural therapy (CBT) approach.  CBT has been found to 
be effective for the treatment of psychological distress related to chronic health conditions 
such as pain  and chronic fatigue syndrome [39], as well as neurological conditions such as 
Parkinson’s Disease [40].  However. it is possible that CBT may not always be the most 
effective therapy for supporting people to manage self-directed emotions such as self-disgust. 
Indeed, on this basis, compassion focused therapy was developed to support people with high 
levels of shame, self-criticism and disgust [41].  Interestingly, one recent study documented 
the benefit of self-compassion in developing resilience for managing the psychological 
impact of epilepsy [42].  A previous study has also demonstrated the effectiveness of 
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Acceptance and Commitment Therapy (ACT) in the reduction of anxiety and depression, 
improved quality of life and self-esteem in people with epilepsy [43]. Clinical psychologists 
may, therefore, be well placed to offer individual psychological interventions aimed at 
helping people with epilepsy manage the condition and the psychological impact of this. 
However, the findings presented here also suggest that individual approaches aimed at 
correcting cognitions or managing emotions may not fully address the needs of people with 
epilepsy.  It is likely that people with the condition will experience discrimination and the 
disabling opinions of others.  Despite this, these wider societal factors are often ignored, even 
within clinical psychology.  As such, interventions aimed at the individual, as opposed to 
societal approaches to epilepsy, could be insufficient.  The current review and empirical 
study suggest the need for improved societal understanding regarding epilepsy in order to 
reduce the stigma and psychological impact of this on the individual. Clinical psychologists 
may, therefore, also have a key role in the dissemination of such knowledge through research 
and publication but also in the development and delivery of educational materials designed 
for this purpose.  It is worthy of reflection that a UK epilepsy charity was involved in the 
recruitment of participants for this study.  Such organisations may also have a particularly 
important role in these interventions, which would be have increased potential influence.  
4. Dissemination of findings 
The findings of this thesis will be disseminated by a number of strategies.  Firstly, 
according to my training course requirements, I have presented a brief summary of the 
project at Lancaster University to an audience of staff and trainee colleagues.  This 
presentation will be available on the Lancaster University Doctorate in Clinical Psychology 
programme website.  Secondly, I aim to submit Section One, the systemic literature review to 
a leading epilepsy journal, Epilepsia.  Section Two of the thesis, the research project, will 
also be submitted for publication in a further epilepsy journal which regularly publishes 
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qualitative research, Epilepsy & Behavior.  Such publications aim to disseminate the findings 
as widely as possible as both of these peer-reviewed journals are circulated worldwide and, 
therefore, assist in the dissemination of scientific knowledge in the epilepsy field.  Finally, in 
line with my ethical approval and to disseminate findings as widely as possible, I will also 
share a brief summary of the research findings with the NHS Trust involved in the research, 
the charity involved in recruitment and with the study participants.  
5. Personal reflections 
 
Throughout the process of writing the thesis, I have attempted to consider how my 
own values, training and clinical experiences and, therefore, my own personal and cultural 
assumptions might have influenced the research process.  I was aware that such preconceived 
ideas may have influenced the research process and might, therefore, influence the outcomes. 
To aid this I regularly made notes in my reflective research journal [44].  
During the research process I became aware of the potential ethical dilemma of the 
difference in my role as a researcher as opposed to a clinician. This is demonstrated by an 
entry in my reflexive diary: 
 I found the ending of the interview difficult and I recognised the desire to be able to 
normalise the participant’s feelings and distress. It felt difficult to know that the participant 
believed there was no appropriate support available and I wanted to offer some words of 
comfort. The debrief information was helpful in order to signpost the participant but I 
recognised a feeling of frustration that I couldn’t offer more. This reminded me of my 
original reason for wanting to conduct the research and how this was continuing to influence 
my thinking. (27/07/2017) 
This reminded me of my original interests in conducting research within this area and 
reflected my frustration at the lack of appropriate psychological support which I believed was 
often unavailable for people with long-term health conditions such as epilepsy.  I therefore 
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gained awareness throughout the interview process of my desire to provide emotional support 
to participants, as this would be a fundamental part of my clinical practice.  In earlier 
interviews I found myself wanting to explore and formulate their distress and consider ways I 
could signpost them to further support, in order to reduce their psychological distress. 
However, through reflection and in discussion within supervision I acknowledged that I was 
not in a clinical role and that my role as a researcher was to listen and explore their 
experiences for this purpose. I was also able to recognise that the clinical skills I had 
developed during training were still relevant.  For example, being aware of risk issues that 
might warrant further action.  The ability to listen to participant stories and summarise this 
remained helpful to the interview process ensuring that I had a good understanding of 
participants’ experiences, rather than relying on my own interpretations and appeared to 
allow participants to feel  heard and understood.  Therefore, during subsequent interviews, I 
was aware that the dilemma remained present, but I was able to manage this by attempting to 
ensure that my questions were relevant to the research question.   
 Overall, the process of this thesis was a difficult one which raised a number of 
challenges for me.  I had not envisaged that the thesis would be as arduous and time 
consuming to complete.  However, due to my personal circumstances, much of the thesis was 
completed after completion of the taught and clinical elements of clinical psychology 
training.  Therefore, I had to manage the demands of full-time employment in a clinical 
psychology service, alongside this research.  I also recognised the impact of the lack of 
regular contact with my cohort for support during this period as well as the reduced 
opportunities for face to face supervision.  However, the thesis process has also been a 
rewarding one, allowing me to develop professional as well as research skills.  
6. Conclusions 
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The systematic literature review explored the important challenge of stigma, faced by 
people with epilepsy.  The research project explored the experiences of self-disgust in people 
with epilepsy.  I believe that, combined, these two individual papers provide additional 
insights into the psychological experiences of people with epilepsy.  They highlight the 
significant challenges that people with epilepsy experience as a result of the condition, their 
perceptions of themselves and others and how they develop strategies in order to cope and 
manage these.  I thereby hope that the findings of this thesis will add to the understanding of 
the psychological impact of epilepsy in clinicians and researchers alike in the hope that the 
distress caused by the condition might be minimised in the future.  
This critical appraisal discusses some of the methodological, practical, ethical and 
professional challenges I encountered and how I attempted to manage these. I hope that these 
reflections will be helpful for other researchers considering conducting work with similar 
populations.  
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Epileptic seizures are short interruptions to the normal electrical functioning of the brain (Altrup, Elger & Reuber, 2009).
There are several types of epileptic seizure which range from alterations in consciousness, to collapsing and shaking
of the whole body.   
High levels of psychological distress have been described in people who experience seizures, including people with a
diagnosis of epilepsy (Beyenburg et al., 2005; Hoppe & Elger, 2011). It has been reported that the rates of people
diagnosed with mood and anxiety disorders are two or three times higher in people with epilepsy than in the general
population (Tellez-Zenteno et al., 2007) and that the number of people who report symptoms of depression may be as
high as 50-55% in people with epilepsy (Boylan et al., 2004; Mendez et al., 1986). Experiencing seizures and
psychological distress has been shown to have a negative impact on emotional, physical and social functioning and
thus people with seizures often experience poorer quality of life, (Reuber, Pukrop, Mitchell, Bauer, & Elger, 2003; Verrotti
et al 2014). 
A number of qualitative studies have considered the impact of seizures on people’s lives, including psychological and
social functioning. Qualitative studies have reported epilepsy being associated with emotions including anger,
frustration, low mood, embarrassment and worry (Kerr et al., 2011) as well as feelings of shame and guilt (Chung et
al., 2012).   People with seizures, have also reported feelings of shame, stigma, prejudice and embarrassment (Raty
& Wilde-Larsson 2011). 
One potential, yet under-researched, emotion relevant to the experience of seizures is disgust. Disgust is a universal
human emotion (Ekman, 1999). A psychological model of disgust has been proposed which describes four
categories of disgust elicitors and the functions (Rozin, Haidt, & McCauley, 2008). These include core elicitors such as
food and body waste products (e.g., faeces, vomit, urine) which protect us from harm and disease; animal-nature
elicitors such as sex, death and hygiene that protect our soul and mortality; interpersonal disgust such as through
contact with contaminated others; and moral disgust elicited by moral violations which protect our social status. 
The concept of disgust was for many years neglected in psychological research. More recently, however disgust has
been increasingly investigated in a range of mental health conditions, including schizophrenia, obsessive-compulsive
disorder and depression (Olatunji & McKay, 2007). The interest in discrete emotions, such as disgust, has also
extended to health research (Consedine & Moscowitz, 2007).   
However, research into self–disgust, disgust directed at oneself, is still in its infancy within psychology. Increased
interest into self-disgust has led to identification of the emotion in other populations, including people with depression
(Powell et al., 2013), eating disorders (Fox, 2009), and social anxiety (Amir, Najmi, Bomyea, & Burns, 2010). But the
concept of self-disgust and its role in adaptation to physical health conditions is in its infancy. It has been suggested






et al., 2015) and there is therefore the potential for further exploration of this relationship. 
Historically epilepsy has been associated with a range of misconceptions and myths (International League Against
Epilepsy (ILAE), 2003). For example, a number of religions have considered those who experienced seizures as being
possessed and that epilepsy was caused by an “unclean dumb and deaf spirit” (p. 12) or that people with epilepsy
were contagious and infectious. The symptoms of seizures may therefore be relevant to all of the disgust categories
described above. Individuals who experience seizures may potentially have to confront a range of disgust-inducing
stimuli, including being sick or vomiting, bladder and bowel problems and being socially stigmatised.   
Summary 
The symptoms associated with seizures and the already recognised emotions and concerns reported by people
seizures may therefore suggest that self-disgust may be worthy of investigation in this population. In those who report
experiencing symptoms of self-disgust, a qualitative methodology will allow for a richer understanding of this currently
unrecognised concept. Such research may help establish what emotions may be relevant for people who experience
seizures and which psychological factors to consider during psychological therapeutic interventions in order to relieve
distress and improve quality of life in these individuals. Using a qualitative methodology, the current study will therefore
explore the experiences of self-disgust in people with seizures. 
A13. Please summarise your design and methodology. It should be clear exactly what will happen to the research
participant, how many times and in what order. Please complete this section in language comprehensible to the lay person.
Do not simply reproduce or refer to the protocol. Further guidance is available in the guidance notes.
Potential participants will be approached via two sources. Either by a member of their neurology care team or via an
epilepsy charity (Epilepsy Action). Participants will be informed about a research study. They will receive an information
sheet, consent form and a measure of self-disgust.
Participants will be allowed time to take this information away and consider the study. Those who wish to take part can
complete the self-disgust questionnaire and consent form and return these to the researcher, either in paper form in
the post or online. Participants will also have opportunities to speak to the researcher directly   to discuss the research
in more detail and ask questions.   Participants will be made aware that a proportion of participants may be invited to
further take part in an in-depth qualitative interview whilst others may not. 
Those who are selected to take part in an interview will be contacted by the researcher to invite them to this. A
convenient time and place to attend will be arranged. Alternatively, participants may choose to take part in a telephone
interview. 
Those who are not invited to attend for an interview will also be notified of this within 4 weeks. 
Interviews will be audio recorded and transcribed verbatim. Interview transcripts will be analysed using Thematic
Analysis to identify emerging themes in the data.
A14-1. In which aspects of the research process have you actively involved, or will you involve, patients, service users,
and/or their carers, or members of the public?
 Design of the research
 Management of the research
 Undertaking the research
 Analysis of results
 Dissemination of findings
 None of the above
Give details of involvement, or if none please justify the absence of involvement.
The research will be advertised by an epilepsy charity (Epilepsy Action) in order to approach eligible participants.
People may share this if they choose.
A summary of the results of the study will be provided to participants if they choose which they will be welcome to
share with others. A copy will also be sent to the charity involved in the recruitment of participants.
4. RISKS AND ETHICAL ISSUES
 RESEARCH PARTICIPANTS















 Generic Health Relevance
 Infection
 Inflammatory and Immune System
 Injuries and Accidents
 Mental Health
 Metabolic and Endocrine
 Musculoskeletal
 Neurological
 Oral and Gastrointestinal
 Paediatrics
 Renal and Urogenital




Gender:  Male and female participants
Lower age limit:  16  Years
Upper age limit:   No upper age limit
A17-1. Please list the principal inclusion criteria (list the most important, max 5000 characters).
• Have received a clinical diagnosis of epilepsy from a neurologist
• Experienced an epileptic seizure in the last 12 months
• Are over the age of 16
• Are English speaking or able to complete a questionnaire and interview in English
• Are able to provide informed consent to take part in the study.
A17-2. Please list the principal exclusion criteria (list the most important, max 5000 characters).
a) Communication or learning problems of sufficient severity to prevent from providing informed consent to take part in
the study.
b) Communication or learning problems of sufficient severity to reduce participants' ability to take part in a semi-
structured interview.
c) Non-English speakers






A18. Give details of all non-clinical intervention(s) or procedure(s) that will be received by participants as part of the
research protocol. These include seeking consent, interviews, non-clinical observations and use of questionnaires.
Please complete the columns for each intervention/procedure as follows:
1. Total number of interventions/procedures to be received by each participant as part of the research protocol.
2. If this intervention/procedure would be routinely given to participants as part of their care outside the research,
how many of the total would be routine?
3. Average time taken per intervention/procedure (minutes, hours or days)
4. Details of who will conduct the intervention/procedure, and where it will take place.
Intervention or





Neurologists will inform patients about a research study. Those interested in
hearing more about this can complete the form for their contact details to be











Participants will be asked to complete the questionnaire at the time of




1 1 hour Conducted by chief investigator in person or over phone with participant.
A21. How long do you expect each participant to be in the study in total?
Participants will be involved in the study for a short period. Some participants will not be invited to an interview
following their completion of the recruitment materials and their input will end then. Participants invited to an interview
will be expected to have completed this within one month. Participants who are not selected for interview will be
notified about this with 4 weeks of providing consent.
A22. What are the potential risks and burdens for research participants and how will you minimise them?
For all studies, describe any potential adverse effects, pain, discomfort, distress, intrusion, inconvenience or changes
to lifestyle. Only describe risks or burdens that could occur as a result of participation in the research. Say what steps
would be taken to minimise risks and burdens as far as possible.
This study has been designed to expose patients to minimal risk. Altough the interview will involve talking about
emotions, should participants become distressed during the interview, the interview will be halted and
participants will be given time to recover. Participants will be asked if they wish to continue and information about how
to access further support will be provided.
Participants will be provided with a Participant Information Sheet and an opportunity to ask the researcher any
questions before giving their informed consent to participate in all phases of the study. They will be informed that they
may withdraw this consent at any time without any effect on their care. 
The interviews will be conducted by trainee clinical psychologist who will be familiar with this particular patient group
(Rebecca Mayor).
A23. Will interviews/ questionnaires or group discussions include topics that might be sensitive, embarrassing or
upsetting, or is it possible that criminal or other disclosures requiring action could occur during the study?
 Yes       No
If Yes, please give details of procedures in place to deal with these issues:
Some participants could find talking about their condition and their emotions upsetting. However, participants will
have had an opportunity to consider the nature of the project and speak to the researcher about this. Participants
can choose whether or not they wish to take part in the research.   
The researcher is familiar in with working with this patient group. Should patients become distressed they will be







Participants will be made aware before they agree to take part in the study that should they share information which
leads the researcher to worry about the safety of the participant or others that this information may need to be
shared.  
A24. What is the potential for benefit to research participants?
The research study may not be of direct benefit to participants themselves. However, we hope that the findings of this
study will develop awareness of the psychological needs of people with epilepsy and inform future support.
A26. What are the potential risks for the researchers themselves? (if any)
There should be limited risk to the researchers themselves. Some interviews may take place in participants' home in
which case the researcher will follow the Lancashire Care lone working policy. 
A buddy system will be used in which a colleague will be fully notified of the   movements of the Lone Worker. They will
have all necessary contact details for the Lone Worker, including personal contact details, such as next of kin and
details of vehicles used by the researcher, for example, registration number, make, model and colour. 
The researcher will ensure regular contact with their colleague, particularly if they are delayed or have to cancel an
appointment. If contact is not received at the agreed time, the buddy will attempt to contact the Lone Worker,   and
Where there is genuine concern, the buddy will follow the agreed local escalation procedures for alerting their Senior
manager or the police. 
In addition, the ‘buddy’ will be made aware that they have been nominated and what the procedures and requirement
for this role are. Contingency arrangements will be in place for someone else to take over the role of the ‘buddy’ in
case the nominated person is unable to carry out this role for any reason.
 RECRUITMENT AND INFORMED CONSENT
In this section we ask you to describe the recruitment procedures for the study. Please give separate details for
different study groups where appropriate.
A27-1. How will potential participants, records or samples be identified? Who will carry this out and what resources
will be used?For example, identification may involve a disease register, computerised search of GP records, or review of
medical records. Indicate whether this will be done by the direct healthcare team or by researchers acting under
arrangements with the responsible care organisation(s).
Potential participants will be approached via two sources. 
1. Existing patients with epilepsy will be approached by a member of their neurology care team. They will be told about
a research study. If they are interested in hearing more about the study they can agree to complete a contact form and
their details will be passed to the researcher. They will be given a study pack (including information sheet, consent
form and questionnaire). Participants will receive a phone call from the researcher at their stated preferred time to
discuss the study. If participants wish to take part they can complete the study materials or complete these online if
they wish.
2. The epilepsy charity, Epilepsy Action will advertise the research study. The invitation letter will be shared via their
website and social media (including Facebook and Twitter). Participants will be invited to contact the researcher for
further information about the study should they wish. A link to consent to take part in the study and complete the study
materials online will be provided.
A27-2. Will the identification of potential participants involve reviewing or screening the identifiable personal
information of patients, service users or any other person?
 Yes       No
Please give details below:
A28. Will any participants be recruited by publicity through posters, leaflets, adverts or websites?






If Yes, please give details of how and where publicity will be conducted, and enclose copy of all advertising material
(with version numbers and dates).
Epilepsy Action will share the recruitment letter via their website and social media.  
A29. How and by whom will potential participants first be approached?
Existing patients will be approached by a member of their care team. They will be provided with paper versions of the
study materials. Participants can consent to their details being passed to the researcher to receive a phone call giving
more details about the study. Participants can complete these and return these to the researcher should they wish to
take part.   
Alternatively, participants may be made aware of the study via the Epilepsy charity's website or social media.
Participants will be invited to access the study documents online. They will be able to click on a link which provides
information about the study via the participant information sheet (PIS). Participants will be provided with contact details
for the researcher should they wish to discuss the study. They will then be given a link to the consent form which will
require them to provide consent via ticking the relevant boxes, following which they will be taken to the questionnaire. 
A30-1. Will you obtain informed consent from or on behalf of research participants?
 Yes       No
If you will be obtaining consent from adult participants, please give details of who will take consent and how it will be
done, with details of any steps to provide information (a written information sheet, videos, or interactive material).
Arrangements for adults unable to consent for themselves should be described separately in Part B Section 6, and for
children in Part B Section 7.
If you plan to seek informed consent from vulnerable groups, say how you will ensure that consent is voluntary and
fully informed.
All participants will be provided with information about what their participation may involve. Participants will also be
invited to contact the researcher directly should they wish to discuss the research in more detail. The researcher will
explain more about the study and answer the participant's questions.
Potential participants will receive an information sheet, consent form and a measure of self-disgust. Those who wish
to take part can complete the self-disgust questionnaire and consent form and return these to the researcher.  
Participants will be made aware that a proportion of participants may be invited to further take part in an in-depth
qualitative interview, whilst others may not.
Only participants able to provide informed consent will be included in the study.
If you are not obtaining consent, please explain why not.
Please enclose a copy of the information sheet(s) and consent form(s).
A30-2. Will you record informed consent (or advice from consultees) in writing?
 Yes       No
A31. How long will you allow potential participants to decide whether or not to take part?
Participants will be recruited over a 3 month period after this period no more participants will be invited to take part in
the study and the online materials will be removed. Participants will be given time to consider the information and ask
the researcher questions should they wish. After completion of the study materials, participants will be expected to
complete the interview within one month.
A33-1. What arrangements have been made for persons who might not adequately understand verbal explanations or
written information given in English, or who have special communication needs?(e.g. translation, use of interpreters)
Non-English speakers or those with communication or learning problems of sufficient severity to reduce patients'






A35. What steps would you take if a participant, who has given informed consent, loses capacity to consent during the
study?  Tick one option only.
 The participant and all identifiable data or tissue collected would be withdrawn from the study. Data or tissue which
is not identifiable to the research team may be retained.
 The participant would be withdrawn from the study. Identifiable data or tissue already collected with consent would
be retained and used in the study. No further data or tissue would be collected or any other research procedures carried
out on or in relation to the participant.
 The participant would continue to be included in the study.
 Not applicable – informed consent will not be sought from any participants in this research.




In this section, personal data means any data relating to a participant who could potentially be identified. It includes
pseudonymised data capable of being linked to a participant through a unique code number.
 Storage and use of personal data during the study
A36. Will you be undertaking any of the following activities at any stage (including in the identification of potential
participants)?(Tick as appropriate)
 Access to medical records by those outside the direct healthcare team
 Access to social care records by those outside the direct social care team
 Electronic transfer by magnetic or optical media, email or computer networks
 Sharing of personal data with other organisations
 Export of personal data outside the EEA
 Use of personal addresses, postcodes, faxes, emails or telephone numbers
 Publication of direct quotations from respondents
 Publication of data that might allow identification of individuals
 Use of audio/visual recording devices
 Storage of personal data on any of the following:
 Manual files (includes paper or film)
 NHS computers
 Social Care Service computers
 Home or other personal computers
 University computers
 Private company computers
 Laptop computers
Further details:
A participant log with participants' personal details, pseudonyms and contact information will be stored securely and
separately from any other study data on a personal space on the Lancaster University server. This will be password






Interviews will be audio recorded. These recordings will be transferred to a personal space on the Lancaster
University server via virtual private network as soon as possible and will be password protected for further protection.
Any identifiable data (including recordings of participants’ voices) will be deleted from the recorder as quickly as
possible and in the meantime the recorder will be stored securely.
Audio files will be transcribed and the audio files will be deleted. All names will be replaced with pseudonyms during
the transcription process and only anonymised quotes would be used in publications resulting from the qualitative
analysis.
All electronic files will be stored on the Lancaster University secure server with access only from the CI.
A37. Please describe the physical security arrangements for storage of personal data during the study?
Manual files will be stored in a lockable filing cabinet   with access only to the researcher during the study. Paper data
will be scanned and stored electronically on   a personal space on the Lancaster University server via virtual private
network as soon as possible and will then be destroyed.
Interviews will be recorded using a digital recorder. For devices which are not encrypted, this data will be transferred to
a computer and then deleted from the device as soon as possible. The interviews will be transcribed and stored
electronically. All electronic data will be stored securely on the Lancaster University server. Files will be password
protected as an additional security measure.
At the end of the study, all study data will be transferred electronically using a secure method that is supported by the
University for long term storage on the
Lancaster University secure server. Documents will be encrypted and password protected. Long term electronic
storage of the encrypted and password protected data will be kept for 10 years by Lancaster University. The data will
then be destroyed by the Lancaster DClinPsy research co-ordinator after this time.  
A38. How will you ensure the confidentiality of personal data?Please provide a general statement of the policy and
procedures for ensuring confidentiality, e.g. anonymisation or pseudonymisation of data.
A participant log with participants personal details, pseudoynms and contact information will be stored securely on a
personal space on the University server and separately from any other study data. 
Transcripts of interviews will be made anonymous (only identifiable by allocated
participant pseudnyms). 
Only anonymous data will be included for publication, using pseudnymns.
A40. Who will have access to participants' personal data during the study? Where access is by individuals outside the
direct care team, please justify and say whether consent will be sought.
Access to participants' personal data will only be granted to the research team.
 R&D require information about participants recruited from their sites as part of routine
service accrual audit. Names of participants from this site and the date they consent to take part will therefore be
shared with the research co-ordinator assigned from the R&D office. No other participant information will be shared
with them.  
 Storage and use of data after the end of the study
A41. Where will the data generated by the study be analysed and by whom?
The study data will be analysed by the chief investigator. No personal data will be included, participants' names will be
replaced by pseudonyms to ensure confidentiality. The transfer of any transcripts or analysed data will be anonymous
and will be password protected as an additional security measure.
A42. Who will have control of and act as the custodian for the data generated by the study?
     
 Title   Forename/Initials  SurnameMiss Rebecca  Mayor







Work Address Clinical Psychology
 Division of Health Research, Furness College
 Lancaster University, Lancaster
Post Code LA1 4YT
Work Email r.mayor@lancaster.ac.uk
Work Telephone 01524 593301
Fax
A43. How long will personal data be stored or accessed after the study has ended?
 Less than 3 months
 3 – 6 months
 6 – 12 months
 12 months – 3 years
 Over 3 years
If longer than 12 months, please justify: 
At the end of the study data (including consent forms) will be transferred electronically using a secure method that is
supported by the University for long term storage on the Lancaster University secure server. Documents will be
encrypted and password protected. Long term electronic storage of the encrypted and password protected data will be
kept for 10 years by Lancaster University. Access will only be granted to the Lancaster University DClinPsy admin
team.
A44. For how long will you store research data generated by the study?
Years: 10 
Months:  
A45. Please give details of the long term arrangements for storage of research data after the study has ended.Say
where data will be stored, who will have access and the arrangements to ensure security.
At the end of the study, data (interview transcripts and any coded data produced during analysis) will be transferred
electronically using a secure method that is supported by the University for long term storage on the Lancaster
University secure server. Documents will be encrypted and password protected. Long term electronic storage of the
encrypted and password protected data will be kept for 10 years by Lancaster University. Access will only be granted to
the Lancaster University DClinPsy admin team.
 INCENTIVES AND PAYMENTS
A46. Will research participants receive any payments, reimbursement of expenses or any other benefits or incentives
for taking part in this research?
 Yes       No
If Yes, please give details. For monetary payments, indicate how much and on what basis this has been determined.
Participants will be granted travel expenses to interview up to £10.
A47. Will individual researchers receive any personal payment over and above normal salary, or any other benefits or
incentives, for taking part in this research?






A48. Does the Chief Investigator or any other investigator/collaborator have any direct personal involvement (e.g.
financial, share holding, personal relationship etc.) in the organisations sponsoring or funding the research that may
give rise to a possible conflict of interest?
 Yes       No
 NOTIFICATION OF OTHER PROFESSIONALS
A49-1. Will you inform the participants’ General Practitioners (and/or any other health or care professional responsible
for their care) that they are taking part in the study?
 Yes       No
If Yes, please enclose a copy of the information sheet/letter for the GP/health professional with a version number and date.
 PUBLICATION AND DISSEMINATION
A50. Will the research be registered on a public database?
 Yes       No
Please give details, or justify if not registering the research.
The research may be registered on the local NHS trust databases involved in the study.
Registration of research studies is encouraged wherever possible.
You may be able to register your study through your NHS organisation or a register run by a medical research charity,
or publish your protocol through an open access publisher. If you are aware of a suitable register or other method of
publication, please give details. If not, you may indicate that no suitable register exists. Please ensure that you have
entered registry reference number(s) in question A5-1.
A51. How do you intend to report and disseminate the results of the study?Tick as appropriate:
 Peer reviewed scientific journals
 Internal report
 Conference presentation
 Publication on website
 Other publication
 Submission to regulatory authorities
 Access to raw data and right to publish freely by all investigators in study or by Independent Steering Committee
on behalf of all investigators
 No plans to report or disseminate the results
 Other (please specify)
The results of the study will be written and submitted to the University of Lancaster as part of a DClinPsy. This will also
be modified for publication in a peerreviewed journal.
A summary report will also be available to participants should they request this as well as the epilepsy charity involved
in recruitment.
A52. If you will be using identifiable personal data, how will you ensure that anonymity will be maintained when
publishing the results?
Quotes from participant inteviews will be included in the write up of the study. All names will be placed by pseudonyms






A53. Will you inform participants of the results?
 Yes       No
Please give details of how you will inform participants or justify if not doing so.
A summary report will also be available to participants should they request this. This summary will also be sent to the
charities involved in the study in order to disseminate this more widely.
 5. Scientific and Statistical Review
A54. How has the scientific quality of the research been assessed?Tick as appropriate:
 Independent external review
 Review within a company
 Review within a multi−centre research group
 Review within the Chief Investigator's institution or host organisation
 Review within the research team
 Review by educational supervisor
 Other
Justify and describe the review process and outcome. If the review has been undertaken but not seen by the
researcher, give details of the body which has undertaken the review:
The study proposal has been reviewed by the research team, including the academic supervisor. This has also been
reviewed by the Lancaster University research office .
For all studies except non-doctoral student research, please enclose a copy of any available scientific critique reports,
together with any related correspondence.
For non-doctoral student research, please enclose a copy of the assessment from your educational supervisor/ institution.
A56. How have the statistical aspects of the research been reviewed?Tick as appropriate:
 Review by independent statistician commissioned by funder or sponsor
 Other review by independent statistician
 Review by company statistician
 Review by a statistician within the Chief Investigator’s institution
 Review by a statistician within the research team or multi−centre group
 Review by educational supervisor
 Other review by individual with relevant statistical expertise
 No review necessary as only frequencies and associations will be assessed – details of statistical input not
required
In all cases please give details below of the individual responsible for reviewing the statistical aspects. If advice has
been provided in confidence, give details of the department and institution concerned.
     
















Please enclose a copy of any available comments or reports from a statistician.
A57. What is the primary outcome measure for the study?
The study uses qualitative methodology. The outcome of the study is therefore the quotes from participants detailing
their experiences.
A58. What are the secondary outcome measures?(if any)
A59. What is the sample size for the research?  How many participants/samples/data records do you plan to study in
total? If there is more than one group, please give further details below.
Total UK sample size: 12 
Total international sample size (including UK):  
Total in European Economic Area:  
Further details:
Up to 12 participants will be interviewed.
A60. How was the sample size decided upon?  If a formal sample size calculation was used, indicate how this was done,
giving sufficient information to justify and reproduce the calculation.
A sample size calculation was not completed as this is a qualitative study. The data will analysed with Thematic
Aanalysis and a study size of 12 should be adequate to ensure that adequate themes are identified.
A61. Will participants be allocated to groups at random?
 Yes       No
A62. Please describe the methods of analysis (statistical or other appropriate methods, e.g. for qualitative research) by
which the data will be evaluated to meet the study objectives.
Interviews will be recorded and transcribed verbatim. The data will be analysed using Thematic Analysis. Based on
the Braun and Clark (2006) model, the data will be analysed to identify, analyse and report patterns (themes) within the
data that are associated with the research question.
This model of qualitative analysis involves 6 phases: 1. Familiarising with the data. 2. Generating initial codes. 3.
Searching for themes. 4. Reviewing Themes. 5. Defining and naming themes. 6. Producing the report.
 6. MANAGEMENT OF THE RESEARCH
A63. Other key investigators/collaborators. Please include all grant co−applicants, protocol co−authors and other key


















 A64. Details of research sponsor(s)
A64-1. Sponsor 
Lead Sponsor
Status:  NHS or HSC care organisation
 Academic
 Pharmaceutical industry
 Medical device industry
 Local Authority
 Other social care provider (including voluntary sector or private
organisation)
 Other
If Other, please specify:  
  Commercial status:  
Contact person
Name of organisation Lancaster University
Given name Diane
Family name Hopkins
Address B14 Furness, Lancaster University
Town/city Lancaster
Post code LA1 4YT
Country  UNITED KINGDOM
Telephone +44 (0) 1524 592838
Fax
E-mail d.hopkins@lancaster.ac.uk
Is the sponsor based outside the UK?






Under the Research Governance Framework for Health and Social Care, a sponsor outside the UK must appoint a
legal representative established in the UK. Please consult the guidance notes.
A65. Has external funding for the research been secured?
 Funding secured from one or more funders
 External funding application to one or more funders in progress
 No application for external funding will be made
What type of research project is this?
 Standalone project
 Project that is part of a programme grant
 Project that is part of a Centre grant
 Project that is part of a fellowship/ personal award/ research training award
 Other
Other – please state: 
A66. Has responsibility for any specific research activities or procedures been delegated to a subcontractor (other
than a co-sponsor listed in A64-1) ?  Please give details of subcontractors if applicable.
 Yes       No
A67. Has this or a similar application been previously rejected by a Research Ethics Committee in the UK or another
country?
 Yes       No
Please provide a copy of the unfavourable opinion letter(s). You should explain in your answer to question A6-2 how the
reasons for the unfavourable opinion have been addressed in this application.
A68-1. Give details of the lead NHS R&D contact for this research:
     
















A69-1. How long do you expect the study to last in the UK?
Planned start date: 01/12/2016
Planned end date: 31/05/2017
Total duration:  
Years: 0 Months: 5 Days: 31 
A71-1. Is this study?
 Single centre
 Multicentre





 Other countries in European Economic Area
Total UK sites in study 1
Does this trial involve countries outside the EU?
 Yes       No
A72. Which organisations in the UK will host the research?Please indicate the type of organisation by ticking the box and
give approximate numbers if known:
 NHS organisations in England 1 
 NHS organisations in Wales  
 NHS organisations in Scotland  
 HSC organisations in Northern Ireland  
 GP practices in England  
 GP practices in Wales  
 GP practices in Scotland  
 GP practices in Northern Ireland  
 Joint health and social care agencies (eg
community mental health teams)
 
 Local authorities  
 Phase 1 trial units  
 Prison establishments  
 Probation areas  
 Independent (private or voluntary sector)
organisations
 
 Educational establishments  
 Independent research units  







Total UK sites in study: 1
A73-1. Will potential participants be identified through any organisations other than the research sites listed above?
 Yes       No
A73-2. If yes, will any of these organisations be NHS organisations?
 Yes       No
If yes, details should be given in Part C.
A74. What arrangements are in place for monitoring and auditing the conduct of the research?
The chief investigator will engage in regular supervision meetings with the academic supervisor and other members
of the research team to ensure appropriate management of the study data.
 A76. Insurance/ indemnity to meet potential legal liabilities  
 Note: in this question to NHS indemnity schemes include equivalent schemes provided by Health and Social Care
(HSC) in Northern Ireland
A76-1. What arrangements will be made for insurance and/or indemnity to meet the potential legal liability of the
sponsor(s) for harm to participants arising from the management of the research?  Please tick box(es) as applicable.
Note: Where a NHS organisation has agreed to act as sponsor or co-sponsor, indemnity is provided through NHS schemes.
Indicate if this applies (there is no need to provide documentary evidence). For all other sponsors, please describe the
arrangements and provide evidence.
 NHS indemnity scheme will apply (NHS sponsors only)
 Other insurance or indemnity arrangements will apply (give details below)
Lancaster University legal liability cover will apply.
Please enclose a copy of relevant documents.
A76-2. What arrangements will be made for insurance and/ or indemnity to meet the potential legal liability of the
sponsor(s) or employer(s) for harm to participants arising from the design of the research?  Please tick box(es) as
applicable.
Note: Where researchers with substantive NHS employment contracts have designed the research, indemnity is provided
through NHS schemes. Indicate if this applies (there is no need to provide documentary evidence). For other protocol
authors (e.g. company employees, university members), please describe the arrangements and provide evidence.
 NHS indemnity scheme will apply (protocol authors with NHS contracts only)
 Other insurance or indemnity arrangements will apply (give details below)
Lancaster University legal liability cover will apply.
Please enclose a copy of relevant documents.
A76-3. What arrangements will be made for insurance and/ or indemnity to meet the potential legal liability of






Note: Where the participants are NHS patients, indemnity is provided through the NHS schemes or through professional
indemnity. Indicate if this applies to the whole study (there is no need to provide documentary evidence). Where non-NHS
sites are to be included in the research, including private practices, please describe the arrangements which will be made at
these sites and provide evidence.
 NHS indemnity scheme or professional indemnity will apply (participants recruited at NHS sites only)
 Research includes non-NHS sites (give details of insurance/ indemnity arrangements for these sites below)
Please enclose a copy of relevant documents.
A78. Could the research lead to the development of a new product/process or the generation of intellectual property?






 PART C: Overview of research sites 
Please enter details of the host organisations (Local Authority, NHS or other) in the UK that will be responsible for the
research sites.   For further information please refer to guidance.
Investigator






















 PART D: Declarations
D1. Declaration by Chief Investigator
1. The information in this form is accurate to the best of my knowledge and belief and I take full responsibility for
it.   
2. I undertake to abide by the ethical principles underlying the Declaration of Helsinki and good practice
guidelines on the proper conduct of research.
3. If the research is approved I undertake to adhere to the study protocol, the terms of the full application as
approved and any conditions set out by review bodies in giving approval.
4. I undertake to notify review bodies of substantial amendments to the protocol or the terms of the approved
application, and to seek a favourable opinion from the main REC before implementing the amendment.
5. I undertake to submit annual progress reports setting out the progress of the research, as required by review
bodies.
6. I am aware of my responsibility to be up to date and comply with the requirements of the law and relevant
guidelines relating to security and confidentiality of patient or other personal data, including the need to register
when necessary with the appropriate Data Protection Officer. I understand that I am not permitted to disclose
identifiable data to third parties unless the disclosure has the consent of the data subject or, in the case of
patient data in England and Wales, the disclosure is covered by the terms of an approval under Section 251 of
the NHS Act 2006.
7. I understand that research records/data may be subject to inspection by review bodies for audit purposes if
required.
8. I understand that any personal data in this application will be held by review bodies and their operational
managers and that this will be managed according to the principles established in the Data Protection Act
1998.
9. I understand that the information contained in this application, any supporting documentation and all
correspondence with review bodies or their operational managers relating to the application:
Will be held by the REC (where applicable) until at least 3 years after the end of the study; and by NHS
R&D offices (where the research requires NHS management permission) in accordance with the NHS
Code of Practice on Records Management.
May be disclosed to the operational managers of review bodies, or the appointing authority for the REC
(where applicable), in order to check that the application has been processed correctly or to investigate
any complaint.
May be seen by auditors appointed to undertake accreditation of RECs (where applicable).
Will be subject to the provisions of the Freedom of Information Acts and may be disclosed in response
to requests made under the Acts except where statutory exemptions apply.
May be sent by email to REC members.
10. I understand that information relating to this research, including the contact details on this application, may be
held on national research information systems, and that this will be managed according to the principles
established in the Data Protection Act 1998.   
11. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I
understand that the summary of this study will be published on the website of the National Research Ethics
Service (NRES), together with the contact point for enquiries named below. Publication will take place no earlier
than 3 months after issue of the ethics committee’s final opinion or the withdrawal of the application.   
Contact point for publication(Not applicable for R&D Forms)
NRES would like to include a contact point with the published summary of the study for those wishing to seek further










 Other – please give details
 None
Access to application for training purposes (Not applicable for R&D Forms)
Optional – please tick as appropriate: 
 I would be content for members of other RECs to have access to the information in the application in confidence
for training purposes. All personal identifiers and references to sponsors, funders and research units would be
removed.   
This section was signed electronically by Miss Rebecca Mayor on 14/12/2016 16:10.








D2. Declaration by the sponsor's representative
If there is more than one sponsor, this declaration should be signed on behalf of the co−sponsors by a representative
of the lead sponsor named at A64-1.
I confirm that:
1. This research proposal has been discussed with the Chief Investigator and agreement in principle to
sponsor the research is in place.
2. An appropriate process of scientific critique has demonstrated that this research proposal is worthwhile and
of high scientific quality.
3. Any necessary indemnity or insurance arrangements, as described in question A76, will be in place before
this research starts. Insurance or indemnity policies will be renewed for the duration of the study where
necessary.
4. Arrangements will be in place before the study starts for the research team to access resources and support
to deliver the research as proposed.
5. Arrangements to allocate responsibilities for the management, monitoring and reporting of the research will
be in place before the research starts.
6. The duties of sponsors set out in the Research Governance Framework for Health and Social Care will be
undertaken in relation to this research.
Please note: The declarations below do not form part of the application for approval above. They will not be
considered by the Research Ethics Committee.   
7. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I
understand that the summary of this study will be published on the website of the National Research Ethics
Service (NRES), together with the contact point for enquiries named in this application. Publication will take
place no earlier than 3 months after issue of the ethics committee's final opinion or the withdrawal of the
application.   
8. Specifically, for submissions to the Research Ethics Committees (RECs) I declare that any and all clinical
trials approved by the HRA since 30th September 2013 (as defined on IRAS categories as clinical trials of
medicines, devices, combination of medicines and devices or other clinical trials) have been registered on a
publically accessible register in compliance with the HRA registration requirements for the UK, or that any
deferral granted by the HRA still applies. 
This section was signed electronically by An authorised approver at ethics@lancaster.ac.uk on 03/01/2017 14:45.








D3. Declaration for student projects by academic supervisor(s)
1. I have read and approved both the research proposal and this application. I am satisfied that the scientific content
of the research is satisfactory for an educational qualification at this level.
2. I undertake to fulfil the responsibilities of the supervisor for this study as set out in the Research Governance
Framework for Health and Social Care.
3. I take responsibility for ensuring that this study is conducted in accordance with the ethical principles underlying
the Declaration of Helsinki and good practice guidelines on the proper conduct of research, in conjunction with
clinical supervisors as appropriate.
4. I take responsibility for ensuring that the applicant is up to date and complies with the requirements of the law and
relevant guidelines relating to security and confidentiality of patient and other personal data, in conjunction with
clinical supervisors as appropriate.
Academic supervisor 1 
This section was signed electronically by jane simpson on 14/12/2016 16:51. 
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CLINICAL AND SCIENTIFIC JUSTIFICATION 
Seizures 
Epilepsy is a group of neurological diseases characterised by the presence of 
epileptic seizures (Fisher et al., 2014). Epileptic seizures are short interruptions to the 
normal electrical functioning of the brain (Altrup, Elger & Reuber, 2009). There are several 
types of epileptic seizure which range from alterations in consciousness, to collapsing and 
shaking of the whole body.  
Difficulties of seizure experiences 
High levels of psychological distress have been described in people who experience 
seizures, including people with a diagnosis of epilepsy (Beyenburg et al., 2005; Hoppe & 
Elger, 2011). It has been reported that the rates of people diagnosed with mood and anxiety 
disorders are two or three times higher in people with epilepsy than in the general population 
(Tellez-Zenteno et al., 2007) and that the number of people who report symptoms of 
depression may be as high as 50-55% in people with epilepsy (Boylan et al., 2004; Mendez 
et al., 1986).  Experiencing seizures and psychological distress has been shown to have a 
negative impact on emotional, physical and social functioning and thus people with seizures 
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often experience poorer quality of life, (Reuber, Pukrop, Mitchell, Bauer, & Elger, 2003; 
Verrotti et al 2014).  
A number of qualitative studies have considered the impact of seizures on people’s 
lives, including psychological and social functioning. One qualitative study looking at the 
impact of epilepsy and associated cognitive difficulties reported themes of living with the 
condition as affecting the whole of the person, impacting on a variety of factors including 
self-esteem and relationships (Gauffin et al., 2011). Other qualitative studies have reported 
epilepsy being associated with emotions including anger, frustration, low mood, 
embarrassment and worry (Kerr et al., 2011) as well as feelings of shame and guilt (Chung 
et al., 2012 People with epilepsy are known to be more avoidant of social situations (Kilinc & 
Campbell, 2009). People with seizures, have also reported feelings of shame, stigma, 
prejudice and embarrassment (Raty, & Wilde-Larsson, 2011).  
Disgust and Self-Disgust 
One potential, yet under-researched, emotion relevant to the experience of seizures 
is disgust. Disgust is a universal human emotion (Ekman, 1999). A psychological model of 
disgust has been proposed which describes four categories of disgust elicitors and the 
functions (Rozin, Haidt, & McCauley, 2008). These include core elicitors such as food and 
body waste products (e.g., faeces, vomit, urine) which protect us from harm and disease; 
animal-nature elicitors such as sex, death and hygiene that protect our soul and mortality; 
interpersonal disgust such as through contact with contaminated others; and moral disgust 
elicited by moral violations which protect our social status.  
The concept of disgust was for many years neglected in psychological research., 
More recently, however disgust has been increasingly investigated in a range of mental 
health conditions, including schizophrenia, obsessive-compulsive disorder and depression 
(Olatunji & McKay, 2007). The interest in discrete emotions, such as disgust, has also 
extended to health research (Consedine & Moscowitz, 2007).   
However, research into self–disgust, disgust directed at oneself, is still in its infancy 
within psychology. Self-disgust has been described as a “harsher” version of shame but 
distinct from low self-esteem (Simpson et al, 2010) and more recently, self-disgust has been 
proposed as a distinct emotional schema, involving both disgust-based feelings and 
cognitive elements. Self-disgust has been found to correlate with disgust, through high 
concurrent validity recorded between the Self-Disgust Scale (Overton, Markland, Taggart, 
Bagshaw, & Simpson, 2008) and the Disgust Sensitivity Scale (Haidt, McCauley, & Rozin, 
1994).  
Increased interest into self-disgust has led to identification of the emotion in other 
populations, including people with depression (Powell et al., 2013), eating disorders (Fox, 
2009), and social anxiety (Amir, Najmi, Bomyea, & Burns, 2010). But the concept of self-
disgust and its role in adaptation to physical health conditions is in its infancy. It has been 
suggested that self-disgust in physical health conditions might have both beneficial and 
detrimental effects on outcomes (Powell et al., 2015) and there is therefore the potential for 
further exploration of this relationship.  
Historically epilepsy has been associated with a range of misconceptions and myths 
(International League Against Epilepsy (ILAE), 2003). For example, a number of religions 
have considered those who experienced seizures as being possessed and that epilepsy was 
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caused by an “unclean dumb and deaf spirit” (p. 12) or that people with epilepsy were 
contagious and infectious. The symptoms of seizures may therefore be relevant to all of the 
disgust categories described above. Individuals who experience epileptic seizures may 
potentially have to confront a range of disgust-inducing stimuli, including, being perceived as 
contaminating, being sick or vomiting, bladder and bowel problems and being socially 
stigmatised.   
Summary 
The symptoms associated with seizures and the already recognised emotions and 
concerns reported by people seizures may therefore suggest that self-disgust may be worthy 
of investigation in this population. In those who report experiencing symptoms of self-
disgust, a qualitative methodology will allow for a richer understanding of this currently 
unrecognised concept. Such research may help establish what emotions may be relevant for 
people who experience seizures and which psychological factors to consider during 
psychological therapeutic interventions in order to relieve distress and improve quality of life 
in these individuals. Using a qualitative methodology, the current study will therefore aim to 
consider whether people with seizures experience self-disgust and if so, what their 
experiences of this are. 
METHODS 
DESIGN 
Semi-structured qualitative interviews will be conducted with up to 12 participants. This should 
allow for a sufficient number of participants in order to address the research question using 
the methodology used and is in line with published research projects in this population using 
a similar research methodology (O’Toole, Lambert, Gallagher, Shahwan, & Austin, 2016).  
Participants in this study will be recruited by a researcher from Lancaster University. Interviews 
will be held in a location of the participant’s choosing or over the phone.  
PARTICIPANTS 
i) Identification of participants
Participants will be identified through two sources. Either by a member of the Neurology care
team in one of the participating centres or through an epilepsy charity.
ii) Inclusion Criteria
a) Participants must have received a clinical diagnosis of epilepsy from a neurologist.
b) Participants must have experienced an epileptic seizure within the past 12 months
c) Participants must be over the age of 16.
iii) Exclusion Criteria
a) Communication or learning problems of sufficient severity to prevent from providing
informed consent to take part in the study.
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b) Communication or learning problems of sufficient severity to reduce participants' ability to
take part in a semi-structured interview.
c) Non-English speakers
MEASURES 
In order to identify people who experience seizures and who have also experienced 
feelings of self-disgust, people who experience epileptic seizures will be asked to complete 
a self-rated measure of self-disgust, the Self Disgust Rating Scale (SDS, Powell, Simpson, 
& Overton, 2015). 
PROCEDURE 
Potential participants will be approached via two sources - either by a member of their 
neurology care team or through an epilepsy charity.  
Participants attending neurology clinics will be informed about a research study. If they 
are interested, they will be provided with a study pack (containing an information sheet, 
consent form and a measure of self-disgust). Participants will be asked whether they agree to 
be contacted by the researcher to discuss the research in more detail and an opportunity to 
ask any questions. The neurologist will ask participants to complete the ‘Consent to Contact’ 
form. At this stage participants are only agreeing to be contacted by the researcher to hear 
more about the study.  
The researcher will then contact participants at their stated preferred time of day. They will 
explain more about the study and answer the participant’s questions. Participants can then 
choose whether they would like to take part in the study. They can complete the study pack 
(consent form and questionnaire) provided by the neurologist and return these to the 
researcher or can complete these online.  
Those recruited through the epilepsy charity will be informed about the research study. 
They will be directed towards a weblink which will provide further information about the study 
and contact details for the researcher should they wish to hear more about the study. The 
researcher will explain more about the study and answer the participant's questions. Those 
who wish to take part can complete the self-disgust questionnaire and consent form. 
All participants will be made aware that a proportion of participants may be invited to further 
take part in an in-depth qualitative interview.  
Participants will be asked to provide contact detail at the time of consent so that the those 
who are selected to take part in an interview can be contacted by the researcher to invite them 
to this. Participants who score highly on the SDS will be invited to attend for an in depth 
interview with the researcher. A convenient time and place to attend will be arranged. 
Alternatively, participants may choose to take part in a telephone interview.  
DATA ANALYSIS 
Interviews will be recorded and transcribed verbatim. The data will be analysed using 
Thematic Analysis. Thematic analysis is a frequently used method of qualitative analysis 
within psychology (Braun & Clarke, 2006).  It allows for themes to be directly identified from 
the data (Fereday & Muir-Cochrane, 2008) and for patterns of data referring to particular 
phenomena and relevant to a specific research question to be summarised (Daly, Kellehear, 
& Gliksman, 1997).  Thematic analysis is therefore a useful method of data analysis when 
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exploring people’s experiences of novel phenomenon. Thematic analysis was therefore 
chosen as the most appropriate methodology for the current study. 
Based on the Braun and Clark (2006) model, the data will be analysed to identify, 
analyse and report patterns (themes) within the data that are associated with the research 
question. This model of qualitative analysis involves 6 phases: 1. Familiarising with the data. 
2. Generating initial codes. 3. Searching for themes. 4. Reviewing Themes. 5. Defining and
naming themes. 6. Producing the report. As part of this model a reflexive journal will also be
kept to track reflections of interviews and analysis which will be incorporated in to the final
reporting of the study.
PRACTICAL ISSUES 
PROJECT MANAGEMENT 
The research will be conducted as a basis for a postgraduate degree (DCinPsy) for 
Rebecca Mayor (Lancaster University) under the supervision of Dr Jane Simpson (Lancaster 
University) and ). 
PROJECT PLAN 
The study will be carried out over 10 months.   
Months 1-3: Ethics and Research Governance approval 
Months 4-6: Recruitment of participants. 
Months 5-7: Transcription and data analysis 
Months 8-9: Write-up 
EXPERTISE OF RESEARCH TEAM 
 has many years of clinical experience with this patient group and has 
conducted and published a large number of studies in this area, including DClinPsy projects. 
Rebecca Mayor has conducted multiple studies within this patient group in the last few years 
and is familiar with qualitative research. Dr Jane Simpson is experienced in supervising 
DClinPsy thesis projects, has published a large number of studies in psychological research 
and has particular interests in the subject area of self-disgust.   
ETHICAL CONSIDERATIONS 
Risk to participants 
This study has been designed to expose participants to minimal risk. The measure of 
self-disgust may lead participants to think about difficult emotions, however, information will 
be provided on where they might access further support for this. The interview schedule has 
been designed to minimise the potential for distress in participants. Should participants 
become distressed during the interview, the interview will be halted and participants will be 
given time to recover. Participants will be asked if they wish to continue and information about 
how to access further support will be provided.    
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The interviews will be conducted by an experienced researcher who will be familiar 
with this particular patient group (Rebecca Mayor). The researcher is a Trainee Clinical 
Psychologist who is experienced in working with people who are distressed. 
Consent 
Participants recruited by their neurologist will be asked to complete a ‘Consent to 
Contact’ form agreeing to be contacted by the researcher to hear more about the study. They 
are only agreeing to hear more about the study at this stage.  
Participants will be provided with a Participant Information Sheet, consent form and 
questionnaire. After speaking to the researcher, if they choose to take part in the research 
they can return the consent form and questionnaire to the researcher or do this online.  Online 
participants will be asked to complete the consent form and questionnaire online.  
All participants will have the researcher’s contact details should they wish to discuss 
the study or ask questions before giving their informed consent to participate in the study. 
They will be informed that they may withdraw this consent at any time without any effect on 
their care. Only participants who are able to provide informed consent will be included in the 
study.  
Data Storage 
All paper data will be stored in a lockable filing cabinet with access only to the researcher. 
Electronic data will be stored securely on a personal space on the Lancaster University server 
via virtual private network. Files will be password-protected as an additional security measure. 
Interviews will be audio recorded using a digital recorder. All data will be transferred to a 
personal space on the Lancaster University server via virtual private network and then deleted 
from the device as soon as possible following transcription. 
All identifiable information will be kept separately from self-report and interview data. 
Participants will be allocated a participant number and self-report forms will only be identifiable 
by this number. The interviews will be transcribed for qualitative analysis. All names will be 
replaced with pseudonyms during the transcription process and only anonymised quotes would 
be used in publications resulting from the qualitative analysis. 
At the end of the study data (consent forms, interview transcripts and any coded data 
produced during analysis) will be transferred electronically using a secure method that is 
supported by the University for long term storage on the Lancaster University secure server. 
Documents will be encrypted and password protected. Long term electronic storage of the 
encrypted and password protected data will be kept for 10 years by Lancaster University. Access 
will only be granted to the Lancaster University DClinPsy admin team. 
DISSEMINATION OF RESULTS 
The write-up of this project will be submitted towards a postgraduate degree (DClinPsy) 
for Rebecca Mayor. It is hoped that the results of this study will be submitted for publication in a 
peer reviewed scientific journal to improve dissemination to the wider public. Participants will 
also be invited to receive a summary of the results of the study if they wish.  
COSTING AND FUNDING 
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This study is supported by Lancaster University. Participants will be offered travel 
expenses for attending interviews. Stationary and postage costs will also be supported.  
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M1 3DZ 
Telephone: 0207 104 8021 
24 March 2017 
Miss Rebecca Mayor 
Trainee Clinical Psychologist 
Lancashire Social Care Trust  
Clinical Psychology, Division of Health Research 
Furness College, Lancaster University 
Lancaster 
LA1 4YT 
Dear Miss Mayor 
Study title: An exploration of the experiences of difficult emotions 
in people with seizures 
REC reference: 17/NW/0088 
IRAS project ID: 211769 
Thank you for your submission.  I can confirm the REC has received the documents listed below 
and that these comply with the approval conditions detailed in our letter dated 13 February 2017 
Documents received 
The documents received were as follows: 
Document Version Date 
Covering letter on headed paper [Response] 20 February 2017 
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Indemnities]  
01 August 2016 
Interview schedules or topic guides for participants [Interview Guide]  2 14 December 2016 
Letter from sponsor [Sponsor Letter] 03 January 2017 
Letters of invitation to participant [Invite/ Consent to contact] v2 14 December 2016 
Other [Debrief] 1 16 February 2017 
Participant consent form [Consent NHS/Online] 2 16 February 2017 
Participant information sheet (PIS) [PIS NHS/Online] 3 16 February 2017 
Validated questionnaire [Demographic/SDRS] 2 14 December 2016 
Approved documents 
The final list of approved documentation for the study is therefore as follows: 
Document Version Date 
Covering letter on headed paper [Response] 20 February 2017 
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only)  
01 August 2016 
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Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Indemnities]  
01 August 2016 
Interview schedules or topic guides for participants [Interview Guide]  2 14 December 2016 
IRAS Application Form [IRAS_Form_03012017] 03 January 2017 
IRAS Checklist XML [Checklist_03012017] 03 January 2017 
Letter from sponsor 03 January 2017 
Letter from sponsor [Sponsor Letter] 03 January 2017 
Letters of invitation to participant [Invite/ Consent to contact] v2 14 December 2016 
Other [Debrief] 1 16 February 2017 
Participant consent form [Consent NHS/Online] 2 16 February 2017 
Participant information sheet (PIS) [PIS NHS/Online] 3 16 February 2017 
Referee's report or other scientific critique report [Peer review] 23 February 2016 
Research protocol or project proposal [Protocol] 2 14 December 2016 
Summary CV for Chief Investigator (CI) 
Summary CV for supervisor (student research) 
Validated questionnaire [Demographic/SDRS] 2 14 December 2016 
You should ensure that the sponsor has a copy of the final documentation for the study.  It is the 
sponsor's responsibility to ensure that the documentation is made available to R&D offices at all 
participating sites. 
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Miss Rebecca  Mayor 
Trainee Clinical Psychologist 
Lancashire Social Care Trust  
Clinical Psychology, Division of Health Research 




07 April 2017 
Dear Miss Mayor 
Study title: An exploration of the experiences of difficult emotions in 
people with seizures 
IRAS project ID: 211769  
REC reference: 17/NW/0088   
Sponsor Lancaster University  
I am pleased to confirm that HRA Approval has been given for the above referenced study, on the 
basis described in the application form, protocol, supporting documentation and any clarifications 
noted in this letter.  
Participation of NHS Organisations in England  
The sponsor should now provide a copy of this letter to all participating NHS organisations in England.  
Appendix B provides important information for sponsors and participating NHS organisations in 
England for arranging and confirming capacity and capability. Please read Appendix B carefully, in 
particular the following sections: 
 Participating NHS organisations in England – this clarifies the types of participating
organisations in the study and whether or not all organisations will be undertaking the same
activities
 Confirmation of capacity and capability - this confirms whether or not each type of participating
NHS organisation in England is expected to give formal confirmation of capacity and capability.
Where formal confirmation is not expected, the section also provides details on the time limit
given to participating organisations to opt out of the study, or request additional time, before
their participation is assumed.
 Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment
criteria) - this provides detail on the form of agreement to be used in the study to confirm
capacity and capability, where applicable.
Further information on funding, HR processes, and compliance with HRA criteria and standards is also 
provided. 
Letter of HRA Approval 
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It is critical that you involve both the research management function (e.g. R&D office) supporting each 
organisation and the local research team (where there is one) in setting up your study. Contact details 
and further information about working with the research management function for each organisation 
can be accessed from www.hra.nhs.uk/hra-approval.  
Appendices 
The HRA Approval letter contains the following appendices: 
 A – List of documents reviewed during HRA assessment
 B – Summary of HRA assessment
After HRA Approval 
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your REC 
favourable opinion, gives detailed guidance on reporting expectations for studies, including:  
 Registration of research
 Notifying amendments
 Notifying the end of the study
The HRA website also provides guidance on these topics, and is updated in the light of changes in 
reporting expectations or procedures. 
In addition to the guidance in the above, please note the following:  
 HRA Approval applies for the duration of your REC favourable opinion, unless otherwise
notified in writing by the HRA.
 Substantial amendments should be submitted directly to the Research Ethics Committee, as
detailed in the After Ethical Review document. Non-substantial amendments should be
submitted for review by the HRA using the form provided on the HRA website, and emailed to
hra.amendments@nhs.net.
 The HRA will categorise amendments (substantial and non-substantial) and issue confirmation
of continued HRA Approval. Further details can be found on the HRA website.
Scope 
HRA Approval provides an approval for research involving patients or staff in NHS organisations in 
England.  
If your study involves NHS organisations in other countries in the UK, please contact the relevant 
national coordinating functions for support and advice. Further information can be found at 
http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/. 
If there are participating non-NHS organisations, local agreement should be obtained in accordance 
with the procedures of the local participating non-NHS organisation. 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the application 
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procedure. If you wish to make your views known please use the feedback form available on the HRA 
website: http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/. 
HRA Training 
We are pleased to welcome researchers and research management staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/  
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Appendix A - List of Documents 
The final document set assessed and approved by HRA Approval is listed below. 
 Document Version Date 
Contract/Study Agreement [SoA/SoE exemption] 29 November 2016 
Covering letter on headed paper [Response] 20 February 2017 
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only)  
01 August 2016 
Interview schedules or topic guides for participants [Interview Guide] 2 14 December 2016 
IRAS Application Form [IRAS_Form_03012017] 03 January 2017 
IRAS Application Form XML file [IRAS_Form_03012017] 03 January 2017 
IRAS Checklist XML [Checklist_03032017] 03 March 2017 
Letter from sponsor [Sponsor Letter] 03 January 2017 
Letters of invitation to participant [Invite/ Consent to contact] v2 14 December 2016 
Other [Debrief] 1 16 February 2017 
Participant consent form [NHS/Online] 3 05 April 2017 
Participant information sheet (PIS) [NHS/Online] 4 05 April 2017 
Research protocol or project proposal [Protocol] 2 14 December 2016 
Summary CV for Chief Investigator (CI) 
Summary CV for supervisor (student research) 
Validated questionnaire [Demographic/SDRS] 2 14 December 2016 
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Appendix B - Summary of HRA Assessment 
This appendix provides assurance to you, the sponsor and the NHS in England that the study, as 
reviewed for HRA Approval, is compliant with relevant standards. It also provides information and 
clarification, where appropriate, to participating NHS organisations in England to assist in assessing 
and arranging capacity and capability. 
For information on how the sponsor should be working with participating NHS organisations in 
England, please refer to the, participating NHS organisations, capacity and capability and 
Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) sections in this appendix.  
The following person is the sponsor contact for the purpose of addressing participating organisation 
questions relating to the study: 
Name: Diane Hopkins 
Tel: 01524 592838 
Email: d.hopkins@lancaster.ac.uk 
HRA assessment criteria 
Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
1.1 IRAS application completed 
correctly 
Yes HRA Approval will only cover research 
activities at the NHS organisation. 
2.1 Participant information/consent 
documents and consent 
process 
Yes The participant information sheet and 
consent form have been updated to 
bring them in line with HRA Approval 
standards via a minor amendment. 
3.1 Protocol assessment Yes No comments 
4.1 Allocation of responsibilities 
and rights are agreed and 
documented  
Yes The participating Trust has confirmed 
that they do not require a Statement of 
Activities and Schedule of Events to be 
completed for this study. 
4.2 Insurance/indemnity 
arrangements assessed 
Yes Where applicable, independent 
contractors (e.g. General Practitioners) 
should ensure that the professional 
indemnity provided by their medical 
defence organisation covers the 
activities expected of them for this 
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4.3 Financial arrangements 
assessed  
Yes No application for external funding 
made. No funds will be provided to the 
participating organisation to support this 
study. 
5.1 Compliance with the Data 
Protection Act and data 
security issues assessed 
Yes No comments 
5.2 CTIMPS – Arrangements for 
compliance with the Clinical 
Trials Regulations assessed 
Not Applicable No comments 
5.3 Compliance with any 
applicable laws or regulations 
Yes No comments 
6.1 NHS Research Ethics 
Committee favourable opinion 
received for applicable studies 
Yes Favourable Opinion with conditions 
issued 13 February 2017. Favourable 
Opinion with conditions met issued 24 
March 2017 
6.2 CTIMPS – Clinical Trials 
Authorisation (CTA) letter 
received 
Not Applicable No comments 
6.3 Devices – MHRA notice of no 
objection received 
Not Applicable No comments 
6.4 Other regulatory approvals 
and authorisations received 
Not Applicable No comments 
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Participating NHS Organisations in England 
This provides detail on the types of participating NHS organisations in the study and a statement as to whether 
the activities at all organisations are the same or different. 
This is a non-commercial student (Doctorate in Clinical Psychology (DClinPsy)) and there is one site 
type. 
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
organisations in England in order to put arrangements in place to deliver the study. The documents 
should be sent to both the local study team, where applicable, and the office providing the research 
management function at the participating organisation. For NIHR CRN Portfolio studies, the Local 
LCRN contact should also be copied into this correspondence.  For further guidance on working with 
participating NHS organisations please see the HRA website. 
If chief investigators, sponsors or principal investigators are asked to complete site level forms for 
participating NHS organisations in England which are not provided in IRAS or on the HRA website, 
the chief investigator, sponsor or principal investigator should notify the HRA immediately at 
hra.approval@nhs.net. The HRA will work with these organisations to achieve a consistent approach 
to information provision.  
Confirmation of Capacity and Capability 
This describes whether formal confirmation of capacity and capability is expected from participating NHS 
organisations in England. 
The HRA has determined that participating NHS organisations in England are not expected to 
formally confirm their capacity and capability to host this research.  
 The HRA has informed the relevant research management offices that you intend to
undertake the research at their organisation. However, you should still support and liaise with
these organisations as necessary.
 Following issue of the Letter of HRA Approval the sponsor may commence the study at these
organisations when it is ready to do so.
 The document “Collaborative working between sponsors and NHS organisations in England
for HRA Approval studies, where no formal confirmation of capacity and capability is
expected” provides further information for the sponsor and NHS organisations on working
with NHS organisations in England where no formal confirmation of capacity and capability is
expected, and the processes involved in adding new organisations. Further study specific
details are provided the Participating NHS Organisations and Allocation of responsibilities and
rights are agreed and documented (4.1 of HRA assessment criteria) sections of this
Appendix.
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Principal Investigator Suitability 
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is correct for each 
type of participating NHS organisation in England and the minimum expectations for education, training and 
experience that PIs should meet (where applicable). 
No PI or LC is expected at the participating organisation. 
GCP training is not a generic training expectation, in line with the HRA statement on training 
expectations. 
HR Good Practice Resource Pack Expectations 
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-engagement checks 
that should and should not be undertaken 
Where arrangements are not already in place, network staff (or similar) undertaking any research 
activities that may impact on the quality of care of the participant, would be expected to obtain an 
honorary research contract from one NHS organisation (if university employed), followed by Letters 
of Access for subsequent organisations. This would be on the basis of a Research Passport (if 
university employed) or an NHS to NHS confirmation of pre-engagement checks letter (if NHS 
employed). These should confirm enhanced DBS checks, including appropriate barred list checks, 
and occupational health clearance. For research team members undertaking activities that do not 
impact on the quality of care of the participant (for example, administering questionnaires), a Letter of 
Access based on standard DBS checks and occupational health clearance would be appropriate. 
Other Information to Aid Study Set-up 
This details any other information that may be helpful to sponsors and participating NHS organisations in 
England to aid study set-up. 
The applicant has indicated that they do not intend to apply for inclusion on the NIHR CRN Portfolio. 
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Research Study Title: Experiences of difficult emotions in people with seizures 
I and my colleagues at Lancaster University and the  are conducting a new 
research study. This study will be part of my Doctorate in Clinical Psychology. 
We would like to invite you to take part in the research study we are currently conducting into the 
experiences of certain emotions in people who experience seizures.  Before you decide whether to 
take part you need to understand why the research is being done and what it would involve for you. 
Please take the time to read the following information carefully. Please do not hesitate to contact us 
with your questions, contact details are below. 
What is the purpose of the study? 
People who experience seizures may experience a range of distressing emotions including worry, 
sadness, anger and shame. These can lead to people experiencing distress and may impact on their 
quality of life. People who have seizures may also experience other emotions which have not yet 
been researched. One of these emotions is self-disgust. By better understanding the relationship 
between seizures and certain emotions, such as self-disgust it may be possible to develop more 
effective treatments, such as psychological interventions. For this reason we would like to explore 
the emotion of self-disgust in people who experience seizures 
Who can take part? 
You are eligible to take part in this study if you: 
 Have received a clinical diagnosis of epilepsy from a neurologist
 Experienced an epileptic seizure in the last 12 months
 Are over the age of 16
 Are English speaking or able to complete a questionnaire and interview in English
 You are able to provide informed consent to take part in the study.
Do I have to take part? 
Your involvement in this study is entirely voluntary. We would like you to read this information sheet 
and think about what it would mean to you to take part. If you decide you would like to take part, 
you can complete the questionnaire included with this information, sign the consent form and 
return these to the researcher. You may contact the researcher should you have any questions and 
who can explain more about the study to you. 
If you agree to take part in this study you are free to withdraw at any time without giving reason. 
This will not affect any care that you might otherwise be receiving. 
What will happen if I decide to take part? 
If you decide to take part in the study you will also need to sign a consent form saying that you agree 
to take part. You will then be asked to complete a questionnaire. This is a measure of feelings of self-
disgust.  
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Approximately 12 of the participants who score high on this questionnaire, will then be invited to 
attend for a one-to-one interview with the researcher (Rebecca Mayor) to discuss their experiences 
of self-disgust in more detail. This can be in person or over the phone, whichever suits you best.   
Participants who score low on the questionnaire will not be asked to take part in an interview. This is 
because this study is interested in hearing more from people who experience feelings of self-disgust. 
Data received from participants who score low on the questionnaire and are not invited to interview 
will not be used in the study and all information provided will be destroyed.  
What will I have to do? 
We ask that you read this information carefully. If you would like to hear more about the study or 
ask questions then you can contact the researcher to discuss this on 07508406193 or via email 
rmayor@lancaster.ac.uk 
If you decide that you would like to take part in the study you can sign the consent form, complete 
the questionnaire and return these to the researcher in the envelope provided. Postage has already 
been paid. Alternatively, you can complete the questionnaire and consent form online. You need 
only complete the paper version OR online version. To access the online version of the questionnaire 
please use the following web address 
https://eu.qualtrics.com/jfe/form/SV_bqp0Gp5Ava3lGEB 
If you are selected to take part in an interview the researcher will contact you to discuss this and 
arrange a convenient time for this. The interview can be done in person or over the phone. The 
interview is expected to last around 1 hour. The researcher will ask you more about your 
experiences of having seizures, your emotions and responses to the questionnaire. 
If you are not selected for interview you will be notified of this within 4 weeks of you consenting to 
take part in the study.  
What are the possible disadvantages and risks of taking part? 
There are minimal risks to taking part in this study. For some people, thinking or talking about 
emotions can be difficult. Should you feel distressed by any of the information you have read then 
talking to someone may help. You may wish to visit your GP to access support. Alternatively, a list of 
possible organisations who offer support is at the end of this information.  
The interview will be conducted by a trainee clinical psychologist who is familiar with talking to 
people who might be upset or who have had similar experiences. Should you find the interview 
distressing you would have the opportunity to discuss this with the researcher and the option to 
stop the interview. The researcher will also be able to provide you with information about how to 
access further support.  
What are the possible benefits to taking part? 
We cannot promise that this study will help you but we hope that the information we get from this study will 
help to inform our understanding of emotions in people with seizures which may inform the development of 
support offered to people who may experience similar difficulties in the future.  
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What will happen to my data? 
Your personal details and other information that you have provided will be stored electronically on 
the secure Lancaster University  server. Paper documents (such as consent forms and 
questionnaires) will be scanned and then destroyed as soon as possible and saved in the same way. 
Electronic files will be password protected as an additional security measure. Interviews will be 
audio recorded, transferred to a computer and transcribed.  
All electronic files will be transferred electronically using a secure method that is supported by the 
University for long term storage on the Lancaster University secure server for a maximum of 10 
years.   
What will happen to my data if I don’t want to carry on with the study? 
You may withdraw from the study without giving reason up until two weeks following an interview .  
If you decide to withdraw from the study before this time we will make all efforts to ensure that all 
data you have provided is destroyed and not used. This will not affect any care that you might 
otherwise be receiving. If you wish to withdraw from the study after longer than two weeks 
following interview we may not be able to remove the data you have provided from the study 
analysis.  
How long do I have to decide whether I want to take part? 
If you decide you would like to take part in the study please ensure you return the consent form and 
questionnaire enclosed with this information sheet as soon as possible. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the researcher who 
will do their best to answer your questions (Rebecca Mayor, tel: ). Alternatively, you may wish to 
speak to my supervisor Dr Jane Simpson - Director of Education: J.simpson2@lancaster.ac.uk, 
Telephone: 01524 592858 
If you remain unhappy and wish to complain formally, you may also contact: Professor Roger Pickup 
- Associate Dean for Research Email: r.pickup@lancaster.ac.uk Telephone: 01524 593746 Address:
Division of Biomedical and Life Science Faculty of Health and Medicine, Lancaster University
Lancaster, LA1 4YG, UK
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept strictly 
confidential. We will allocate you a study number so all the information that you provide us with will 
be anonymous and stored separately to your contact details. Electronic copies of the consent forms 
and questionnaires will be stored securely and will be destroyed after 10 years.   
Your name will be replaced with pseudonyms to make these anonymous during the transcription 
process and only anonymised quotes would be used in publications.  
Will you tell anyone else I have taken part? 
We will not routinely share your involvement with anyone else. However, if you share any 
information with the research team which leads us to worry about your, or someone else’s, safety, 
then we may be required to share this information in order to maximise safety. 
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Data collected during the study may occasionally be shared with the research team or members of 
the NHS Trust. However, only your study number will be shared. No identifiable information such as 
your name will be shared.  
What will happen to the results of the study?  
The results of the study will be summarised and written up to be used as part of academic work 
towards a postgraduate degree for the researcher (Rebecca Mayor). All information will be 
anonymous and no identifiable data will be used. The results of this study will also be published in a 
peer-reviewed journal (again, no identifiable information will be published). 
A shorter summary report will also be sent to the organisations which advertised the study. You may 
request a copy of this shorter report if you wish from the researcher.  
Who is sponsoring the research? 
This study is being sponsored by Lancaster University under the Research Governance Framework. 
Who has reviewed the study?  
All research in the NHS is looked at by an independent group of people, called a Research Ethics 
Committee to protect your safety, rights, wellbeing and dignity. This study has been reviewed and 
given favourable opinion by the xxx Research Ethics Committee. 
Further information and contact details 
You can contact Rebecca Mayor (email: r.mayor@lancaster.ac.uk or tel: 07508406193) if you have 
any questions about the research or want to discuss your involvement.  You may talk to others about 
the study if you wish. 
Possible sources of support 
Mind Website: http://www.mind.org.uk/ Telephone: 0300 123 3393  
Samaritans Website: http://www.samaritans.org/ Telephone: 08457 90 90 90 
Epilepsy Action: https://www.epilepsy.org.uk/ Telephone: 0808 800 5050 
Thank you for taking time to read this sheet and considering whether to take part in this study. 
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Experiences of the emotion of self-disgust in people with seizures 
Previous research has shown that how people feel about themselves can have important 
effects on their quality of life and even the outcome of health problems. Feelings such as 
anger, shame, guilt, worry may all be relevant. One emotion which has attracted attention 
recently is self-disgust. 
On behalf of the Lancaster University Clinical Psychology Doctorate programme, I am looking 
for participants to take part in a study looking into the experiences of certain emotions in people 
with seizures. In particular, this study will consider the emotion of self-disgust.   
Participation involves completing a short questionnaire and then the possibility of an in-depth 
interview with the researcher. Before deciding to take part you will have the opportunity to read 
some more detailed information about why the study is being done, who can take part and 
what it would involve for you.  
If you would be interested in hearing more about the study you are welcome to contact the 
researcher (Rebecca Mayor) by phone on xxx or email r.mayor@lancaster.ac.uk The 
researcher will explain the study to you and will answer your questions. 
Please follow this link for more information and to take part in the study 
 [insert link here] 
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Experiences of difficult emotions in people with seizures 
Previous research has shown that how people feel about themselves can have important 
effects on their quality of life and even the outcome of health problems. Feelings such as 
anger, shame, guilt, worry may all be relevant. One emotion which has attracted attention 
recently is self-disgust. On behalf of the Lancaster University Clinical Psychology Doctorate 
programme, I am looking for participants to take part in a study looking into the experiences 
of self-disgust in people with epilepsy.  
Participation involves completing a short questionnaire and then the possibility of an in-depth 
interview with the researcher. An information sheet is enclosed which provides you with 
more information about why the study is being done, whether you are eligible to take part 
and what it would involve for you. Please consider this information before deciding whether 
or not you would like to take part in this study.  
If you would be interested in hearing more about the study you can complete the ‘Consent to 
Contact’ form to receive a phone from me to hear more about the study. You can also 
welcome to contact me by phone on xxx or email r.mayor@lancaster.ac.uk if you have any 
further questions.  
If you would like to take part in the study you can complete the consent form and 
questionnaire and return these to me in the stamped addressed envelope (postage is 
already paid). Alternatively, you can complete these online by following the below link. [insert 
link here] You need only complete the paper OR online version of the consent form and 
questionnaire.  
Thank you for your time in considering this study. 
Kind Regards 
Rebecca Mayor 
Trainee Clinical Psychologist 
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CONSENT FORM 
Study Title: Experiences of difficult emotions in people with seizures 
Researcher: Rebecca Mayor 
If you wish to take part in the research study please initial and sign this form. 
Please initial each box 
1. I confirm that I have read and understand the Participant Information
Sheet Version (v4, 05/04/2017) and I have had the opportunity to
consider the information, ask questions and have had these answered
satisfactorily.
2. I understand that my participation is voluntary and that I am free to
withdraw from the study at any time without giving any reason. I
understand that this will not affect any care that I might be receiving.
3. I understand that the researcher has a professional responsibility to
share information I provide if they believe I am at risk of harming myself
or someone else in order to maximise safety.
4. I agree to take part in an interview which will be audio recorded and
transcribed for further analysis.
5. I agree that anonymised parts of the interview recording and transcript
can be used for publications and for educational purposes.
6. I understand that relevant sections of data collected during the study
may be looked at by members of the research team from Lancaster
University, regulatory authorities or representatives from the NHS Trust,
where it is relevant to my taking part in this research. I give permission
for these individuals to have access to my records.
7. I agree to take part in the research.
_______________  ________________ _________________ 
Name of participant Date   Signature  
_______________  ________________ _________________ 
Name of person taking consent Date   Signature  
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CONSENT FORM: ONLINE 
Study Title: Experiences of difficult emotions in people with seizures 
Researcher: Rebecca Mayor 
Before you consent to participating in this study we ask that you read the participant information 
provided. Please read the following statements and tick the box below if you are happy to take part 
in the study.
1. I confirm that I have read and understand the Participant Information Sheet Version 4,
05/04/2017 and I have had the opportunity to consider the information, ask questions and
have had these answered satisfactorily.
2. I understand that my participation is voluntary and that I am free to withdraw from the study
at any time without giving any reason. I understand that this will not affect any care that I
might be receiving.
3. I understand that the researcher has a professional responsibility to share information I
provide if they believe I am at risk of harming myself or someone else in order to maximise
safety.
4. I agree to take part in an interview which will be audio recorded and transcribed for further
analysis.
5. I agree that anonymised parts of the interview recording and transcript can be used for
publications and for educational purposes.




Age (in years): 
Sex:   Male  Female  Prefer not to say 
Contact telephone number: 
Contact email address: 
Diagnosis: (Please indicate if you received a diagnosis of epilepsy) 
How long ago did you receive this diagnosis? 
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The Self-Disgust Scale (SDS) 
This questionnaire is concerned with how you feel about yourself. When responding to the statements 
below, please circle the appropriate number according to the following definitions: 1 = Strongly 
disagree; 2 = Very much disagree; 3 = Slightly disagree; 4 = Neither agree nor disagree;  5 = Slightly 





1. I find myself repulsive. 1 2 3 4 5 6 7 
2. I am proud of who I am. 1 2 3 4 5 6 7 
3. The way I behave makes me despise myself 1 2 3 4 5 6 7 
4. I hate being me 1 2 3 4 5 6 7 
5. I enjoy the company of others. 1 2 3 4 5 6 7 
6. I like the way I look
1 2 3 4 5 6 7 
7. Overall, people dislike me
1 2 3 4 5 6 7 
8. I enjoy being outdoors 1 2 3 4 5 6 7 
9. I feel good about the way I behave
1 2 3 4 5 6 7 
10. I do not want to be seen
1 2 3 4 5 6 7 
11. I am a sociable person 1 2 3 4 5 6 7 
12. I often do things I find revolting
1 2 3 4 5 6 7 
13. Sometimes I feel happy
1 2 3 4 5 6 7 
14. I am an optimistic person
1 2 3 4 5 6 7 
15. It bothers me to look at myself
1 2 3 4 5 6 7 
16. Sometimes I feel sad 1 2 3 4 5 6 7 
17. I detest aspects of my personality
1 2 3 4 5 6 7 
18. My behavior repels people
1 2 3 4 5 6 7 
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Participant Debrief Sheet 
Research Study Title: Experiences of difficult emotions in people with seizures 
Thank you for completing the questionnaire and helping in this research study. We realise that some people can 
find some questions distressing. If you have been upset by the questionnaire and would like further support, the 
following organisations may be able to help you:  
Possible sources of support 
Samaritans Website: http://www.samaritans.org/ Telephone: 08457 90 90 90 (24 hour, Freephone) 
Mind Website: http://www.mind.org.uk/ Telephone: 0300 123 3393  
Epilepsy Action: https://www.epilepsy.org.uk/ Telephone: 0808 800 5050 
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